Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,neutrophil degranulation (GO:0043312),0.6389335894944159,3.2985932102087845,0.0,0.0,0.0,63/140,15.91%,RAC1;FTH1;RAP1A;RHOA;NDUFC2;B2M;PSMA2;CSNK2B;SRP14;PSMB1;GSTP1;PRDX6;ARPC5;COMMD3;RAP1B;DYNLL1;VAPA;PNP;TRAPPC1;GMFG;CSTB;ATP6V0C;CD47;COTL1;BRI3;GDI2;RHOG;TMEM179B;ACTR10;LAMTOR2;SDCBP;CTSB;ERP44;ATP6V1D;DEGS1;RAB18;ATP6AP2;GOLGA7;HMGB1;RAB10;GGH;LAMTOR1;CNN2;CTSC;SURF4;COPB1;CYBA;CAT;CAP1;CTSA;HEXB;PYCARD;VPS35L;GLB1;ITGB2;DERA;KCMF1;ASAH1;YPEL5;LTA4H;LAMTOR3;RAB4B;CYB5R3
gsea,neutrophil activation involved in immune response (GO:0002283),0.6377537837963027,3.2914432358974945,0.0,0.0,0.0,63/141,15.91%,RAC1;FTH1;RAP1A;RHOA;NDUFC2;B2M;PSMA2;CSNK2B;SRP14;PSMB1;GSTP1;PRDX6;ARPC5;COMMD3;RAP1B;DYNLL1;VAPA;PNP;TRAPPC1;GMFG;CSTB;ATP6V0C;CD47;COTL1;BRI3;GDI2;RHOG;TMEM179B;ACTR10;LAMTOR2;SDCBP;CTSB;ERP44;ATP6V1D;DEGS1;RAB18;ATP6AP2;GOLGA7;HMGB1;RAB10;GGH;LAMTOR1;CNN2;CTSC;SURF4;COPB1;CYBA;CAT;CAP1;CTSA;HEXB;PYCARD;VPS35L;GLB1;ITGB2;DERA;KCMF1;ASAH1;YPEL5;LTA4H;LAMTOR3;RAB4B;CYB5R3
gsea,cellular protein metabolic process (GO:0044267),0.7345214962147605,3.272319126490657,0.0,0.0,0.0,73/146,13.68%,RPS15A;SPCS1;RPL39;RPS7;RPS10;RPL27;RPS13;UBE2D3;UBE2I;UBL5;RPL29;RPL32;RPL30;MRPS33;MRPS14;RPL9;MRPS21;RPS24;RPL34;RPL36A;RPL23;MRPS36;NEDD8;PSENEN;RPL22;MRPS16;SHISA5;MRPS18C;RPS3;MRPL34;RPL35;RPS11;RPS4X;SPCS2;RPS9;RPS16;RPL27A;SEC11C;RPL12;RPL24;RPS20;SEC11A;RPL18;MRPL36;MRPL32;APH1A;RPS14;RPS23;MRPL24;RPLP2;RPS28;RPS21;MRPL23;MRPL52;PCMT1;RPL37;MRPS17;RPS27;RPL19;RPS5;MRPL10;RPL11;MRPL43;UBE2L3;MSRB1;MRPL41;MRPL27;FBXO22;RPL21;UBE2G1;RPS6;RPL17;LCMT1
gsea,neutrophil mediated immunity (GO:0002446),0.6314983347142266,3.2722105593585358,0.0,0.0,0.0,63/143,15.91%,RAC1;FTH1;RAP1A;RHOA;NDUFC2;B2M;PSMA2;CSNK2B;SRP14;PSMB1;GSTP1;PRDX6;ARPC5;COMMD3;RAP1B;DYNLL1;VAPA;PNP;TRAPPC1;GMFG;CSTB;ATP6V0C;CD47;COTL1;BRI3;GDI2;RHOG;TMEM179B;ACTR10;LAMTOR2;SDCBP;CTSB;ERP44;ATP6V1D;DEGS1;RAB18;ATP6AP2;GOLGA7;HMGB1;RAB10;GGH;LAMTOR1;CNN2;CTSC;SURF4;COPB1;CYBA;CAT;CAP1;CTSA;HEXB;PYCARD;VPS35L;GLB1;ITGB2;DERA;KCMF1;ASAH1;YPEL5;LTA4H;LAMTOR3;RAB4B;CYB5R3
gsea,aerobic electron transport chain (GO:0019646),0.8498300255735581,3.236851449439437,0.0,0.0,0.0,39/52,9.93%,COX8A;COX7C;COX6C;COX5A;NDUFC2;UQCRB;NDUFA7;NDUFA8;UQCRH;NDUFB5;NDUFB6;NDUFB4;COX7B;COX6B1;COX6A1;UQCRFS1;NDUFV2;NDUFC1;NDUFA6;COX5B;NDUFB2;NDUFB9;COX4I1;UQCRC2;NDUFB8;NDUFB11;NDUFS5;NDUFA3;NDUFB10;NDUFS3;NDUFA9;NDUFB3;NDUFS8;NDUFA11;NDUFS4;UQCR10;NDUFA1;SDHC;UQCRQ
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.8412965004492993,3.212363290647969,0.0,0.0,0.0,39/53,9.93%,COX8A;COX7C;COX6C;COX5A;NDUFC2;UQCRB;NDUFA7;NDUFA8;UQCRH;NDUFB5;NDUFB6;NDUFB4;COX7B;COX6B1;COX6A1;UQCRFS1;NDUFV2;NDUFC1;NDUFA6;COX5B;NDUFB2;NDUFB9;COX4I1;UQCRC2;NDUFB8;NDUFB11;NDUFS5;NDUFA3;NDUFB10;NDUFS3;NDUFA9;NDUFB3;NDUFS8;NDUFA11;NDUFS4;UQCR10;NDUFA1;SDHC;UQCRQ
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),0.795252475961981,3.168581354601249,0.0,0.0,0.0,38/52,15.34%,NDUFC2;NDUFA7;NDUFA8;NDUFB5;NDUFB6;NDUFB4;TMEM126A;UQCRFS1;NDUFV2;NDUFC1;NDUFA6;NDUFB2;NDUFB9;NDUFB8;NDUFB11;NDUFS5;NDUFA3;NDUFB10;COA3;COX14;NDUFS3;NDUFA9;NDUFB3;NDUFS8;COX16;NDUFA11;NDUFS4;DMAC1;COX20;NDUFA1;SURF1;SMIM20;SDHAF4;NDUFAF3;NDUFS2;UQCC2;OXA1L;NDUFA2
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.6455239657491008,3.1387715769289413,0.0,0.0,0.0,53/93,20.62%,CAPZB;BCAP31;DYNLL1;VAPA;SEC13;PDCD6;ARF4;TRAPPC1;SAR1B;IER3IP1;CNIH1;KDELR1;CAPZA1;ACTR10;TMED9;TRAPPC4;VAMP4;YIF1B;TRAPPC2L;TRAPPC6B;TEX261;PEF1;TRAPPC5;TRAPPC3;TMED10;BET1;CTSC;RAB2A;DCTN6;COPB1;SEC22B;DCTN2;ERGIC3;DCTN3;TFG;TMED5;VTI1B;COG8;NAPA;COPE;RAB1B;TRAPPC2;YIF1A;SAR1A;COPZ1;NRBP1;TRAPPC6A;TMED7;ERGIC2;RAB29;MPPE1;TMED3;VAPB
gsea,gene expression (GO:0010467),0.7246255118843407,3.133075158603961,0.0,0.0,0.0,66/127,13.66%,RBM3;RPS15A;RPL39;RPS7;RPS10;RPL27;RPS13;RPL29;RPL32;RPL30;MRPS33;MRPS14;RPL9;MRPS21;RPS24;RPL34;RPL36A;RPL23;MRPS36;RPL22;MRPS16;SEC13;MRPS18C;POLR2K;RPS3;MRPL34;POLR2G;RPL35;RPS11;RPS4X;RPS9;RPS16;RPL27A;RPL12;RPL24;RPS20;POLR2D;RPL18;MRPL36;MRPL32;HNRNPL;RPS14;RPS23;MRPL24;RPLP2;RPS28;RPS21;MRPL23;MRPL52;RPL37;MRPS17;RPS27;RPL19;THOC7;RPS5;MRPL10;RPL11;MRPL43;MRPL41;CLP1;MRPL27;RPL21;U2AF1L4;POLR2I;RPS6;RPL17
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),0.8239019808773119,3.0943525991613883,0.0,0.0,0.0,25/37,8.14%,NDUFC2;NDUFA7;NDUFA8;NDUFB5;NDUFB6;NDUFB4;TMEM126A;NDUFV2;NDUFC1;NDUFA6;NDUFB2;NDUFB9;NDUFB8;NDUFB11;NDUFS5;NDUFA3;NDUFB10;NDUFS3;NDUFA9;NDUFB3;NDUFS8;NDUFA11;NDUFS4;DMAC1;NDUFA1
gsea,NADH dehydrogenase complex assembly (GO:0010257),0.8239019808773119,3.0943525991613883,0.0,0.0,0.0,25/37,8.14%,NDUFC2;NDUFA7;NDUFA8;NDUFB5;NDUFB6;NDUFB4;TMEM126A;NDUFV2;NDUFC1;NDUFA6;NDUFB2;NDUFB9;NDUFB8;NDUFB11;NDUFS5;NDUFA3;NDUFB10;NDUFS3;NDUFA9;NDUFB3;NDUFS8;NDUFA11;NDUFS4;DMAC1;NDUFA1
gsea,mitochondrial translation (GO:0032543),0.7984660231505495,3.0907637904635847,0.0,0.0,0.0,29/41,11.18%,NDUFA7;MRPS33;MRPS14;MRPS21;MRPS36;MRPS16;MRPS18C;MRPL34;MRPS24;AURKAIP1;MRPL36;MRPL32;MRPS23;MRPL57;MRPL24;MRPL23;MRPL21;MRPL52;MRPL33;MRPL4;MRPS17;MRPL14;MRPL48;MRPL10;MRPL43;MRPL58;MRPL30;MRPL41;MRPL27
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.6757233450483356,3.070264254871463,0.0,0.0,0.0,38/81,17.13%,LSM5;NUDT21;SNRPG;SF3B6;UBL5;RALY;SNRPC;SF3B5;LSM6;POLR2K;POLR2G;CWC15;DDX5;BCAS2;SNRPD2;ELAVL1;POLR2D;HNRNPL;ZCRB1;SMNDC1;ISY1;GEMIN7;PPIL3;SNRPB2;LSM4;SNRNP27;ZMAT2;CLP1;PUF60;SYF2;U2AF1L4;POLR2I;WBP4;DNAJC8;FRG1;POLR2J;SF1;RBM22
gsea,translational termination (GO:0006415),0.7989091446962273,3.0613128108888192,0.0,0.0,0.0,29/41,11.18%,TRMT112;MRPS33;MRPS14;MRPS21;MRPS36;MRPS16;MRPS18C;MRPL34;MRPS24;AURKAIP1;MRPL36;MRPL32;MRPS23;MRPL57;MRPL24;MRPL23;MRPL21;MRPL52;MRPL33;MRPL4;MRPS17;MRPL14;MRPL48;MRPL10;MRPL43;MRPL58;MRPL30;MRPL41;MRPL27
gsea,cellular macromolecule biosynthetic process (GO:0034645),0.7676523915460105,3.0448253481885916,0.0,0.0,0.0,60/109,13.66%,RPS15A;RPL39;RPS7;RPS10;RPL27;RPS13;RPL29;RPL32;RPL30;MRPS33;MRPS14;RPL9;MRPS21;RPS24;RPL34;RPL36A;RPL23;MRPS36;RPL22;MRPS16;MRPS18C;POLR2K;RPS3;MRPL34;POLR2G;RPL35;RPS11;RPS4X;RPS9;RPS16;RPL27A;RPL12;RPL24;RPS20;POLR2D;RPL18;MRPL36;MRPL32;RPS14;RPS23;MRPL24;RPLP2;RPS28;RPS21;MRPL23;MRPL52;RPL37;MRPS17;RPS27;RPL19;RPS5;MRPL10;RPL11;MRPL43;MRPL41;MRPL27;RPL21;POLR2I;RPS6;RPL17
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.6485252998572553,3.018685646624724,0.0,0.0,0.0,43/88,19.43%,LSM5;NUDT21;SNRPG;SF3B6;UBL5;RALY;SNRPC;SF3B5;LSM6;POLR2K;POLR2G;CWC15;DDX5;DCPS;BCAS2;SNRPD2;ELAVL1;POLR2D;HNRNPL;ZCRB1;SMNDC1;ISY1;GEMIN7;PPIL3;SNRPB2;LSM4;SNRNP27;ZMAT2;CLP1;PUF60;SYF2;U2AF1L4;POLR2I;WBP4;DNAJC8;FRG1;POLR2J;SF1;RBM22;GEMIN4;TRA2B;SCNM1;PQBP1
gsea,mRNA processing (GO:0006397),0.6349330896135481,3.0176642772297297,0.0,0.0,0.0,43/99,17.13%,LSM5;NUDT21;SNRPG;SF3B6;UBL5;RALY;SNRPC;SF3B5;LSM6;POLR2K;POLR2G;CWC15;AURKAIP1;DDX5;BCAS2;SNRPD2;ELAVL1;CCNH;POLR2D;HNRNPL;ZCRB1;RAMAC;SMNDC1;ISY1;GEMIN7;PPIL3;SNRPB2;THOC7;LSM4;SNRNP27;ZMAT2;CLP1;PUF60;SYF2;U2AF1L4;POLR2I;WBP4;DNAJC8;FRG1;POLR2J;GTF2H5;SF1;RBM22
gsea,mitochondrial translational elongation (GO:0070125),0.8026647229705184,3.0127757639276083,0.0,0.0,0.0,28/37,11.18%,MRPS33;MRPS14;MRPS21;MRPS36;MRPS16;MRPS18C;MRPL34;MRPS24;AURKAIP1;MRPL36;MRPL32;MRPS23;MRPL57;MRPL24;MRPL23;MRPL21;MRPL52;MRPL33;MRPL4;MRPS17;MRPL14;MRPL48;MRPL10;MRPL43;MRPL58;MRPL30;MRPL41;MRPL27
gsea,mitochondrial translational termination (GO:0070126),0.794095732677348,3.0003481974101174,0.0,0.0,0.0,28/39,11.18%,MRPS33;MRPS14;MRPS21;MRPS36;MRPS16;MRPS18C;MRPL34;MRPS24;AURKAIP1;MRPL36;MRPL32;MRPS23;MRPL57;MRPL24;MRPL23;MRPL21;MRPL52;MRPL33;MRPL4;MRPS17;MRPL14;MRPL48;MRPL10;MRPL43;MRPL58;MRPL30;MRPL41;MRPL27
gsea,protein targeting (GO:0006605),0.6856755226305501,2.998160114870144,0.0,0.0,0.0,27/55,16.45%,SPCS1;TOMM22;NACA;SRP14;TOMM7;SEC61G;BCAP31;TSPO;GABARAP;SPCS2;DNAJC19;TIMM17B;SDCBP;ZFAND6;YIF1B;TIMM10B;GOLGA7;MFF;RPL11;ZDHHC4;ARL6;FIS1;AIP;ZDHHC3;TOMM34;AP4S1;ATG3
gsea,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.861690108153964,2.9978369690919475,0.0,0.0,0.0,23/31,8.14%,NDUFC2;NDUFA7;NDUFA8;NDUFB5;NDUFB6;NDUFB4;NDUFV2;NDUFC1;NDUFA6;NDUFB2;NDUFB9;NDUFB8;NDUFB11;NDUFS5;NDUFA3;NDUFB10;NDUFS3;NDUFA9;NDUFB3;NDUFS8;NDUFA11;NDUFS4;NDUFA1
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.5794387922489779,2.9935607410506497,0.0,0.0,0.0,62/159,18.66%,PSMB3;NDFIP1;PSMA2;UBE2D3;UBE2I;RBX1;PSMB9;UBE2A;PSMB1;ANAPC11;RNF7;NEDD8;UBE2B;PSME1;PSMA1;PSMD8;TBX21;VPS28;PTTG1;SQSTM1;RNF187;SIRT2;RNF115;TSG101;UBE2K;PSMA7;NDFIP2;NTAN1;PSMB8;UBE2E1;UBXN1;PCNP;CDC26;UBE2L3;UBL7;PSMB4;ARRB2;PSMD5;FBXO22;GSK3A;RNF166;PSMD10;CTNNB1;ANAPC16;RNF34;GID8;UBE2G1;MAEA;UBE2W;RNF114;RCHY1;TRIM2;RNF122;FBXO8;PSMB10;UBE2R2;PPP1R11;PSMD4;UFD1;PSMD13;ANAPC10;RNF4
gsea,cytokine-mediated signaling pathway (GO:0019221),0.585482880442707,2.9865466383371184,0.0,0.0,0.0,53/142,18.89%,PSMB3;YWHAZ;B2M;CDC42;PSMA2;CSNK2B;RBX1;PSMB9;PSMB1;TALDO1;ARF1;RAP1B;PSME1;PSMA1;PSMD8;IL2RG;CAPZA1;ILK;CRLF2;MSN;SQSTM1;ADIPOR1;LCK;PSMA7;CSK;TXNDC17;PSMB8;CNN2;PSMB4;PSMD5;PSMD10;IFNGR1;IL10RB;COMMD7;PITPNA;AIP;PYCARD;CD27;GRB2;ITGB2;SP100;TNFRSF12A;UBC;PSMB10;APPL1;IL12RB2;PSMD4;IRF9;RELA;MCL1;PSMD13;RPS6KA4;IL15
gsea,translational elongation (GO:0006414),0.767212850420265,2.964224129740008,0.0,0.0,0.0,28/40,11.18%,MRPS33;MRPS14;MRPS21;MRPS36;MRPS16;MRPS18C;MRPL34;MRPS24;AURKAIP1;MRPL36;MRPL32;MRPS23;MRPL57;MRPL24;MRPL23;MRPL21;MRPL52;MRPL33;MRPL4;MRPS17;MRPL14;MRPL48;MRPL10;MRPL43;MRPL58;MRPL30;MRPL41;MRPL27
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5827364169367013,2.963796067956013,0.0,0.0,0.0,60/134,21.17%,PSMB3;SEC61B;PSMA2;UBE2D3;RBX1;PSMB9;UBE2A;PSMB1;ANAPC11;UBE2B;PSME1;PSMA1;PSMD8;TBX21;AUP1;PTTG1;RNF187;SIRT2;UBE2K;PSMA7;DERL1;PSMB8;UBE2E1;UBXN1;PCNP;CDC26;PSMB4;ARRB2;UBXN8;PSMD5;GSK3A;PSMD10;UBE2J2;CTNNB1;ANAPC16;RNF34;GID8;UBE2G1;MAEA;UBE2W;FBXO4;TRIM2;UBC;RNF122;PSMB10;PSMD4;UBE2J1;FBXL5;UFD1;FBXO6;PSMD13;FBXO9;ANAPC10;RNF4;RNF121;DCAF12;DNAJB9;WFS1;UBXN2A;DNAJC18
gsea,cellular response to interleukin-1 (GO:0071347),0.6602402605830753,2.9222462637996447,0.0,0.0,0.0,22/49,18.50%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;CD47;SQSTM1;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;PYCARD;UBC;PSMB10;PSMD4;RELA;PSMD13;RPS6KA4
gsea,cellular response to tumor necrosis factor (GO:0071356),0.7046102497665764,2.918533042668903,0.0,0.0,0.0,26/44,18.41%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;RPS3;PSMD8;CIB1;ILK;ZFAND6;PSMA7;TXNDC17;PSMB8;PSMB4;PSMD5;PSMD10;COMMD7;PYCARD;CD27;TNFRSF12A;ASAH1;PSMB10;PSMD4;RELA;PSMD13
gsea,translation (GO:0006412),0.8110549009344447,2.917780662934117,0.0,0.0,0.0,57/87,9.51%,RPS15A;RPL39;RPS7;RPS10;RPL27;NDUFA7;RPS13;RPL29;RPL32;TRMT112;RPL30;MRPS33;MRPS14;RPL9;MRPS21;RPS24;RPL34;RPL36A;RPL23;MRPS36;RPL22;MRPS16;MRPS18C;RPS3;MRPL34;RPL35;RPS11;RPS4X;RPS9;MRPS24;RWDD1;RPS16;RPL27A;RPL12;RPL24;RPS20;RPL18;MRPL36;MRPL32;MRPL57;RPS14;RPS23;MRPL24;RPLP2;RPS28;RPS21;MRPL23;MRPL52;RPL37;MRPS17;TMA7;RPS27;RPL19;RPS5;MRPL10;RPL11;MRPL43
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.7043966054325391,2.879478013457535,0.0,0.0,0.0,32/50,18.54%,PSMB3;PSMA2;PSMB9;PSMB1;ANAPC11;DYNLL1;PSME1;PSMA1;PSMD8;ID2;SIRT2;MAPRE1;PSMA7;PSMB8;UBE2E1;SSNA1;CETN2;CDC26;PSMB4;PSMD5;DCTN2;DCTN3;PSMD10;ANAPC16;MAD2L1BP;PPP2R1A;UBC;PSMB10;APPL1;PSMD4;PSMD13;ANAPC10
gsea,mitochondrion organization (GO:0007005),0.6623902454170654,2.874388512476594,0.0,0.0,0.0,26/53,18.92%,TOMM22;CHCHD2;TOMM7;COX7A2;RAB5IF;BCAP31;TSPO;HIGD2A;DNAJC19;TIMM17B;FMC1;CHCHD3;TIMM10B;MFF;BNIP3L;SSBP1;SLIRP;FIS1;AIP;MTFR1L;TOMM34;COX7A2L;OXA1L;TMEM11;ATPAF1;RAB29
gsea,positive regulation of intracellular protein transport (GO:0090316),0.6505128509293092,2.869432160980972,0.0,0.0,0.0,29/62,17.44%,YWHAZ;RAC2;YWHAH;UBE2D3;UBL5;OAZ1;TOMM7;PDCD10;CIB1;SAR1B;SH3GLB1;EMD;MFF;ZFAND1;YWHAB;UBE2L3;PPP3CC;CASP8;GSK3A;CHP1;FIS1;UBE2J2;HDAC3;BAD;ITGB2;ITGB1BP1;LEPROT;RBM22;SAR1A
gsea,proteasomal protein catabolic process (GO:0010498),0.5921591187690841,2.83591168512675,0.0,0.0,0.0,37/92,18.66%,PSMB3;PSMA2;UBE2D3;RBX1;PSMB9;UBE2A;PSMB1;UBE2B;PSME1;PSMA1;PSMD8;TBX21;RNF187;SIRT2;UBE2K;PSMA7;DERL1;PSMB8;UBXN1;PCNP;PSMB4;ARRB2;PSMD5;GSK3A;PSMD10;CTNNB1;RNF34;GID8;UBE2G1;MAEA;UBE2W;TRIM2;RNF122;PSMB10;PSMD4;PSMD13;RNF4
gsea,ribonucleoprotein complex assembly (GO:0022618),0.697181253873612,2.8347768001849976,0.0,0.0,0.0,19/41,11.87%,NUDT21;SNRPG;SNRPC;RPL24;MCTS1;SNRPD2;POLR2D;RPS14;RAMAC;RPS28;ISY1;GEMIN7;RPS27;RPS5;RPL11;ABT1;LSM4;CLP1;PUF60
gsea,post-translational protein modification (GO:0043687),0.6017817628837188,2.8342610472482104,0.0,0.0,0.0,47/107,22.82%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;RNF7;NEDD8;SHISA5;PSME1;PSMA1;PSMD8;COPS6;COMMD1;RAB11A;ELOB;PSMA7;RAB8A;PSMB8;PSMB4;RAB2A;PSMD5;DDA1;FBXO22;PSMD10;ATG5;UBE2F;RAB11B;RAB1B;FBXO4;ASB8;LRRC41;PNPLA2;PSMB10;BTBD1;PSMD4;FBXL5;ASB3;FBXO6;PSMD13;FBXO9;COPS8;FUCA2;FBXO7;WFS1;OBSL1;RAB1A;MXRA8
gsea,peptide biosynthetic process (GO:0043043),0.8191813601093526,2.8276159066911193,0.0,0.0,0.0,54/79,11.95%,RPS15A;RPL39;RPS7;RPS10;RPL27;RPS13;RPL29;RPL32;RPL30;MRPS33;MRPS14;RPL9;MRPS21;RPS24;RPL34;RPL36A;RPL23;MRPS36;RPL22;MRPS16;MRPS18C;RPS3;MRPL34;RPL35;RPS11;RPS4X;RPS9;RPS16;RPL27A;RPL12;RPL24;RPS20;RPL18;MRPL36;MRPL32;RPS14;RPS23;MRPL24;RPLP2;RPS28;RPS21;MRPL23;MRPL52;RPL37;MRPS17;RPS27;RPL19;RPS5;MRPL10;RPL11;MRPL43;MRPL41;MRPL27;RPL21
gsea,COPII-coated vesicle budding (GO:0090114),0.712048709312698,2.811550250297557,0.0,0.0,0.0,23/37,18.01%,VAPA;SEC13;PDCD6;TRAPPC1;SAR1B;CNIH1;PPP6C;TRAPPC4;TRAPPC2L;TRAPPC6B;PEF1;TRAPPC5;TRAPPC3;TMED10;BET1;CTSC;SEC22B;TFG;NAPA;RAB1B;TRAPPC2;SAR1A;TRAPPC6A
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.6800782881814115,2.800314357682032,0.0,0.0,0.0,20/41,18.50%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;SQSTM1;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;UBC;PSMB10;PSMD4;RELA;PSMD13;RPS6KA4
gsea,COPII vesicle coating (GO:0048208),0.7309298225422458,2.7857203953699723,0.0,0.0,0.0,20/34,14.60%,SEC13;PDCD6;TRAPPC1;SAR1B;CNIH1;PPP6C;TRAPPC4;TRAPPC2L;TRAPPC6B;PEF1;TRAPPC5;TRAPPC3;TMED10;BET1;CTSC;SEC22B;TFG;NAPA;RAB1B;TRAPPC2
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.7309298225422458,2.7857203953699723,0.0,0.0,0.0,20/34,14.60%,SEC13;PDCD6;TRAPPC1;SAR1B;CNIH1;PPP6C;TRAPPC4;TRAPPC2L;TRAPPC6B;PEF1;TRAPPC5;TRAPPC3;TMED10;BET1;CTSC;SEC22B;TFG;NAPA;RAB1B;TRAPPC2
gsea,vesicle coating (GO:0006901),0.7309298225422458,2.7857203953699723,0.0,0.0,0.0,20/34,14.60%,SEC13;PDCD6;TRAPPC1;SAR1B;CNIH1;PPP6C;TRAPPC4;TRAPPC2L;TRAPPC6B;PEF1;TRAPPC5;TRAPPC3;TMED10;BET1;CTSC;SEC22B;TFG;NAPA;RAB1B;TRAPPC2
gsea,membrane organization (GO:0061024),0.5779159006308128,2.7820858430626343,0.0,0.0,0.0,39/95,21.47%,ARPC3;SNX3;ACTR3;ARPC4;ARPC5;ARPC2;CD3G;VAPA;CLTA;GLTP;SAR1B;SH3GLB1;EMD;TOR1A;CHMP5;VAMP4;SLC9A3R1;ARPC1A;CD3D;VAMP3;MTCH1;ARRB2;CHMP3;CHP1;VTI1B;NAPA;GRB2;OXA1L;UBC;SAR1A;RABIF;CHMP1A;LPCAT3;AP2M1;CHMP2A;TOR1AIP2;VAPB;UBXN2A;VPS4B
gsea,cellular protein-containing complex assembly (GO:0034622),0.6344975501006613,2.7581289300561145,0.0,0.0,0.0,22/56,20.10%,CD3E;CSNK2B;FKBP1A;COX7A2;TBCA;RAB5IF;HIGD2A;CLTA;POMP;SRP19;GTF2B;VAMP4;VAMP3;CYBA;CHMP3;ARL6;COX7A2L;RTN4;PSMD4;PSMD13;AP2M1;CHMP2A
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.7532443758724822,2.754413409596699,0.0,0.0,0.0,15/24,16.64%,YWHAZ;RAC2;YWHAH;UBE2D3;UBL5;TOMM7;SH3GLB1;YWHAB;UBE2L3;PPP3CC;CASP8;GSK3A;UBE2J2;BAD;LEPROT
gsea,Fc receptor signaling pathway (GO:0038093),0.6799552960594111,2.7523864709824903,0.0,0.0,0.0,21/42,18.41%,PSMB3;RAC1;PSMA2;PSMB9;PSMB1;CALM1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;LAT;PSMD10;BCL10;GRB2;PSMB10;PSMD4;RELA;PSMD13
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7694304616251852,2.7462874073167978,0.0,0.0,0.0,22/28,18.54%,PSMB3;PSMA2;PSMB9;PSMB1;ANAPC11;PSME1;PSMA1;PSMD8;PTTG1;PSMA7;PSMB8;UBE2E1;CDC26;PSMB4;PSMD5;PSMD10;ANAPC16;UBC;PSMB10;PSMD4;PSMD13;ANAPC10
gsea,T cell receptor signaling pathway (GO:0050852),0.6220718862291273,2.7431569024654894,0.0,0.0,0.0,31/53,21.37%,PSMB3;PSMA2;CD3E;PSMB9;PSMB1;CD3G;THY1;PSME1;PSMA1;PSMD8;SKAP1;LCK;PSMA7;CSK;PSMB8;CD3D;PSMB4;PSMD5;WAS;LAT;PSMD10;BCL10;CD28;EIF2B2;PSMB10;PSMD4;RELA;PSMD13;KHDRBS1;ZAP70;CD247
gsea,cellular response to starvation (GO:0009267),0.626207681229956,2.7399103838007703,0.0,0.0,0.0,25/59,16.82%,ATP6V1F;GABARAPL2;RHEB;LAMTOR5;SEC13;GABARAP;ATP6V0C;SH3GLB1;LAMTOR2;LAMTOR4;MAP1LC3B;ATP6V1D;BECN1;GABARAPL1;LAMTOR1;ATP6V1G1;ATP6V0D1;ATG5;RRAGA;ATP6V1E1;PRKAG1;LAMTOR3;ATP6V0B;ATP6V1C1;STK26
gsea,MAPK cascade (GO:0000165),0.605271368711891,2.7383630370101595,0.0,0.0,0.0,32/96,17.11%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PPP1CC;CALM1;PSME1;PSMA1;PSMD8;IL2RG;LGALS9;LAMTOR2;GOLGA7;PSMA7;PSMB8;RCE1;LYPLA1;YWHAB;PSMB4;MAP2K1;PSMD5;LAT;PSMD10;ABHD17A;GRB2;UBC;LAMTOR3;KRAS;PSMB10;FNTA;PSMD4
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.6178049870459607,2.7362244150537625,0.0,0.0,0.0,31/57,19.06%,PSMB3;PSMA2;CD3E;PSMB9;PSMB1;CD3G;THY1;PSME1;PSMA1;PSMD8;SKAP1;SPG21;LCK;PSMA7;CSK;PSMB8;CD3D;LIME1;PSMB4;PSMD5;WAS;LAT;PSMD10;BCL10;CD28;EIF2B2;PSMB10;PSMD4;RELA;PSMD13;KHDRBS1
gsea,ephrin receptor signaling pathway (GO:0048013),0.7772459095793633,2.7350699627716506,0.0,0.0,0.0,13/34,7.56%,ARPC3;RAC1;RHOA;CDC42;ACTR3;ARPC4;ARPC5;ARPC2;PSENEN;APH1A;ARPC1B;SDCBP;ARPC1A
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.6623239161950262,2.7295313605287506,0.0,0.0,0.0,21/43,18.41%,PSMB3;RAC1;PSMA2;PSMB9;PSMB1;CALM1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;LAT;PSMD10;BCL10;GRB2;PSMB10;PSMD4;RELA;PSMD13
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.7279627840107291,2.724657876066211,0.0,0.0,0.0,20/36,18.44%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;FBXO4;PSMB10;PSMD4;FBXL5;FBXO6;PSMD13;FBXO9
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.682107657464903,2.722813849318332,0.0,0.0,0.0,20/54,12.08%,PSMB3;RAC1;RHOA;CDC42;PSMA2;PSMB9;PSMB1;CALM1;PSME1;PSMA1;GNB1;PSMD8;PSMA7;GNG2;PSMB8;PSMB4;ARRB2;PSMD5;PSMD10;CTNNB1
gsea,regulation of mRNA stability (GO:0043488),0.685676800790473,2.7216170833995155,0.0,0.0,0.0,22/40,18.41%,PSMB3;YWHAZ;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ELAVL1;CIRBP;PSMA7;PSMB8;YWHAB;PSMB4;PSMD5;PSMD10;YTHDF2;DCP2;UBC;PSMB10;PSMD4;PSMD13
gsea,protein targeting to mitochondrion (GO:0006626),0.8039233596864652,2.7147642017555094,0.0,0.0,0.0,14/20,13.92%,TOMM22;TOMM7;BCAP31;TSPO;IMMP1L;DNAJC19;TIMM17B;PAM16;TIMM10B;MFF;ROMO1;FIS1;AIP;TOMM34
gsea,cellular response to amino acid starvation (GO:0034198),0.7023287553774721,2.7107235424816682,0.0,0.0,0.0,17/33,16.66%,ATP6V1F;RHEB;LAMTOR5;SEC13;ATP6V0C;SH3GLB1;LAMTOR2;LAMTOR4;ATP6V1D;LAMTOR1;ATP6V1G1;ATP6V0D1;RRAGA;ATP6V1E1;LAMTOR3;ATP6V0B;ATP6V1C1
gsea,response to amino acid starvation (GO:1990928),0.7023287553774721,2.7107235424816682,0.0,0.0,0.0,17/33,16.66%,ATP6V1F;RHEB;LAMTOR5;SEC13;ATP6V0C;SH3GLB1;LAMTOR2;LAMTOR4;ATP6V1D;LAMTOR1;ATP6V1G1;ATP6V0D1;RRAGA;ATP6V1E1;LAMTOR3;ATP6V0B;ATP6V1C1
gsea,protein-DNA complex assembly (GO:0065004),0.7580785526237079,2.709010766191547,0.0,0.0,0.0,23/31,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;CCNH;PSMA7;PSMB8;CETN2;HMGB2;PSMB4;PSMD5;PSMD10;UBC;NAA60;PSMB10;GTF2H5;PSMD4;ORC4;PSMD13
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.6972347391562596,2.699446280655974,0.0,0.0,0.0,15/37,12.71%,RHOA;CALM1;THY1;PDCD10;CIB1;CCNH;CALM3;PPP2CA;TSG101;LIME1;MAP2K1;CCNI;EZH2;PYCARD;SERTAD1
gsea,regulation of primary metabolic process (GO:0080090),0.6823230810738994,2.6936429487420512,0.0,0.0,0.0,25/45,20.85%,PSMB3;PSMA2;OAZ1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ID2;SIN3B;ADIPOR1;CERS2;PSMA7;PSMB8;PSMB4;PSMD5;EDF1;PSMD10;HDAC3;PSMB10;PSMD4;PSMD13;PRKAB1;PSAP;SMARCD3
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7108894638655587,2.6887096103378005,0.0,0.0,0.0,20/41,11.51%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;DYNLL1;PSME1;PSMA1;PSMD8;RAB11A;MAPRE1;PSMA7;PSMB8;SSNA1;CETN2;PSMB4;PSMD5;DCTN2;DCTN3;PSMD10
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.7341950551274014,2.687354380427715,0.0,0.0,0.0,12/30,10.58%,ARPC3;RAC1;CDC42;ACTR3;ARPC4;ARPC5;ARPC2;CD3G;BRK1;ARPC1B;ARPC1A;WAS
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.7341950551274014,2.687354380427715,0.0,0.0,0.0,12/30,10.58%,ARPC3;RAC1;CDC42;ACTR3;ARPC4;ARPC5;ARPC2;CD3G;BRK1;ARPC1B;ARPC1A;WAS
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.7150449628335357,2.6754720230217934,0.0,0.0,0.0,16/40,11.51%,PSMB3;RAC1;RHOA;CDC42;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;ARRB2;PSMD5;PSMD10
gsea,protein ubiquitination (GO:0016567),0.47590256781370993,2.6724865418834165,0.0,0.0,0.0,64/206,18.66%,PSMB3;PSMA2;UBE2D3;RBX1;PSMB9;UBE2A;PSMB1;ANAPC11;RNF7;NEDD8;UBE2B;PSME1;PSMA1;PSMD8;COMMD1;RNF187;ELOB;RNF115;UBE2K;PSMA7;MKRN1;DERL1;PSMB8;UBE2E1;PCNP;UBE2L3;PSMB4;RNF181;ARRB2;PSMD5;DDA1;FBXO22;RNF166;PSMD10;WDR61;UBE2J2;CTNNB1;ANAPC16;RNF34;BCL10;UBE2G1;RRAGA;UBE2W;TRIM27;RNF114;RCHY1;FBXO4;TRIM2;UBC;MKRN2;RNF122;PSMB10;ATG3;UBE2R2;PSMD4;UBE2J1;RNFT1;PEX13;FBXL5;KLHL7;FBXO6;PSMD13;FBXO9;RNF4
gsea,regulation of mRNA catabolic process (GO:0061013),0.6652249103483274,2.6643449210627748,0.0,0.0,0.0,22/39,18.41%,PSMB3;YWHAZ;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ELAVL1;PSMA7;PSMB8;YWHAB;PSMB4;PSMD5;PSMD10;YTHDF2;CNOT8;DCP2;UBC;PSMB10;PSMD4;PSMD13
gsea,cellular response to hypoxia (GO:0071456),0.6848102854834326,2.6592840679939145,0.0,0.0,0.0,21/36,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ELOB;SIRT2;PSMA7;BNIP3L;PSMB8;PSMB4;PSMD5;PSMD10;BAD;UBC;PSMB10;PSMD4;PSMD13
gsea,DNA-dependent DNA replication (GO:0006261),0.7301055935388747,2.6538747788347576,0.0,0.0,0.0,20/31,18.41%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;POLE4;PSMD8;PSMA7;PSMB8;SSBP1;PSMB4;PSMD5;PSMD10;UBC;PSMB10;PSMD4;ORC4;POLD4;PSMD13
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),0.7153951095716978,2.6506258794860464,0.0,0.0,0.0,51/89,15.18%,RPS15A;RPL39;RPS7;RPS10;RPL27;RPS13;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPS3;POLR2G;RPL35;RPS11;RPS4X;RPS9;DDX5;RPS16;RPL27A;EIF3E;RPL12;RPL24;DCPS;RPS20;POLR2D;RPL18;RPS14;RPS23;RPLP2;PPP2CA;RPS28;RPS21;LSM1;RPL37;RPS27;RPL19;RPS5;NBDY;RPL11;RPL21;RPS6;RPL17;CNOT8;DCP2;PPP2R1A;TENT2
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.7154995956599078,2.6490776219363026,0.0,0.0,0.0,12/31,10.58%,ARPC3;RAC1;CDC42;ACTR3;ARPC4;ARPC5;ARPC2;CD3G;BRK1;ARPC1B;ARPC1A;WAS
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6743675751944583,2.647150334214979,0.0,0.0,0.0,19/37,18.41%,PSMB3;KLRD1;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;BCL10;KRAS;PSMB10;PSMD4;RELA;PSMD13
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6743675751944583,2.647150334214979,0.0,0.0,0.0,19/37,18.41%,PSMB3;KLRD1;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;BCL10;KRAS;PSMB10;PSMD4;RELA;PSMD13
gsea,cellular response to lectin (GO:1990858),0.6743675751944583,2.647150334214979,0.0,0.0,0.0,19/37,18.41%,PSMB3;KLRD1;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;BCL10;KRAS;PSMB10;PSMD4;RELA;PSMD13
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.705356927984955,2.6445113571655368,0.0,0.0,0.0,22/35,18.41%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ILK;PSMA7;TXNDC17;PSMB8;PSMB4;PSMD5;PSMD10;COMMD7;PYCARD;CD27;TNFRSF12A;PSMB10;PSMD4;RELA;PSMD13
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.7843608479129968,2.6425072827711227,0.0,0.0,0.0,14/25,11.51%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;NABP2;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10
gsea,protein-containing complex assembly (GO:0065003),0.5682547315284379,2.6390721232647634,0.0,0.0,0.0,33/98,15.05%,CD3E;CSNK2B;RBX1;CD3G;SEC13;PDCD6;TRAPPC1;SAR1B;CNIH1;CAPZA1;PPP6C;ELOB;TRAPPC4;SLC9A3R1;TRAPPC2L;TRAPPC6B;PEF1;TRAPPC5;TRAPPC3;TMED10;BET1;VAMP3;CTSC;SEC22B;WAS;CASP8;TFG;CTNNB1;NAPA;BAD;RAB1B;TRAPPC2;PPP2R1A
gsea,protein insertion into ER membrane (GO:0045048),0.784494709141705,2.6355663102934823,0.0,0.0,0.0,12/20,12.65%,SEC61B;SEC61G;EMC6;VAPA;CYB5A;WDR83OS;EMD;EMC2;EMC7;TRAM1;UBE2J2;EMC10
gsea,regulation of establishment of planar polarity (GO:0090175),0.7132441761593008,2.6355050833592752,0.0,0.0,0.0,16/42,11.51%,PSMB3;RAC1;RHOA;CDC42;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;ARRB2;PSMD5;PSMD10
gsea,mitochondrial transport (GO:0006839),0.770934704057772,2.62853339027819,0.0,0.0,0.0,16/21,17.53%,TOMM22;TMEM14C;TOMM7;BCAP31;TSPO;DNAJC19;TIMM17B;TIMM10B;MFF;MAIP1;FIS1;AIP;TOMM34;BAD;OXA1L;SLC25A16
gsea,modification-dependent protein catabolic process (GO:0019941),0.5464784958739912,2.626392132173688,0.0,0.0,0.0,31/84,18.54%,NDFIP1;UBE2I;RBX1;UBE2A;ANAPC11;RNF7;NEDD8;UBE2B;PTTG1;SQSTM1;UBE2K;NDFIP2;NTAN1;UBE2E1;CDC26;UBE2L3;UBL7;FBXO22;RNF166;ANAPC16;RNF34;UBE2G1;RNF114;RCHY1;UBC;FBXO8;UBE2R2;PPP1R11;UFD1;PSMD13;ANAPC10
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.7077193431847992,2.6252016444540627,0.0,0.0,0.0,9/28,11.51%,RHOA;CALM1;PDCD10;CIB1;CALM3;PPP2CA;MAP2K1;EZH2;PSMD10
gsea,regulation of mitotic cell cycle (GO:0007346),0.621777905178943,2.6249829722751525,0.0,0.0,0.0,28/56,18.54%,PSMB3;PSMA2;PSMB9;PSMB1;ANAPC11;PSME1;PSMA1;PSMD8;BTG3;SDCBP;SRA1;SLC9A3R1;PSMA7;PSMB8;UBE2E1;CDC26;BTG1;DYNLT3;PSMB4;PSMD5;PSMD10;ANAPC16;MAEA;PSMB10;CDK9;PSMD4;PSMD13;ANAPC10
gsea,cellular respiration (GO:0045333),0.7782258043015895,2.6243529126248624,0.0,0.0,0.0,16/20,16.04%,UQCRB;UQCRH;UQCRFS1;ETFA;UQCRC2;NDUFS8;NDUFS4;UQCR10;SDHB;SURF1;SDHC;SDHAF4;COQ10B;MTFR1L;OXA1L;BLOC1S1
gsea,protein polyubiquitination (GO:0000209),0.4998011796353598,2.621497099111045,0.0,0.0,0.0,47/140,18.66%,PSMB3;PSMA2;UBE2D3;RBX1;PSMB9;UBE2A;PSMB1;ANAPC11;UBE2B;PSME1;PSMA1;PSMD8;RNF187;RNF115;UBE2K;PSMA7;MKRN1;PSMB8;UBE2E1;CDC26;UBE2L3;PSMB4;PSMD5;DDA1;FBXO22;RNF166;PSMD10;UBE2J2;CTNNB1;RNF34;UBE2G1;UBE2W;TRIM27;RNF114;FBXO4;TRIM2;UBC;PSMB10;UBE2R2;PSMD4;UBE2J1;FBXL5;FBXO6;PSMD13;FBXO9;ANAPC10;RNF4
gsea,regulation of cell cycle phase transition (GO:1901987),0.764431664231058,2.6113747523051885,0.0,0.0,0.0,20/27,18.54%,PSMB3;PSMA2;PSMB9;PSMB1;ANAPC11;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;UBE2E1;CDC26;PSMB4;PSMD5;PSMD10;ANAPC16;PSMB10;PSMD4;PSMD13;ANAPC10
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.7473266190461857,2.606595140281772,0.0,0.0,0.0,8/23,7.37%,RAC1;RAC2;CDC42;ACTR3;ARPC2;BRK1;MIEN1;TWF2
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.6884207852835127,2.5991905385665297,0.0,0.0,0.0,16/29,14.27%,BCAP31;PDCD6;RPS3;LGALS9;ARL6IP5;PDCD5;BEX3;PDCD2;HMGB1;LCK;MTCH1;CASP8;FIS1;PYCARD;BCL10;BAD
gsea,macroautophagy (GO:0016236),0.5785077414713976,2.5930752854288484,0.0,0.0,0.0,27/67,20.10%,TOMM22;CSNK2B;TOMM7;GABARAPL2;DYNLL1;GABARAP;TOMM6;VPS28;MAP1LC3B;SQSTM1;TSG101;BECN1;GABARAPL1;VPS36;FUNDC1;CHMP3;VTA1;ATG5;VTI1B;PGAM5;PRKAG1;ATG4B;ATG3;MTERF3;PRKAB1;MAP1LC3A;CHMP2A
gsea,protein transport (GO:0015031),0.5161756918149649,2.589876044153724,0.0,0.0,0.0,59/157,20.47%,YWHAH;ARF1;CD3G;ATP6V1F;VPS29;SEC13;PDCD6;ARF4;ARF5;ATP6V0C;SAR1B;ARL6IP5;ARF6;SVBP;TMED9;ATP6V1D;VAMP4;RAB18;GOLGA7;RAB8A;RAB10;SCAMP3;TMED10;ATP6V1G1;SNX1;UNC119;SNX17;CTSA;CHMP3;ATP6V0D1;ARL6;RAB28;STX8;TMED5;SNX6;RAB11B;NAPA;RAB1B;SYS1;ATP6V1E1;ARFRP1;ATP6V0B;VMP1;RAB21;SCAMP2;ATP6V1C1;SAR1A;COPZ1;NEURL1B;ATP6AP1;CHMP1A;TMED7;RAB29;RAB5C;ATP6V0A1;ARL4A;ACD;CHMP2A;TMED3
gsea,substantia nigra development (GO:0021762),0.8238706091147895,2.5859531225467918,0.0,0.0,0.0,10/18,9.33%,RHOA;CDC42;YWHAH;COX6B1;CALM1;DYNLL1;CALM3;NDUFS3;SIRT2;CNP
gsea,establishment of protein localization to mitochondrion (GO:0072655),0.8024699776782465,2.5844367829023116,0.0,0.0,0.0,13/18,13.92%,TOMM22;TOMM7;BCAP31;TSPO;DNAJC19;TIMM17B;PAM16;TIMM10B;MFF;ROMO1;FIS1;AIP;TOMM34
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6981167300621484,2.5749336028967464,0.0,0.0,0.0,19/31,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ELOB;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;UBC;PSMB10;PSMD4;KLF2;PSMD13
gsea,regulation of stem cell differentiation (GO:2000736),0.7109732278922648,2.5730472061026046,0.0,0.0,0.0,19/32,19.28%,PSMB3;NUDT21;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;OCIAD1;PSMD10;YTHDF2;PSMB10;PSMD4;PSMD13;LDB1
gsea,protein N-linked glycosylation (GO:0006487),0.7477830417694467,2.56843612024785,0.0,0.0,0.0,13/25,13.71%,TMEM258;KRTCAP2;OST4;OSTC;DAD1;TUSC3;DPM1;DPM3;DPM2;SRD5A3;ALG5;MGAT2;TMEM165
gsea,protein targeting to ER (GO:0045047),0.830948904182736,2.559583332633481,0.0,0.0,0.0,42/63,9.41%,RPS15A;SPCS1;RPL39;RPS7;RPS10;RPL27;RPS13;SRP14;SRP9;RPL29;SEC61G;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPS3;RPL35;RPS11;RPS4X;SPCS2;RPS9;RPS16;RPL27A;RPL12;RPL24;SRP19;RPS20;RPL18;RPS14;RPS23;RPLP2;RPS28;RPS21;RPL37;RPS27;RPL19;RPS5;RPL11
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.6787584524057811,2.55339674691543,0.0,0.0,0.0,19/32,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;ELOB;SIRT2;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;UBC;PSMB10;PSMD4;PSMD13
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.7511069374949488,2.549221470696963,0.0,0.0,0.0,14/27,11.51%,PSMB3;PSMA2;RBX1;CDK2AP2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10
gsea,protein localization to organelle (GO:0033365),0.6158655299555161,2.5375542161076816,0.0,0.0,0.0,22/59,15.76%,SEC61B;SEC61G;GABARAPL2;VAPA;CYB5A;WDR83OS;ARF6;EMD;AUP1;TOR1A;RAB11A;ATP6V1D;IFT20;RPL11;CNEP1R1;TRAM1;ARL6;UBE2J2;UBAC2;SYS1;ARL3;ARFRP1
gsea,ribosome biogenesis (GO:0042254),0.7778150900577419,2.528074243684853,0.0,1.6212995667887558e-05,0.001,34/54,13.66%,RPL39;RPS7;RPL27;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPL35;RPS9;RBIS;C1D;RPS16;RPL27A;RPL12;RPL24;RPL18;MRPL36;IMP3;RPS14;RPLP2;RPS28;RPL37;RPS27;RPL19;RPL11;PAK1IP1;RPL21;RPS6;RPL17
gsea,pre-replicative complex assembly (GO:0036388),0.7795416049451926,2.5253271384459484,0.0,1.6050865711208683e-05,0.001,17/21,18.41%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;UBC;PSMB10;PSMD4;ORC4;PSMD13
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.6461493287694186,2.5233097951318464,0.0,1.5583364768163767e-05,0.001,12/34,11.07%,CAPZB;ARF1;DYNLL1;SEC13;CLTA;SAR1B;CAPZA1;ACTR10;AP1S1;DCTN6;DCTN2;DCTN3
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.6461493287694186,2.5233097951318464,0.0,1.5583364768163767e-05,0.001,12/34,11.07%,CAPZB;ARF1;DYNLL1;SEC13;CLTA;SAR1B;CAPZA1;ACTR10;AP1S1;DCTN6;DCTN2;DCTN3
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.6461493287694186,2.5233097951318464,0.0,1.5583364768163767e-05,0.001,12/34,11.07%,CAPZB;ARF1;DYNLL1;SEC13;CLTA;SAR1B;CAPZA1;ACTR10;AP1S1;DCTN6;DCTN2;DCTN3
gsea,rRNA processing (GO:0006364),0.7913148897266967,2.5192484112095976,0.0,1.543352472231604e-05,0.001,30/52,9.41%,RPL39;RPS7;RPL27;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;LSM6;RPL35;RPS9;C1D;RPS16;RPL27A;RPL12;RPL24;RPL18;IMP3;RPS14;RPLP2;RPS28;RPL37;RPS27;RPL19;NSA2;RPL11
gsea,protein insertion into membrane (GO:0051205),0.8036972467949206,2.517386993941233,0.0,1.5286538772579694e-05,0.001,10/15,15.25%,SEC61B;SEC61G;VAPA;CYB5A;WDR83OS;EMD;MAIP1;TRAM1;UBE2J2;OXA1L
gsea,endoplasmic reticulum organization (GO:0007029),0.679767296935922,2.5129141359167044,0.0,3.02846522852994e-05,0.001,15/29,20.62%,SEC61B;SEC61G;VAPA;CYB5A;WDR83OS;EMD;RAB18;REEP5;RAB10;TRAM1;UBE2J2;RTN4;LPCAT3;TOR1AIP2;VAPB
gsea,mitochondrion disassembly (GO:0061726),0.7190913556662103,2.503848148833811,0.0,4.500242722768789e-05,0.001,14/22,20.30%,FUNDC2;GABARAPL2;GABARAP;CISD2;MAP1LC3B;SQSTM1;BECN1;GABARAPL1;FUNDC1;ATG5;FIS1;ATG3;MAP1LC3A;FBXO7
gsea,protein modification by small protein conjugation (GO:0032446),0.47750567309848013,2.5020504818748712,0.0,4.4585738086690786e-05,0.001,47/143,20.82%,UBE2D3;UBE2I;RBX1;UBE2A;SUMO1;ANAPC11;RNF7;NEDD8;UBE2B;DCUN1D5;COMMD1;RNF187;ELOB;UBE2K;MKRN1;DERL1;UBE2E1;PCNP;UFC1;UBE2L3;RNF181;ARRB2;UFM1;WDR61;UBE2J2;ANAPC16;UBE2F;RNF34;BCL10;UBE2G1;RRAGA;NSMCE2;UBE2W;TRIM27;RCHY1;FBXO4;UBC;MKRN2;ATG3;UBE2R2;PEX13;FBXL5;KLHL7;FBXO9;FBXO7;RNF138;URM1
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.7032914490125438,2.5011621783811577,0.0,4.417669461800554e-05,0.001,18/28,19.28%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PDCD2;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;YTHDF2;PSMB10;PSMD4;PSMD13;LDB1
gsea,Ras protein signal transduction (GO:0007265),0.6517942978129544,2.499188526447602,0.0,4.3775088303296404e-05,0.001,14/43,15.96%,RAC1;RAP1A;RHOA;RAC2;ARHGDIB;RAP1B;BRK1;GNB1;RHOG;WAS;LAT;GRB2;RRAS;KRAS
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.530567781314129,2.488859928116642,0.0,4.338071813840185e-05,0.001,23/78,15.39%,RHOA;NDFIP1;FKBP1A;GSTP1;VAPA;LAMTOR5;SHISA5;LGALS9;LITAF;TMEM9B;SQSTM1;CARD19;ZFAND6;NDFIP2;LIME1;CASP8;SLC35B2;TFG;PYCARD;BCL10;GOLT1B;TRIM27;S100A13
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6947400611859121,2.4878371979058884,0.0,4.299339029788039e-05,0.001,20/29,18.41%,PSMB3;B2M;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;VAMP3;PSMB4;SEC22B;PSMD5;CYBA;PSMD10;NCF4;PSMB10;PSMD4;PSMD13
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.7100762854328352,2.4860070901958204,0.0,4.261291781736818e-05,0.001,17/27,19.28%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;YTHDF2;PSMB10;PSMD4;PSMD13;LDB1
gsea,positive regulation of protein targeting to mitochondrion (GO:1903955),0.7621109295444285,2.482931760899723,0.0,4.2239120292654425e-05,0.001,9/16,12.05%,RAC2;UBE2D3;UBL5;TOMM7;SH3GLB1;PDCD5;UBE2L3;GSK3A;UBE2J2
gsea,cotranslational protein targeting to membrane (GO:0006613),0.824664550289086,2.480999869375867,0.0,4.187182359445744e-05,0.001,44/59,13.66%,RPS15A;RPL39;RPS7;RPS10;RPL27;RPS13;SRP14;SRP9;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPS3;RPL35;RPS11;RPS4X;RPS9;RPS16;RPL27A;RPL12;RPL24;SRP19;RPS20;RPL18;RPS14;RPS23;RPLP2;RPS28;RPS21;RPL37;RPS27;RPL19;RPS5;RPL11;TRAM1;RPL21;SEC62;RPS6;RPL17
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.5772679469813243,2.4802604208425194,0.0,4.151085959795349e-05,0.001,21/59,18.41%,PSMB3;PSMA2;PSMB9;PSMB1;UBE2B;PSME1;PSMA1;PSMD8;ATP6V0C;ILK;ATP6AP2;PSMA7;PSMB8;PSMB4;PSMD5;GSKIP;PSMD10;GID8;PSMB10;PSMD4;PSMD13
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.7864200157270185,2.478052539700101,0.0,4.115606592617611e-05,0.001,14/22,11.64%,PSMB3;PSMA2;OAZ1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;PANK2
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.716787693819807,2.4778754168370356,0.0,4.080728570646275e-05,0.001,14/26,14.62%,BCAP31;LAMTOR5;PDCD6;ARL6IP5;PDCD5;BEX3;HMGB1;DNAJB6;FIS1;PYCARD;BCL10;IGBP1;BAD;TRIAP1
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.79862245979239,2.4752134610448397,0.0,4.046436733918156e-05,0.001,13/20,11.51%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10
gsea,autophagy of mitochondrion (GO:0000422),0.6989771672685123,2.472109500038436,0.0,4.0127164278021705e-05,0.001,14/23,20.30%,FUNDC2;GABARAPL2;GABARAP;CISD2;MAP1LC3B;SQSTM1;BECN1;GABARAPL1;FUNDC1;ATG5;FIS1;ATG3;MAP1LC3A;FBXO7
gsea,negative regulation of gene expression (GO:0010629),0.5377919915438529,2.471329399792938,0.0,3.979553482117855e-05,0.001,34/88,23.01%,SRGN;LSM5;NDFIP1;CD3E;RPS13;TMBIM6;LSM6;RPS3;PDCD10;LGALS9;ID2;PAIP2;RNH1;EIF4E2;NDFIP2;MAP2K1;NUDT16L1;NPTN;EZH2;PCIF1;SNX12;CNPY2;YTHDF2;CD28;CNOT8;DCP2;TRIM27;PPP1R11;RPS6KA4;LSM14A;CD46;SFMBT2;MALSU1;ERP29
gsea,ncRNA processing (GO:0034470),0.7356261171050752,2.4707663449200505,0.0,3.946934191280824e-05,0.001,33/59,13.95%,RPL39;RPS7;RPL27;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPL35;RPS9;C1D;RPS16;RPL27A;RPL12;RPL24;RPL18;IMP3;RPS14;RPLP2;RPS28;RPL37;RPS27;RPL19;RPL11;RPP21;RPL21;RPS6;RPL17;POP7
gsea,positive regulation of lamellipodium organization (GO:1902745),0.8431111089198601,2.45857142924351,0.0,3.914845295416751e-05,0.001,8/15,7.37%,RAC1;RAC2;CDC42;ACTR3;ARPC2;BRK1;CORO1B;TWF2
gsea,positive regulation of intracellular signal transduction (GO:1902533),0.508651171612121,2.4560661392135854,0.0,3.8832739623891975e-05,0.001,49/151,17.57%,RAC1;RHOA;RAC2;NDFIP1;FKBP1A;RPL23;BCAP31;RHEB;VAPA;LAMTOR5;SHISA5;SEC13;RPS3;LGALS9;LITAF;RPS20;RHOG;LAMTOR2;ILK;LAMTOR4;TMEM9B;SLC9A3R1;RPL37;HMGB1;LCK;NDFIP2;BECN1;LAMTOR1;HCST;CASP8;SLC35B2;FIS1;TFG;BCL10;HDAC3;CD27;RRAGA;CD28;GRB2;NMI;BAD;GOLT1B;TRIM27;S100A13;LAMTOR3;ITGB1BP1;RTN4;RUNDC3A;RELA
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.8400061747691558,2.4546534246097527,0.0,3.852207770690084e-05,0.001,40/58,9.41%,RPS15A;RPL39;RPS7;SEC61B;RPS10;RPL27;RPS13;SRP14;SRP9;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPS3;RPL35;RPS11;RPS4X;RPS9;RPS16;RPL27A;RPL12;RPL24;SRP19;RPS20;RPL18;RPS14;RPS23;RPLP2;RPS28;RPS21;RPL37;RPS27;RPL19;RPS5;RPL11
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.6782283656683711,2.453481648033441,0.0,3.821634693144925e-05,0.001,20/30,18.41%,PSMB3;B2M;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;VAMP3;PSMB4;SEC22B;PSMD5;CYBA;PSMD10;NCF4;PSMB10;PSMD4;PSMD13
gsea,positive regulation of binding (GO:0051099),0.6784958026834319,2.4525695966046372,0.0,3.791543081387878e-05,0.001,10/26,13.72%,B2M;FKBP1A;DPH3;SIRT2;HMGB1;DERL1;HMGB2;RPL11;EDF1;NMD3
gsea,cytoplasmic translation (GO:0002181),0.8376672478430892,2.4495524607177526,0.0,3.761921651064535e-05,0.001,39/57,9.41%,RPS15A;RPL39;RPS7;RPS10;RPL27;EIF3M;RPS13;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPS3;RPL35;RPS11;RPS4X;RPS9;RWDD1;RPS16;RPL27A;RPL12;RPL24;RPS20;EIF3I;RPL18;RPS14;RPS23;RPS28;RPS21;RPL37;TMA7;RPS27;RPL19;RPS5;RPL11
gsea,regulation of apoptotic process (GO:0042981),0.48635221542571816,2.443739315889084,0.0,3.7327594677229494e-05,0.001,78/188,26.61%,TPT1;YWHAZ;SAP18;CD3E;GSTP1;TMBIM6;PSENEN;NAA38;RPS3;HIGD2A;PDCD10;ARF4;MIEN1;PRDX2;CIB1;ARL6IP5;TMBIM4;IER3IP1;APH1A;PDCD5;PRDX5;PDCD2;SQSTM1;CTSB;ZFAND6;SRA1;HMGB1;BNIP3L;TMEM219;GLO1;MTCH1;UFM1;CASP8;CAT;PSMD10;STK17B;CTNNB1;PYCARD;BCL10;HDAC3;CD27;CD28;RPS6;LCMT1;BAG1;BABAM2;BAD;TNFRSF12A;TRIAP1;TRIM2;UBC;RNF122;STK26;RTN4;ING3;TAX1BP1;RELA;MCL1;CASP6;DIABLO;NCSTN;HYPK;MYD88;EVI2B;WFS1;TIAM2;CDK5;TAF9B;TRADD;ACER2;TMEM14A;BNIP2;RASGRF2;UBA52;RPS6KA1;IL7;RPS6KA2;IGF1R
gsea,rRNA metabolic process (GO:0016072),0.7818509467046627,2.4427484029378776,0.0,3.70404593335585e-05,0.001,29/51,9.41%,RPL39;RPS7;RPL27;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPL35;RPS9;C1D;RPS16;RPL27A;RPL12;RPL24;RPL18;IMP3;RPS14;RPLP2;RPS28;TRIR;RPL37;RPS27;RPL19;RPL11
gsea,regulation of cellular amine metabolic process (GO:0033238),0.7846402693463193,2.4403455746503124,0.0,4.863898700366267e-05,0.001,13/21,11.51%,PSMB3;PSMA2;OAZ1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.7846402693463193,2.4403455746503124,0.0,4.863898700366267e-05,0.001,13/21,11.51%,PSMB3;PSMA2;OAZ1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10
gsea,regulation of protein ubiquitination (GO:0031396),0.5746193841992379,2.4401101844623923,0.0,4.8273280334462204e-05,0.001,22/45,16.39%,NDFIP1;FKBP1A;RPS3;CENPX;VPS28;COMMD1;SVBP;SQSTM1;NDFIP2;DERL1;UBXN1;UBE2L3;ARRB2;GSK3A;CHP1;PSMD10;BCL10;HDAC3;RCHY1;NSMCE3;FBXO4;PTTG1IP
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5883958550488508,2.436527236217056,0.0,4.7913031973757253e-05,0.001,20/53,18.41%,PSMB3;PSMA2;PSMB9;PSMB1;UBE2B;PSME1;PSMA1;PSMD8;ILK;ATP6AP2;PSMA7;PSMB8;PSMB4;PSMD5;GSKIP;PSMD10;GID8;PSMB10;PSMD4;PSMD13
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5306604803595452,2.434875298924156,0.0,4.75581206258035e-05,0.001,44/124,20.43%,ARPC3;RAC1;RHOA;CDC42;CD3E;ACTR3;ARPC4;ARPC5;ARPC2;ATP6V1F;PSENEN;BRK1;POLR2K;POLR2G;ATP6V0C;POLR2D;APH1A;ARPC1B;SDCBP;SIRT2;ATP6V1D;STAP1;ARPC1A;LCK;ATP6V1G1;PTPN2;CYBA;GSK3A;ATP6V0D1;POLR2I;GRB2;NCF4;CD8A;ATP6V1E1;POLR2J;ATP6V0B;APPL1;ATP6V1C1;ATP6AP1;EFNB1;ATP6V0A1;AP2M1;NCSTN;ZAP70
gsea,regulation of cytokinesis (GO:0032465),0.7248739268469397,2.4325508046792756,0.0,4.7208428562378476e-05,0.001,8/21,8.99%,RHOA;CDC42;CALM1;SH3GLB1;CALM3;RAB11A;BECN1;CETN2
gsea,positive regulation of protein localization to membrane (GO:1905477),0.6483753797463965,2.428006429805848,0.0,4.6863841492580087e-05,0.001,16/34,16.62%,YWHAZ;YWHAH;CIB1;ARF6;PDCD5;RHOG;SQSTM1;MFF;YWHAB;PPP3CC;CASP8;CHP1;FIS1;BAD;ITGB2;ITGB1BP1
gsea,NIK/NF-kappaB signaling (GO:0038061),0.7298789726010886,2.426316586964354,0.0,4.6524248438286033e-05,0.001,17/26,18.60%,PSMB3;PSMA2;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;PSMA7;PSMB8;PSMB4;PSMD5;PSMD10;PSMB10;PSMD4;RELA;PSMD13;COPS8
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.6921463331883113,2.420973915633999,0.0,4.618954161498901e-05,0.001,15/21,18.60%,RBX1;POLR2K;POLR2G;CCNH;POLR2D;COPS6;ISY1;ERCC1;POLR2I;TCEA1;POLR2J;UBC;GTF2H5;POLD4;COPS8
gsea,protein deubiquitination (GO:0016579),0.5073249985182471,2.4166857707356106,0.0,5.732452039717386e-05,0.001,29/92,18.41%,PSMB3;RHOA;PSMA2;PSMB9;SNX3;PSMB1;EIF3F;NEDD8;PSME1;PSMA1;PSMD8;ENY2;TAF10;PSMA7;BECN1;PSMB8;RCE1;PSMB4;ARRB2;PSMD5;PSMD10;OTUB1;BABAM2;UBC;PSMB10;BABAM1;PSMD4;UFD1;PSMD13
gsea,protein modification by small protein removal (GO:0070646),0.5113855358586864,2.4153390469816203,0.0,5.69179635149244e-05,0.001,31/94,18.60%,PSMB3;RHOA;PSMA2;PSMB9;SNX3;PSMB1;EIF3F;NEDD8;PSME1;PSMA1;PSMD8;COPS6;TOR1A;TAF10;PSMA7;BECN1;PSMB8;RCE1;PSMB4;ARRB2;PSMD5;PSMD10;OTUB1;BABAM2;UBC;PSMB10;BABAM1;PSMD4;UFD1;PSMD13;COPS8
gsea,cellular response to oxygen-containing compound (GO:1901701),0.5448199678418082,2.41181933401986,0.0,5.651713278594606e-05,0.001,23/80,13.23%,RAP1A;RHOA;GSTP1;RAP1B;LAMTOR5;RPS3;GNB1;PRDX5;LAMTOR2;LAMTOR4;CHMP5;STAP1;TWF2;ZFAND1;HMGB1;GNG2;ROMO1;LAMTOR1;HMGB2;PDK3;PYCARD;BCL10;RRAGA
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7861663416478415,2.4031120506355017,0.0,5.612190808114924e-05,0.001,38/63,9.41%,RPS15A;RPL39;RPS7;RPS10;RPL27;RPS13;RPL29;RPL32;RPL30;RPL9;RPS24;RPL34;RPL36A;RPL23;RPL22;RPS3;RPL35;RPS11;RPS4X;RPS9;RPS16;RPL27A;EIF3E;RPL12;RPL24;RPS20;RPL18;RPS14;RPS23;RPLP2;PPP2CA;RPS28;RPS21;RPL37;RPS27;RPL19;RPS5;RPL11
gsea,cellular component assembly (GO:0022607),0.5396403144074611,2.3954062897572226,0.0,6.687860713003618e-05,0.001,35/86,28.29%,RAC1;RHOA;YWHAZ;RAC2;CDC42;CD3E;VASP;CD3G;PDCD10;RHOG;CAPZA1;CORO1B;ILK;ELOB;SLC9A3R1;VAMP3;WAS;YTHDF2;PPP2R1A;VMP1;RTN4;ACD;PARVG;AIF1L;CD247;RHOD;RHOV;RSPH9;LIMS1;BAIAP2L2;STAG3;SLC9A3R2;HAS3;TAPBP;FOXJ1
gsea,protein processing (GO:0016485),0.6680994984694238,2.3924380687920657,0.0,7.748693791617984e-05,0.001,8/27,8.82%,SRGN;SPCS1;PSENEN;SPCS2;SEC11C;SEC11A;APH1A;RCE1
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5923349757590227,2.3897702973957173,0.0,7.695620546469916e-05,0.001,19/36,22.77%,RER1;ARF4;ARF5;KDELR1;TMED9;TMED10;SURF4;COPB1;SEC22B;ERGIC3;NAPA;COPE;RAB1B;COPZ1;TMED7;ERGIC2;TMED3;ATP9A;RAB1A
gsea,positive regulation of translation (GO:0045727),0.6388261365855196,2.3875690943752916,0.0,7.643269386289848e-05,0.001,15/34,15.94%,RBM3;POLR2G;RPS4X;RPS9;EIF3E;ELAVL1;POLR2D;COA3;CIRBP;NGRN;PCIF1;YTHDF2;CD28;UQCC2;MPV17L2
gsea,post-Golgi vesicle-mediated transport (GO:0006892),0.5530648678883296,2.3845341710638395,0.0,7.591625674220322e-05,0.001,21/45,20.10%,FTH1;ARF1;CLTA;COMMD1;GOLGA7;RAB10;AP1S1;SCAMP3;BLOC1S4;VPS35L;NAPA;SYS1;AP4S1;ARL3;BLOC1S1;SCAMP2;CLINT1;BLOC1S3;RABIF;AP1S2;CHMP2A
gsea,negative regulation of programmed cell death (GO:0043069),0.5091632567806053,2.3823697719676833,0.0,8.617914475816741e-05,0.001,48/97,29.92%,TPT1;YWHAZ;GSTP1;TMBIM6;NAA38;HIGD2A;PDCD10;ARF4;MIEN1;PRDX2;CIB1;DCPS;TMBIM4;PRDX5;SQSTM1;ZFAND6;BNIP3L;GLO1;UFM1;CAT;PSMD10;CTNNB1;HDAC3;CD27;CD28;BAG1;BABAM2;TRIAP1;UBC;TAX1BP1;RELA;MCL1;HYPK;MYD88;EVI2B;WFS1;TAF9B;TMEM14A;BNIP2;UBA52;RPS6KA1;IL7;IGF1R;PAK2;HTATIP2;SIAH2;TOPORS;DDRGK1
gsea,protein-containing complex disassembly (GO:0032984),0.6446298109658486,2.373538608285298,0.0,9.630519426725209e-05,0.002,10/29,12.13%,PPP1CA;RPL23;GABARAPL2;GABARAP;MAP1LC3B;TSG101;GABARAPL1;CHMP3;CTNNB1;VTI1B
gsea,cellular response to interleukin-12 (GO:0071349),0.7206187160246785,2.368339654347467,0.0,9.566741152376036e-05,0.002,10/18,12.23%,CDC42;TALDO1;ARF1;RAP1B;CD47;CAPZA1;MSN;CNN2;PITPNA;AIP
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.6030039850669406,2.3675454709249246,0.0,9.503802065847244e-05,0.002,15/40,15.01%,RBX1;SUMO1;EIF3H;GABARAP;COMMD1;SDCBP;ELOB;SIRT2;UBXN1;RPL11;DDA1;FBXO22;GSK3A;PSMD10;RCHY1
gsea,positive regulation of protein ubiquitination (GO:0031398),0.6188449831066263,2.3667453971807655,0.0,9.441685712475695e-05,0.002,19/33,16.39%,NDFIP1;FKBP1A;RBX1;PDCD6;DCUN1D5;CENPX;COMMD1;NDFIP2;PEF1;DERL1;UBE2L3;GSK3A;PSMD10;BCL10;HDAC3;RCHY1;NSMCE3;FBXO4;PTTG1IP
gsea,protein K48-linked ubiquitination (GO:0070936),0.6182442505656377,2.365606599996888,0.0,9.380376064992087e-05,0.002,12/31,18.66%,UBE2D3;RBX1;UBE2A;UBE2B;RNF187;RNF115;UBE2K;UBE2E1;RNF34;UBE2G1;UBE2R2;RNF4
gsea,nucleotide-excision repair (GO:0006289),0.617659436192015,2.360549839364093,0.0,9.319857509734072e-05,0.002,17/30,18.60%,RBX1;POLR2K;POLR2G;CCNH;POLR2D;COPS6;COMMD1;ISY1;CETN2;ERCC1;POLR2I;TCEA1;POLR2J;UBC;GTF2H5;POLD4;COPS8
gsea,intracellular protein transmembrane transport (GO:0065002),0.7346278069761703,2.3604060348891336,0.0,9.260114833389624e-05,0.002,7/18,12.21%,SEC61B;SEC61G;DNAJC19;TIMM17B;PAM16;ROMO1;SEC62
gsea,mitotic spindle organization (GO:0007052),0.6309830942864993,2.3596284429751377,0.0,9.201133210247016e-05,0.002,16/27,23.82%,RHOA;PPP1CC;DYNLL1;SEC13;RAB11A;MAPRE1;RPS27;DCTN6;DCTN2;MZT1;NDEL1;TUBG2;LSM14A;B9D2;SBDS;TBCE
gsea,autophagosome maturation (GO:0097352),0.7158938462950113,2.3517972185054887,0.0,9.142898189928996e-05,0.002,9/18,16.06%,CALM1;GABARAPL2;GABARAP;MAP1LC3B;TSG101;GABARAPL1;CHMP3;VTI1B;VMP1
gsea,cytoskeleton organization (GO:0007010),0.6216297693200522,2.348577527500055,0.0,9.085395685589819e-05,0.002,7/39,9.22%,RAC1;RHOA;RAC2;CAPZB;THY1;RHOG;CNN2
gsea,ribonucleoprotein complex biogenesis (GO:0022613),0.7922066193515015,2.34052877666255,0.0,9.028611962554883e-05,0.002,9/18,13.40%,RPS7;RPS24;RBIS;RPS16;MRPL36;RPS28;RPL11;PAK1IP1;RPS6
gsea,regulation of cell-matrix adhesion (GO:0001952),0.7288062518383366,2.3398224851287757,0.0,8.972533627383735e-05,0.002,5/18,4.00%,RHOA;CD3E;THY1;SKAP1;CIB1
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.5980253009408417,2.3329896714342033,0.0,9.907941797042396e-05,0.003,22/64,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;EMD;SLC9A3R1;PSMA7;PSMB8;PSMB4;PSMD5;GSK3A;PFDN5;PSMD10;MAD2L2;UBAC2;PSMB10;PSMD4;PSMD13
gsea,intracellular protein transport (GO:0006886),0.4519269442931395,2.331936284252345,0.0,9.847156878042135e-05,0.003,54/124,27.54%,YWHAH;ARF1;VPS29;SEC13;PDCD6;GABARAP;ARF4;ARF5;SAR1B;ARF6;VPS28;TMED9;RAB18;TMED10;RPL11;VPS36;SURF4;SNX1;MAIP1;SNX17;CTSA;CHP1;ARL6;RAB28;STX8;TMED5;SNX6;NAPA;RAB1B;FAM53A;OXA1L;AP4S1;ARFRP1;RAB21;PTTG1IP;APPL1;SAR1A;COPZ1;TMED7;RAB29;RAB5C;ARL4A;ACD;TMED3;TBC1D10A;RAB1A;ERP29;VPS26C;STRADB;VPS26A;ARFIP1;VPS25;RTN2;STX12
gsea,double-strand break repair (GO:0006302),0.5890093231853257,2.3315192367939965,0.0,9.787113238541879e-05,0.003,15/43,16.51%,SEM1;SWI5;SUMO1;CIB1;MORF4L1;HMGB1;NABP2;UBXN1;HMGB2;SFR1;ERCC1;MAD2L2;NSMCE2;BABAM2;BABAM1
gsea,regulation of actin filament-based process (GO:0032970),0.6786505741393883,2.3288583736308826,0.0,9.727797400732534e-05,0.003,7/23,9.22%,ABRACL;RAC1;RHOA;RAC2;RHOG;TWF2;CNN2
gsea,positive regulation of protein transport (GO:0051222),0.6429119634338677,2.328720967236508,0.0,9.669196211571494e-05,0.003,8/23,11.40%,OAZ1;PDCD10;ARF6;IER3IP1;VPS28;ZFAND1;TMED10;CHP1
gsea,transcription by RNA polymerase II (GO:0006366),0.4840853621949857,2.328043597520849,0.0,9.61129683305909e-05,0.003,36/103,17.86%,NUDT21;SNRPG;POLR2K;POLR2G;DDX5;CCNH;POLR2D;GTF2B;GTF2A2;SSU72;TAF10;ELOB;NABP2;TAF12;ARRB2;SNAPC5;ABT1;CLP1;WDR61;LSM10;TAF11;POLR2I;MED18;HDAC3;NRBF2;TCEA1;TAF13;POLR2J;PHAX;INTS12;GTF2H5;TBPL1;CDK9;IRF9;NR4A1;NRBP1
gsea,nuclear membrane reassembly (GO:0031468),0.6820876926404215,2.3256121250988326,0.0,0.00010509495406148543,0.003,11/21,21.05%,UBE2I;SUMO1;SEC13;EMD;PPP2CA;SIRT2;CHMP3;PPP2R1A;PPP2R2A;CHMP2A;UBXN2A
gsea,endomembrane system organization (GO:0010256),0.514812431417256,2.314056243327153,0.0,0.0001139706441032569,0.004,24/61,22.77%,SRGN;CDC42;VAPA;PLEKHJ1;TOR1A;SQSTM1;TMED9;SLC9A3R1;REEP5;TMED10;LAMTOR1;RAB2A;SURF4;TMED5;VMP1;TMED7;RAB29;TMED3;TOR1AIP2;VAPB;UBXN2A;VPS51;OBSL1;RAB1A
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.6874563906556652,2.308931760346401,0.0,0.00012274191426218405,0.004,7/25,4.66%,RBX1;SUMO1;RAP1B;BRK1;RPS3;SKAP1;SH3GLB1
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.6884482240961493,2.3079252234257543,0.0,0.00012131468270099586,0.004,10/20,20.10%,UBE2I;SUMO1;SEC13;EMD;PPP2CA;SIRT2;CHMP3;PPP2R1A;PPP2R2A;CHMP2A
gsea,mitotic nuclear membrane organization (GO:0101024),0.6884482240961493,2.3079252234257543,0.0,0.00012131468270099586,0.004,10/20,20.10%,UBE2I;SUMO1;SEC13;EMD;PPP2CA;SIRT2;CHMP3;PPP2R1A;PPP2R2A;CHMP2A
gsea,supramolecular fiber organization (GO:0097435),0.5547747468420665,2.306501739395051,0.0,0.00012061344176052766,0.004,18/79,12.61%,RAC1;RHOA;RAC2;B2M;CDC42;ITM2B;FKBP1A;PSENEN;PPIB;CIB1;APH1A;RHOG;CORO1B;CRIPT;DNAJB6;CHP1;MAD2L2;KATNA1
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.7059687298328099,2.301362068539374,0.0,0.00012914489652696642,0.004,9/17,12.23%,CDC42;TALDO1;ARF1;RAP1B;CAPZA1;MSN;CNN2;PITPNA;AIP
gsea,ribosomal small subunit biogenesis (GO:0042274),0.8111761662449035,2.3001541055214942,0.0,0.00012840692568966947,0.004,9/15,13.40%,RPS7;RPS24;LSM6;RPS16;RPS14;RPS28;RPS27;RPS5;RPS6
gsea,positive regulation of cellular process (GO:0048522),0.4958603544256021,2.297622737415334,0.0,0.0001276773408846145,0.004,50/134,26.82%,RPS15A;RAC1;CDC42;CST7;UBE2A;COPS9;RPL23;PDCD10;RPS4X;RPS9;IL2RG;CIB1;CD47;MCTS1;RHOG;SDCBP;GNAI2;CRLF2;RNF187;SIRT2;ROMO1;CYBA;EZH2;PSMD10;PYCARD;SERTAD1;GID8;RPS6;CNOT8;S100A13;MTPN;MEIS3;KRAS;EAPP;ITGB1BP1;IL12RB2;RELA;IL15;RHOD;CHTOP;PRODH;TAF9B;ACER2;CSNK2A1;AQP11;CNOT7;RPS6KA1;IL7;IGF1R;NOXO1
gsea,protein glycosylation (GO:0006486),0.6008437057541555,2.295415669805686,0.0,0.00013602428568820917,0.005,10/34,14.25%,TMEM258;KRTCAP2;DAD1;TUSC3;DPM1;DPM3;ALG5;MGAT2;TMEM165;C1GALT1C1
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5675380825975161,2.295188876195417,0.0,0.00013526010430793832,0.005,17/49,18.19%,RAP1A;YWHAZ;GSTP1;CIB1;LGALS9;DDT;SLC9A3R1;HMGB1;PTPN2;ARRB2;MAP2K1;PYCARD;SYNJ2BP;RRAS;PTPN1;ITGB1BP1;ATP6AP1
gsea,regulation of cell division (GO:0051302),0.7308627367816467,2.2948449969895437,0.0,0.00013450446126711185,0.005,9/21,8.99%,CDK2AP2;CALM1;CIB1;SH3GLB1;CALM3;RAB11A;SIRT2;BECN1;CETN2
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.6824603216803768,2.2916927471765445,0.0,0.00013375721426007233,0.005,10/21,12.08%,COPS9;RPS3;VPS28;SVBP;SQSTM1;UBXN1;RPL11;ARRB2;CHP1;CTNNB1
gsea,cellular protein localization (GO:0034613),0.4625563252876913,2.2895134981629117,0.0,0.0001330182241260388,0.005,61/123,32.66%,YWHAH;ARF1;VPS29;SEC13;PDCD6;ARF4;ARF5;SAR1B;ARF6;CORO1B;LAMTOR2;TMED9;RAB18;TMED10;LAMTOR1;SNX1;SNX17;CTSA;ARL6;RAB28;STX8;CTNNB1;TMED5;ABHD17A;TM9SF1;UNC50;SNX6;NAPA;RRAGA;RAB1B;OXA1L;LAMTOR3;ARFRP1;RAB21;SAR1A;COPZ1;TMED7;RAB29;RAB5C;ARL4A;ACD;TMED3;TBC1D10A;RAB1A;ERP29;VPS26C;PIGK;VPS26A;ARFIP1;RRAGC;HPS6;STX12;FOXJ1;TMED4;SNX8;RAB19;DMD;SLU7;RAB6A;CAPN3;PTPRU
gsea,positive regulation of endocytosis (GO:0045807),0.7112434692913426,2.2891588476860623,0.0,0.00013228735476270893,0.005,5/16,7.17%,B2M;CDC42;VPS28;TOR1A;STAP1
gsea,protein targeting to membrane (GO:0006612),0.5820921719972848,2.2876750382312587,0.0,0.00013156447304269413,0.005,23/39,31.51%,NACA;SRP14;SRP19;SDCBP;YIF1B;GOLGA7;TRAM1;ZDHHC4;ARL6;FIS1;SEC62;ZDHHC3;PXMP4;ATG3;PEX13;ZDHHC20;AQP11;PEX11B;ATAD1;PEX19;PEX14;SGTA;VPS37D
gsea,regulation of protein targeting to mitochondrion (GO:1903214),0.7076972781075883,2.287422818801172,0.0,0.0001395727453148581,0.006,8/17,12.05%,RAC2;UBE2D3;UBL5;TOMM7;SH3GLB1;UBE2L3;GSK3A;UBE2J2
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),0.6713527025783924,2.2855171587341983,0.0,0.0001388182980428859,0.006,10/20,14.46%,BCAP31;RPS3;SLC9A3R1;LCK;BECN1;FIS1;PYCARD;BCL10;BAD;TNFRSF12A
gsea,selective autophagy (GO:0061912),0.66639940965618,2.283403258367665,0.0,0.00013807196310717146,0.006,10/20,15.51%,DYNLL1;AUP1;MAP1LC3B;SQSTM1;BECN1;UFC1;UFM1;ATG5;TEX264;UBC
gsea,RNA processing (GO:0006396),0.5283434557721398,2.2829858405617522,0.0,0.00013733361036328282,0.006,18/59,15.18%,RBM3;LSM5;NUDT21;SNRPG;LSM6;AURKAIP1;BCAS2;SNRPD2;HNRNPL;ZCRB1;PPP2CA;LSM1;USB1;LSM4;CLP1;WBP4;PPP2R1A;TENT2
gsea,positive regulation of epithelial cell migration (GO:0010634),0.6254366042786341,2.2752068274278385,0.0,0.00013660311243581856,0.006,8/23,16.92%,RAC1;PDCD6;ARF6;RAB11A;EMC10;RRAS;ITGB1BP1;RTN4
gsea,Golgi organization (GO:0007030),0.5517067585057999,2.2721774876232765,0.0,0.00014437286618547491,0.007,20/44,22.77%,YWHAZ;CDC42;PDCD10;TMED9;VAMP4;TMED10;BET1;RAB2A;SURF4;SEC22B;TMED5;VTI1B;VMP1;TMED7;RAB29;TMED3;UBXN2A;VPS51;OBSL1;RAB1A
gsea,positive regulation of cell-substrate adhesion (GO:0010811),0.7076170408775193,2.2681196708513136,0.0,0.00015206083305355594,0.007,6/22,6.23%,RAC1;CDC42;CD3E;SKAP1;CIB1;ILK
gsea,negative regulation of apoptotic process (GO:0043066),0.48304051498601625,2.265816585691315,0.0,0.00015126470303756872,0.007,57/128,30.00%,TPT1;YWHAZ;GSTP1;TMBIM6;LAMTOR5;NAA38;HIGD2A;PDCD10;ARF4;MIEN1;PRDX2;CIB1;TMBIM4;PRDX5;BEX3;SQSTM1;ZFAND6;BNIP3L;GLO1;DNAJB6;UFM1;CAT;PSMD10;CTNNB1;SNX6;HDAC3;CD27;CD28;IGBP1;MAEA;BAG1;BABAM2;TRIAP1;TRIM27;UBC;TAX1BP1;RELA;MCL1;HYPK;MYD88;EVI2B;WFS1;TAF9B;NR4A2;CSNK2A1;TMEM14A;BNIP2;UBA52;RPS6KA1;IL7;IGF1R;PAK2;HTATIP2;SIAH2;TOPORS;DDRGK1;UNC5B
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.6149467864179827,2.2656699229158384,0.0,0.00015047686604258137,0.007,11/30,15.01%,RBX1;SUMO1;BCAP31;GABARAP;ELOB;SIRT2;DDA1;FBXO22;GSK3A;PSMD10;RCHY1
gsea,DNA repair (GO:0006281),0.5013614866795729,2.262642747231039,0.0,0.00014969719316153173,0.007,21/62,18.29%,UBE2A;SUMO1;UBE2B;CIB1;CENPX;COMMD1;NABP2;UBXN1;CETN2;ERCC1;MAD2L2;ALKBH3;BABAM2;TEX264;NSMCE3;UBC;FAAP20;BABAM1;GTF2H5;POLD4;FBXO6
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.5546697627006104,2.261300179196984,0.0,0.00015719920026441493,0.007,15/47,19.28%,RBM3;RPS4X;EIF3E;ELAVL1;ARPP19;CIRBP;PTPN2;CNEP1R1;CHP1;PCIF1;CD28;NMD3;APPL1;KLF2;LDB1
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.5183036236106668,2.258816488986082,0.0,0.0001563930505194692,0.007,29/103,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PPP1CA;UBE2B;PSME1;PSMA1;PSMD8;EMD;ILK;SLC9A3R1;ATP6AP2;PSMA7;PSMB8;PSMB4;PSMD5;GSKIP;GSK3A;PFDN5;PSMD10;MAD2L2;CTNNB1;GID8;UBAC2;PSMB10;PSMD4;PSMD13
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.5697226967158321,2.2560511329880866,0.0,0.0001719735611915216,0.007,22/70,18.41%,PSMB3;PSMA2;RBX1;PSMB9;PSMB1;PSME1;PSMA1;PSMD8;EMD;SLC9A3R1;PSMA7;PSMB8;PSMB4;PSMD5;GSK3A;PFDN5;PSMD10;MAD2L2;UBAC2;PSMB10;PSMD4;PSMD13
gsea,mRNA metabolic process (GO:0016071),0.6645719955821215,2.2559184811859896,0.0,0.00017110059895197071,0.007,11/25,14.73%,LSM5;NUDT21;SNRPG;LSM6;AURKAIP1;DDX5;RNH1;NUDT16L1;LSM10;YTHDF2;DCP2
gsea,cellular protein modification process (GO:0006464),0.41112669544843683,2.251659203127022,0.0,0.00017023645451281935,0.007,98/349,22.82%,PSMB3;YWHAZ;PSMA2;UBE2D3;UBE2I;RBX1;UBL5;PSMB9;DAD1;PSMB1;PPP1CA;PPP1CC;CD3G;RNF7;NEDD8;SHISA5;PSME1;PSMA1;ARF4;GMFG;PSMD8;PPP6C;COPS6;COMMD1;PPP2CA;ILK;RAB11A;ELOB;SIRT2;LCK;PSMA7;RAB8A;CSK;PSMB8;UBE2E1;RCE1;HCST;UBE2L3;PSMB4;RAB2A;PPP3CC;MAP2K1;PSMD5;ALG5;DDA1;PDK3;SETD3;FBXO22;GSK3A;PSMD10;ATG5;STK17B;UBE2F;CTBP1;RAB11B;LCMT1;RAB1B;PPP2R1A;PRKAG1;FBXO4;ASB8;PTPN1;ATG4B;LRRC41;PNPLA2;PSMB10;ATG3;SGK3;STK26;BTBD1;CDK9;PSMD4;UBL4A;FBXL5;NRBP1;PPP2R2A;ASB3;FBXO6;PSMD13;FBXO9;RPS6KA4;PIGS;COPS8;PRKAB1;FUCA2;FBXO7;ZAP70;WFS1;VRK2;CD247;PKN3;PTPN18;PTPN14;NGLY1;OBSL1;CDK5;RAB1A;MXRA8
gsea,regulation of programmed cell death (GO:0043067),0.578097288600568,2.2507111285846997,0.0,0.0001855125182702511,0.007,18/40,23.89%,TPT1;CD3E;RPS3;PRDX2;DCPS;CTSB;SRA1;BNIP3L;TMEM219;LCMT1;TRIAP1;ASAH1;STK26;RTN4;CASP6;WFS1;CDK5;ACER2
gsea,actin filament organization (GO:0007015),0.6409002412874589,2.249201772055433,0.0,0.00018458495567889985,0.007,9/34,11.54%,RAC1;RHOA;RAC2;CDC42;ARPC4;RHOG;CORO1B;WAS;MAD2L2
gsea,regulation of translation (GO:0006417),0.5558409784211844,2.2482132111643987,0.0,0.00018366662256606952,0.007,25/45,27.57%,RBM3;EIF1;EIF3H;RPS3;RPS4X;EIF3E;EIF1B;ELAVL1;PAIP2;EIF4E2;CIRBP;PCIF1;CD28;EIF2B2;CNOT8;METTL18;MTPN;LSM14A;MALSU1;CTIF;EEF2;CNOT7;RPS6KA1;UPF3A;CPEB3
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.5233708430884565,2.2476000427009417,0.0,0.0001827573818602969,0.007,19/50,17.86%,POLR2K;POLR2G;CCNH;POLR2D;GTF2B;GTF2A2;TAF10;TAF12;DR1;TAF11;POLR2I;HDAC3;NRBF2;TAF13;POLR2J;GTF2H5;CDK9;NR4A1;NRBP1
gsea,regulation of actin cytoskeleton organization (GO:0032956),0.6127669811554372,2.2471449530867433,0.0,0.00018185709919103432,0.007,6/29,7.37%,RAC1;RHOA;RAC2;ARHGDIB;RHOG;TWF2
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.6673316196523984,2.2417845843298614,0.0,0.00019574226477083758,0.009,14/22,17.00%,POLR2K;POLR2G;POLR2D;GTF2B;GTF2A2;NABP2;SNAPC5;TAF11;POLR2I;TAF13;POLR2J;PHAX;INTS12;CDK9
gsea,snRNA transcription (GO:0009301),0.6673316196523984,2.2417845843298614,0.0,0.00019574226477083758,0.009,14/22,17.00%,POLR2K;POLR2G;POLR2D;GTF2B;GTF2A2;NABP2;SNAPC5;TAF11;POLR2I;TAF13;POLR2J;PHAX;INTS12;CDK9
gsea,regulation of cell population proliferation (GO:0042127),0.47698795630502616,2.2415721365269516,0.0,0.00019479205960204712,0.009,63/168,26.65%,RPS15A;FTH1;RHOA;CSNK2B;UBE2A;COPS9;RPL23;TSPO;PDCD10;RPS4X;RPS9;CIB1;CD47;BTG3;ID2;MCTS1;PDCD5;RHOG;SDCBP;GNAI2;CRLF2;RNF187;SIRT2;SLC9A3R1;ROMO1;HMGB2;BTG1;PTPN2;MAP2K1;EZH2;CTNNB1;CTBP1;SERTAD1;GID8;RPS6;NMI;CNOT8;CD164;S100A13;MEIS3;KRAS;EAPP;ITGB1BP1;SGK3;IL12RB2;RELA;COPS8;IL15;PTPN14;CHTOP;IGFBP6;ACER2;CSNK2A1;IFI35;AQP11;INCA1;LIMS1;TES;CNOT7;IL7;RPS6KA2;IGF1R;TMEM115
gsea,protein stabilization (GO:0050821),0.5288220961586159,2.236654950318478,0.0,0.00020160507656590617,0.01,25/55,25.71%,RPS7;SUMO1;RPL23;UBE2B;PDCD10;PPIB;PDCL3;CCNH;ATP1B3;GOLGA7;RPL11;CHP1;GLMP;BAG1;MFSD1;RAB21;RTN4;SUGT1;PER3;HYPK;WFS1;TAF9B;DNLZ;MTMR9;ATP1B2
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.7143121915638188,2.231907800458515,0.0,0.00021606934611242458,0.011,10/16,14.73%,LSM5;LSM6;POLR2G;DCPS;LSM1;LSM4;NT5C3B;WDR61;CNOT8;DCP2
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.6736440680347571,2.2306307524529077,0.0,0.00021503552148987708,0.011,10/19,14.27%,BCAP31;PDCD6;ARL6IP5;PDCD5;HMGB1;CASP8;FIS1;PYCARD;BCL10;BAD
gsea,regulation of macroautophagy (GO:0016241),0.5394460145510074,2.2216410518616576,0.0,0.0002445846203612751,0.013,21/52,19.38%,RHEB;LAMTOR5;ATP6V0C;SH3GLB1;LAMTOR2;LAMTOR4;ATP6V1D;BNIP3L;LAMTOR1;ATP6V1G1;ATP6V0D1;GNAI3;SNX6;RRAGA;ATP6V1E1;PRKAG1;LAMTOR3;ATP6V0B;ATP6V1C1;PRKAB1;ATP6V0A1
gsea,response to metal ion (GO:0010038),0.6822671308319869,2.2205626019726363,0.0,0.0002510324969051595,0.013,7/23,8.31%,PPP1CA;CALM1;PDCD6;CALM3;PPP2CA;ANXA11;PEF1
gsea,metal ion transport (GO:0030001),0.6322847430358214,2.2114733302359553,0.0,0.0002801330336390194,0.016,5/28,7.91%,TPT1;NDFIP1;SELENOK;TUSC3;NDFIP2
gsea,regulation of autophagy (GO:0010506),0.4683407232233023,2.2045742428786252,0.0,0.0002863534727821267,0.016,38/92,26.85%,RHEB;VPS29;LAMTOR5;ATP6V0C;SH3GLB1;TMEM59;LAMTOR2;CISD2;LAMTOR4;SIRT2;ATP6V1D;HMGB1;RAB8A;LAMTOR1;ATP6V1G1;CTSA;GSK3A;ATP6V0D1;SNX6;RRAGA;BAD;TRIM27;ATP6V1E1;PRKAG1;LAMTOR3;ATP6V0B;ATP6V1C1;MCL1;PRKAB1;ATP6V0A1;PSAP;DCAF12;CDK5;ACER2;VPS26A;MTMR9;RRAGC;SOGA1
gsea,cell junction organization (GO:0034330),0.6736788635160155,2.2034005682791777,0.0,0.0002850153724420233,0.016,7/23,16.06%,RHOA;CDC42;VASP;CAPZA1;ILK;SNCB;VMP1
gsea,positive regulation of TOR signaling (GO:0032008),0.6193453651364421,2.203119094558976,0.0,0.00028368971954694416,0.016,9/22,15.63%,RHEB;LAMTOR5;SEC13;LAMTOR2;LAMTOR4;LAMTOR1;HDAC3;RRAGA;LAMTOR3
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.639926040806067,2.199170154595812,0.0,0.0002972382539112719,0.016,12/19,23.82%,PPP1CC;DYNLL1;SEC13;MAPRE1;RPS27;DCTN6;DCTN2;NDEL1;TUBG2;B9D2;SBDS;TBCE
gsea,organelle organization (GO:0006996),0.43652747169741746,2.1963299138908643,0.0,0.000303265204681823,0.017,51/134,30.73%,CDC42;CHCHD2;CAPZB;VAPA;THY1;SAR1B;AUP1;PLAAT3;TOR1A;CHMP5;TMED9;RAB18;SLC9A3R1;REEP5;TMED10;CNN2;SSBP1;RAB2A;SURF4;CHMP3;TMED5;YTHDF2;VMP1;TMEM11;SAR1A;CHMP1A;FAM161A;TMED7;RAB29;CHMP2A;TMED3;TOR1AIP2;VAPB;UBXN2A;VPS4B;VPS51;FAF2;OBSL1;RAB1A;ATP7A;PEX11B;CHMP2B;CSPG5;HPS6;CHMP1B;TMED4;PEX19;PEX14;TFB2M;COG1;LONP2
gsea,regulation of cellular component size (GO:0032535),0.7004878110102638,2.194130548997949,0.0019646365422396855,0.00032396242719870736,0.018,6/17,7.31%,RAC1;PPP1CA;LAMTOR5;LAMTOR4;MSN;SLC9A3R1
gsea,T cell activation (GO:0042110),0.6351554708876718,2.1871240224007793,0.0,0.0003591289588352627,0.021,13/26,20.43%,CD3E;FKBP1A;CD3G;CD2;MSN;LCK;PTPN2;CASP8;LAT;CD28;CD8A;RAB29;ZAP70
gsea,autophagosome organization (GO:1905037),0.5641350519222329,2.177549712037857,0.0,0.0003793840986285688,0.021,14/31,22.77%,EMC6;GABARAPL2;GABARAP;MAP1LC3B;BECN1;GABARAPL1;ATG5;RAB1B;VMP1;ATG3;MAP1LC3A;UBXN2A;TMEM41B;RAB1A
gsea,cellular response to oxidative stress (GO:0034599),0.5937447196381824,2.176998929264182,0.0,0.0003776674284990278,0.021,13/35,14.23%,CHCHD2;GSTP1;PRDX6;RPS3;PRDX2;PRDX5;SIRT2;ZFAND1;ROMO1;CYBA;CAT;NUDT2;NCF4
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.494078975434464,2.166106222153305,0.0,0.00046995777983268667,0.025,22/61,24.05%,RHOA;NDFIP1;FKBP1A;VAPA;LAMTOR5;SHISA5;LGALS9;LITAF;TMEM9B;NDFIP2;CASP8;SLC35B2;TFG;BCL10;GOLT1B;TRIM27;S100A13;RELA;MYD88;ALPK1;TRADD;TIRAP
gsea,establishment of protein localization to membrane (GO:0090150),0.6306150552907895,2.1639186364622462,0.0,0.0004822457410990949,0.025,12/27,16.45%,NACA;SDCBP;RAB11A;YIF1B;GOLGA7;RAB10;ZDHHC4;ARL6;ZDHHC3;RAB11B;OXA1L;ATG3
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.6737516350523715,2.1629678215296946,0.0,0.000480092858326331,0.025,7/17,9.41%,RPS7;RPL23;EIF3H;PDCL3;SDCBP;UBXN1;RPL11
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.6699180204417101,2.1577334992976205,0.0,0.0005278951389464188,0.028,8/19,15.28%,CDC42;VASP;ARF6;WDR1;STAP1;PYCARD;PFDN2;KATNBL1
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.69275862150599,2.144916604140811,0.0,0.0006249894613214,0.033,8/17,13.65%,RAC1;RAC2;ARF4;SIRT2;ROMO1;PDK3;DHRS4;GRB2
gsea,positive regulation of protein binding (GO:0032092),0.675285676281529,2.143224191974718,0.0,0.0006222362037825392,0.033,6/17,13.72%,B2M;FKBP1A;PPP2CA;DERL1;RPL11;NMD3
gsea,sulfur compound biosynthetic process (GO:0044272),0.5784798940492509,2.141891696232015,0.0,0.0006195070976255983,0.033,16/36,26.03%,ESD;GCLM;GSTP1;AKR1A1;MAT2B;HAGH;CHST12;SLC35B2;MPST;PAPSS1;B4GALT3;UGDH;GSTM4;CNDP2;B3GNT2;CSPG5
gsea,regulation of immune response (GO:0050776),0.5833046434119047,2.1397005629157686,0.0,0.0006238109381212107,0.034,15/37,16.56%,KLRD1;B2M;CD3E;KLRC1;FKBP1A;CD3G;KLRK1;CSK;CD3D;HCST;CASP8;PDCD1;ITGB2;CD8A;APPL1
gsea,cortical cytoskeleton organization (GO:0030865),0.7113107892211843,2.1394520795969383,0.0,0.0006210987166511186,0.034,5/16,5.22%,RAC1;RHOA;RAC2;ARF6;RHOG
gsea,regulation of endothelial cell migration (GO:0010594),0.626813981930831,2.133686456622616,0.0,0.0006462036844772326,0.036,8/18,16.62%,RAC1;PDCD6;SVBP;EMC10;SP100;SYNJ2BP;RRAS;ITGB1BP1
gsea,positive regulation of cellular amide metabolic process (GO:0034250),0.6324389133748942,2.13327466226411,0.0,0.000643418323768279,0.036,9/24,13.27%,RBM3;RPS4X;EIF3E;ELAVL1;CIRBP;GSK3A;IFNGR1;PCIF1;CD28
gsea,RNA splicing (GO:0008380),0.5789570410807996,2.1298912741944656,0.0,0.0006544344388690234,0.038,14/31,19.32%,SNRPG;LSM6;BCAS2;SNRPD2;ZCRB1;PPP2CA;SMNDC1;LSM1;USB1;LSM4;WBP4;PPP2R1A;TRA2B;SCNM1
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5693206724805381,2.1274275568916856,0.0,0.0006653563991398471,0.039,16/31,16.39%,NDFIP1;FKBP1A;DCUN1D5;CENPX;COMMD1;NDFIP2;DERL1;UBE2L3;GSK3A;PSMD10;BCL10;HDAC3;RCHY1;NSMCE3;FBXO4;PTTG1IP
gsea,positive regulation of protein kinase activity (GO:0045860),0.5415247786935498,2.1269804522773055,0.0,0.0006625250953137201,0.039,14/46,15.73%,RAP1A;RHOA;CALM1;PDCD10;CIB1;CALM3;PPP2CA;JTB;MAP2K1;UNC119;LAT;EZH2;PRKAG1;PTPN1
gsea,"transcription, DNA-templated (GO:0006351)",0.47506797574813237,2.1248795471581587,0.0,0.0006665189998722249,0.039,34/69,31.68%,POLR2K;POLR2G;DDX5;CCNH;POLR2D;GTF2B;GTF2A2;TAF10;ELOB;TAF12;ARRB2;ABT1;WDR61;TAF11;POLR2I;TCEA1;TAF13;POLR2J;GTF2H5;TBPL1;CDK9;IRF9;TAF9B;PAF1;NR4A2;RRAGC;NELFA;ELL3;CRCP;CBFB;TOPORS;TFB2M;SNAPC3;DRAP1
gsea,"DNA-templated transcription, termination (GO:0006353)",0.6649065702618251,2.1242216257984565,0.0,0.0006637066834170679,0.039,9/18,16.59%,NUDT21;SNRPG;POLR2K;CCNH;SSU72;CLP1;LSM10;MED18;GTF2H5
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6962109358292291,2.1212679085764226,0.0,0.0006609179998732988,0.039,9/15,14.73%,LSM5;LSM6;DCPS;LSM1;LSM4;NT5C3B;WDR61;CNOT8;DCP2
gsea,regulation of TOR signaling (GO:0032006),0.5730099619076949,2.1135761466151917,0.0,0.0006917318695625498,0.042,12/30,18.44%,RHEB;LAMTOR5;SEC13;PDCD6;LAMTOR2;LAMTOR4;LAMTOR1;GSK3A;HDAC3;RRAGA;LAMTOR3;FBXO9
gsea,protein maturation (GO:0051604),0.5590529133520723,2.1125184813645896,0.0,0.0006955375141523763,0.042,7/29,10.11%,SRGN;CIAO2A;PSENEN;CIAO2B;APH1A;NFU1;ISCA1
gsea,organelle assembly (GO:0070925),0.4227584798753884,2.109869812025767,0.0,0.0007059716868830374,0.044,64/169,32.68%,ACTR3;EMC6;GABARAPL2;DYNLL1;GABARAP;RPS3;ARF4;AUP1;RPS23;VPS28;CHMP5;RAB11A;MAP1LC3B;ATP6V1D;MAPRE1;TSG101;IFT20;CIRBP;RAB8A;BECN1;GABARAPL1;VPS36;LSM4;CHMP3;VTA1;ATP6V0D1;ARL6;ATG5;HDAC3;YTHDF2;RAB1B;CFAP20;ARL3;VMP1;BBIP1;ATG3;BBS5;TRAPPC6A;CHMP1A;FAM161A;LSM14A;MAP1LC3A;CHMP2A;UBXN2A;TMEM41B;TTC8;VPS4B;TXNDC15;B9D2;RAB1A;CHMP2B;VPS25;BBS7;STX12;MVB12A;FOXJ1;CHMP1B;RAB19;TMOD3;VPS37D;IFT52;TMOD2;CAPN3;TTC26
gsea,cellular response to lipid (GO:0071396),0.513554056906575,2.1097949501172413,0.0,0.0007030544485074877,0.044,16/42,23.37%,RHOA;GSTP1;CHMP5;MSN;STAP1;TWF2;HMGB1;HMGB2;UBE2L3;PDK3;PYCARD;BCL10;RELA;MYD88;LY96;PAF1
gsea,"DNA-templated transcription, initiation (GO:0006352)",0.4744918177997997,2.1056855791066855,0.0,0.0007530035765752222,0.049,24/57,28.22%,POLR2K;POLR2G;CCNH;POLR2D;GTF2B;GTF2A2;TAF10;TAF12;TAF11;POLR2I;HDAC3;NRBF2;TAF13;POLR2J;GTF2H5;TBPL1;CDK9;NR4A1;NRBP1;TAF9B;NR4A2;SNW1;CRCP;MED17
gsea,RNA metabolic process (GO:0016070),0.5461794675624149,2.102744915707526,0.0,0.0007762303909518952,0.049,14/39,17.56%,RBM3;POLR2K;POLR2G;LAGE3;POLR2D;HNRNPL;LSM1;RNASEH2C;CLP1;POLR2I;WTAP;TENT2;POLR2J;XRN2
gsea,regulation of protein dephosphorylation (GO:0035304),0.6609452693398048,2.1009237434775363,0.002304147465437788,0.0007861648511612416,0.051,7/16,10.85%,CALM1;CALM3;ARPP19;CAMTA1;YWHAB;PPP1R2;CNEP1R1
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5990861962081746,2.100094267526449,0.0,0.0007829690590833503,0.051,7/24,14.23%,RAC1;RHOA;CDC42;BRK1;PDCD6;CYBA;NCF4
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.6348230632292338,2.0998944897110134,0.0,0.0007797991438643893,0.051,6/17,12.08%,AURKAIP1;BTG3;SLC9A3R1;NABP2;BTG1;CTNNB1
gsea,regulation of translational initiation (GO:0006446),0.5674738930662949,2.099883807868461,0.0,0.0007766547924778394,0.051,9/28,14.00%,EIF1;EIF3H;POLR2G;EIF3E;EIF1B;POLR2D;PAIP2;YTHDF2;EIF2B2
gsea,cellular response to chemical stress (GO:0062197),0.6224291700993556,2.099258555519027,0.0,0.0007735356969257196,0.051,11/24,14.23%,CHCHD2;GSTP1;PRDX6;PRDX2;PRDX5;SIRT2;ZFAND1;CYBA;CAT;NUDT2;NCF4
gsea,amyloid fibril formation (GO:1990000),0.672489313279009,2.0962146730426907,0.0,0.0007832822467069838,0.052,5/16,4.95%,B2M;ITM2B;FKBP1A;PSENEN;APH1A
gsea,ceramide metabolic process (GO:0006672),0.6332327741537991,2.0928426333847727,0.0,0.0007993459019526237,0.052,8/20,15.05%,SPTSSA;PPP2CA;ORMDL2;DEGS1;ORMDL1;CERS2;ASAH1;PPP2R1A
gsea,protein modification process (GO:0036211),0.5583218868632682,2.091893316002311,0.0,0.0008089126767156756,0.053,9/31,17.67%,UBE2D3;UBE2I;UBL5;NEDD8;UBE2L3;FBXO22;LCMT1;ATG3;UBL4A
gsea,tRNA processing (GO:0008033),0.6588643635901116,2.088645505073158,0.0,0.0008247480404968888,0.055,7/16,14.41%,RTRAF;ZBTB8OS;CLP1;RPP21;POP7;RTCB;TRMT10B
gsea,positive regulation of cell population proliferation (GO:0008284),0.47434526824385126,2.08758095644511,0.0,0.0008467779548432926,0.057,39/102,26.61%,RPS15A;UBE2A;COPS9;RPL23;PDCD10;RPS4X;RPS9;CIB1;CD47;ID2;MCTS1;RHOG;SDCBP;GNAI2;CRLF2;RNF187;NDUFS4;ROMO1;EZH2;SERTAD1;GID8;RPS6;CNOT8;BAD;S100A13;MEIS3;KRAS;EAPP;ITGB1BP1;IL12RB2;RELA;IL15;CHTOP;ACER2;CSNK2A1;AQP11;CNOT7;IL7;IGF1R
gsea,iron ion transport (GO:0006826),0.6116527480878231,2.0868200581682492,0.0,0.000843457256981162,0.057,12/23,19.38%,FTH1;ATP6V1F;ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0D1;RAB11B;ATP6V1E1;ATP6V0B;ATP6V1C1;ATP6AP1;ATP6V0A1
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5668920461983735,2.0861239542811045,0.0,0.0008401625020710794,0.057,9/32,16.45%,RAC1;CDC42;CAPZB;ARF6;TWF2;IFT20;WAS;ATG5;ATG3
gsea,regulation of protein kinase B signaling (GO:0051896),0.5569270724416152,2.0847259534034035,0.0,0.0008431388603164094,0.057,13/49,16.92%,RAC1;RAC2;PDCD6;CIB1;RHOG;SLC9A3R1;LCK;ARRB2;CD28;GRB2;RRAS;ITGB1BP1;RTN4
gsea,cellular response to cytokine stimulus (GO:0071345),0.4164560037137383,2.0794077642942743,0.0,0.0008771984749148932,0.061,36/108,27.69%,RHOA;YWHAZ;RPS3;IL2RG;CIB1;CD47;LGALS9;CRLF2;ZFAND6;UBE2K;LCK;CSK;PTPN2;GSK3A;IFNGR1;IL10RB;PYCARD;GRB2;ITGB2;ASAH1;UBC;IL12RB2;CDK9;RELA;MCL1;SELPLG;PTPN18;PTPN14;AIM2;IL3RA;TRADD;IL20RB;UBA52;IL7;PDE12;TCF7
gsea,positive regulation of supramolecular fiber organization (GO:1902905),0.6358795555370341,2.0766228084555984,0.0,0.0009171923263547819,0.064,7/23,12.32%,RAC1;VASP;RPS3;ARF6;WDR1;MAPRE1;PYCARD
gsea,Rho protein signal transduction (GO:0007266),0.6690877518420614,2.073004687262415,0.0,0.0009568785327835945,0.066,5/19,10.58%,RHOA;ARHGDIB;CDC42;RHOG;WAS
gsea,autophagosome assembly (GO:0000045),0.5344690982141067,2.0671389599453325,0.0,0.0009839611163959343,0.07,14/32,22.77%,EMC6;GABARAPL2;GABARAP;MAP1LC3B;BECN1;GABARAPL1;ATG5;RAB1B;VMP1;ATG3;MAP1LC3A;UBXN2A;TMEM41B;RAB1A
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.5664069585876965,2.0660856642607714,0.0,0.0009985843934835934,0.073,14/26,24.05%,RHOA;GSTP1;CHMP5;SIRT2;STAP1;HMGB1;HMGB2;PYCARD;BCL10;RELA;MYD88;LY96;PAF1;TIRAP
gsea,protein autoubiquitination (GO:0051865),0.5459340319027228,2.0659440282951977,0.0,0.0009947874946490552,0.073,9/28,18.66%,UBE2D3;UBE2A;UBE2B;RNF187;RNF115;RNF181;RNF122;RNFT1;RNF4
gsea,regulation of stress fiber assembly (GO:0051492),0.6736894666116393,2.065484299334088,0.0,0.0010031791069505427,0.075,5/20,10.58%,RAC1;RHOA;CDC42;CD47;WAS
gsea,regulation of cell cycle process (GO:0010564),0.5789399993895138,2.0629768826046315,0.0019569471624266144,0.00101756431678606,0.077,9/26,13.11%,CDC42;CALM1;SH3GLB1;CALM3;RAB11A;BECN1;CETN2;CTNNB1;YTHDF2
gsea,organonitrogen compound biosynthetic process (GO:1901566),0.5339849746230356,2.056248842576983,0.0,0.001043909687232745,0.078,19/52,25.45%,ESD;CSNK2B;GSTP1;SPTSSA;VAPA;AKR1A1;DEGS1;CERS2;NFS1;CEPT1;LPCAT3;MOCS2;ELOVL1;VAPB;PAM;GSTM4;ACER2;CSNK2A1;PEMT
gsea,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.7094236797721396,2.054296301978361,0.0016339869281045752,0.001058034593697651,0.078,4/15,6.23%,RAC1;CDC42;CIB1;ILK
gsea,Golgi to plasma membrane transport (GO:0006893),0.5854001242747618,2.053766191847059,0.0,0.0010660649614160989,0.078,8/27,15.76%,COMMD1;VAMP4;GOLGA7;RAB10;VPS35L;SYS1;ARL3;ARFRP1
gsea,mitotic cell cycle phase transition (GO:0044772),0.4718401014547726,2.0526055752775174,0.0,0.0010740356237983505,0.08,17/51,20.10%,DYNLL1;CCNH;PPP6C;ARPP19;MAPRE1;SSNA1;CETN2;DCTN2;DCTN3;CCNI;CRLF3;MAX;LCMT1;PPP2R1A;PPP2R2A;KHDRBS1;CHMP2A
gsea,nucleic acid metabolic process (GO:0090304),0.6520282960617486,2.052201040069963,0.0,0.0010760024791588042,0.08,11/19,24.02%,POLR2K;POLR2G;POLR2D;HNRNPL;LSM1;POLR2I;WTAP;POLR2J;XRN2;TREX1;DNASE1L2
gsea,innate immune response (GO:0045087),0.5294642419626551,2.0516333420798816,0.0,0.0010838776476572653,0.081,16/50,20.43%,KLRD1;RPL39;B2M;CAPZA1;RNF187;HMGB1;LCK;CYBA;MSRB1;BCL10;SP100;TRIM27;RELA;CYBC1;MYD88;ZAP70
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.6834089480205167,2.0509642548565536,0.0,0.0010975959640752994,0.082,9/17,17.92%,BCAP31;NDUFS3;SLC9A3R1;LCK;BECN1;FIS1;PYCARD;BAD;MCL1
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6967519108377566,2.044061206939998,0.0017761989342806395,0.0011641287219118386,0.093,7/15,20.75%,TPT1;TMBIM6;NDUFS3;ARMC10;PTTG1IP;MCL1;TXNDC12
gsea,intra-Golgi vesicle-mediated transport (GO:0006891),0.5838495269355731,2.043876439431196,0.0024449877750611247,0.0011598800769413572,0.093,13/20,33.39%,GABARAPL2;TRAPPC3;COPB1;VTI1B;COG8;NAPA;COPE;COPZ1;COG6;GOSR1;COG1;RAB6A;VTI1A
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.5476605195783285,2.043740832278392,0.0019047619047619048,0.0011556623312070251,0.093,12/36,16.39%,RBM3;RPS4X;AURKAIP1;EIF3E;ELAVL1;MSN;CIRBP;CASP8;PCIF1;CD28;BAD;PTTG1IP
gsea,plasma membrane bounded cell projection assembly (GO:0120031),0.46559328514284526,2.0431590220334592,0.0,0.0011514751488475793,0.093,29/103,22.77%,RAC1;RAP1A;ACTR3;RAP1B;DYNLL1;FXYD5;ARF4;ARF6;SDCBP;RAB11A;ATP6V1D;SLC9A3R1;IFT20;RAB8A;ATP6V0D1;ARL6;CFAP20;ARL3;BBIP1;STK26;BBS5;FAM161A;AIF1L;P2RY12;TTC8;RHOD;TXNDC15;B9D2;RAB1A
gsea,fatty acid oxidation (GO:0019395),0.6001510036891075,2.0430878203700726,0.002288329519450801,0.0011473181988517398,0.093,9/21,19.30%,SCP2;ECHS1;ADIPOR1;HADHB;ACAT1;PHYH;HSD17B4;PEX13;ECI2
gsea,cell projection organization (GO:0030030),0.7037967416302309,2.0429474694447047,0.0,0.0011489648476728518,0.093,4/15,5.22%,RAC1;RAC2;CDC42;RHOG
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.5231728116601421,2.039652983786263,0.0,0.0011678586879481586,0.094,11/35,17.20%,RBX1;SUMO1;GABARAP;ELOB;SIRT2;DDA1;FBXO22;GSK3A;PSMD10;RCHY1;RNFT1
gsea,regulation of myeloid cell differentiation (GO:0045637),-0.663870812780041,-2.039301581992397,0.0,0.06450694012844417,0.176,8/15,13.95%,PURB;EP300;KMT2E;TNRC6B;NR4A3;TNRC6C;AGO4;AGO3
gsea,regulation of neuron differentiation (GO:0045664),0.6683275094728622,2.037181456206386,0.0,0.0011923500242612165,0.096,3/19,4.47%,RHOA;YWHAH;ID2
gsea,vesicle organization (GO:0016050),0.6579238771497414,2.0360419679050508,0.0,0.0011938188375952364,0.097,5/16,9.00%,SRGN;SAR1B;PLEKHJ1;SQSTM1;LAMTOR1
gsea,sphingolipid metabolic process (GO:0006665),0.4913638130144577,2.033200972506176,0.0,0.0012237362155708745,0.101,19/47,23.89%,SPTSSA;VAPA;GLTP;PPP2CA;ORMDL2;DEGS1;ORMDL1;CERS2;TECR;CTSA;HEXB;GLB1;ASAH1;PPP2R1A;ELOVL1;PSAP;VAPB;SMPD2;ACER2
gsea,positive regulation of gene expression (GO:0010628),0.4704642783123843,2.031632336901124,0.0,0.0012420987953196826,0.105,44/120,28.78%,RBM3;RPS7;CD3E;RPL23;LAMTOR5;POLR2K;RPS3;PDCD10;RPS4X;DDX5;PDCL3;LGALS9;EIF3E;ID2;ELAVL1;PDCD5;MSN;STAP1;CIRBP;RPL11;MAP2K1;GSK3A;IFNGR1;PCIF1;WBP2;CD28;PRKAG1;S100A13;KRAS;RBM22;IL15;PRKAB1;MYD88;CD46;ERP29;EEF2;POU3F1;EMILIN1;LIMS1;DTNBP1;UPF3A;CPEB3;SF3B1;STOX1
gsea,spindle assembly (GO:0051225),0.6518060312307145,2.031458426833744,0.002036659877800407,0.0012377252080122188,0.105,6/17,13.00%,RHOA;RPS3;RAB11A;MAPRE1;MZT1;HDAC3
gsea,peptidyl-serine modification (GO:0018209),-0.4862896891340903,-2.0284308726696576,0.0,0.03687849596022374,0.195,26/60,18.45%,SMG1;PRKCH;MKNK2;PKN1;MARK2;UHMK1;CSNK1G2;PKN2;IKBKB;PKD1;TGFBR2;MAPK14;MARK3;GSK3B;STK38;TGFBR1;DGKQ;AKT3;GALNT2;TNKS;MORC3;PRKX;ULK3;CAB39;SRPK2;TLK1
gsea,protein polymerization (GO:0051258),0.6497302176518415,2.0281863200285057,0.0,0.00127280549148532,0.108,9/18,21.28%,RAC1;UBE2K;WASHC3;MSRB1;WAS;CHMP3;ARL6;CHMP2A;GAS7
gsea,cellular response to organic cyclic compound (GO:0071407),0.5457600760213707,2.0185190801296438,0.0,0.0013637623663719266,0.113,8/38,12.08%,RAP1A;RAP1B;GNB1;ARL6IP5;MSN;GNG2;UBE2L3;CTNNB1
gsea,positive regulation of MAPK cascade (GO:0043410),0.5015299515828706,2.0179708608643203,0.0,0.0013590105811232438,0.113,12/47,12.32%,RAP1A;PDCD10;CIB1;LGALS9;ARL6IP5;DDT;HMGB1;LAMTOR1;ARRB2;MAP2K1;EZH2;PYCARD
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.4979150557503271,2.014231420136701,0.0,0.0014490364878174504,0.124,16/42,24.31%,CSNK2B;RPL23;RPS20;TAF10;RPL37;TAF12;RPL11;PAK1IP1;TAF11;RNF34;PRKAG1;TAF13;PRKAB1;CDK5;TAF9B;CSNK2A1
gsea,endosome transport via multivesicular body sorting pathway (GO:0032509),0.6195903272339106,2.010600687925246,0.0,0.0014829000501358886,0.129,12/19,28.52%,TMEM50A;LEPROTL1;CHMP5;CHMP3;VTA1;LEPROT;CHMP1A;CHMP2A;VPS4B;CHMP2B;MVB12A;CHMP1B
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),0.5351738870619691,2.008906336793451,0.0,0.0014888561642465983,0.13,14/31,23.69%,SEC61B;AUP1;DERL1;UBXN8;UBE2J2;UBE2J1;UFD1;FBXO6;RNF121;DNAJB9;WFS1;DNAJC18;FAF2;JKAMP
gsea,muscle contraction (GO:0006936),0.6037817440469406,2.008341811992548,0.0,0.0014947713428651384,0.13,5/33,5.05%,MYL12A;MYL12B;CALM1;EMD;MYL6
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.6212012804028447,2.006854180404661,0.0,0.0015116397501994479,0.132,4/16,12.32%,GSTP1;CARD19;CASP8;PYCARD
gsea,transferrin transport (GO:0033572),0.621800571754451,2.0060059405951898,0.0,0.0015174367924931076,0.133,11/20,19.38%,ATP6V1F;ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0D1;RAB11B;ATP6V1E1;ATP6V0B;ATP6V1C1;ATP6AP1;ATP6V0A1
gsea,peptidyl-serine phosphorylation (GO:0018105),-0.4836304055442102,-2.0022079464308495,0.0,0.03269974449278365,0.25,25/59,18.45%,SMG1;PRKCH;MKNK2;PKN1;MARK2;UHMK1;CSNK1G2;PKN2;IKBKB;PKD1;TGFBR2;MAPK14;MARK3;GSK3B;STK38;TGFBR1;DGKQ;AKT3;TNKS;MORC3;PRKX;ULK3;CAB39;SRPK2;TLK1
gsea,positive regulation of transport (GO:0051050),0.5826091004545998,2.0008768625613036,0.0,0.001572329702322483,0.137,7/22,18.89%,IL2RG;CD47;CYBA;GSK3A;CHP1;PYCARD;IL15
gsea,negative regulation of intracellular signal transduction (GO:1902532),0.47565369185129297,1.9988223644656893,0.0,0.0015887636568382832,0.14,17/63,17.92%,GSTP1;UBE2B;PDCD6;CIB1;NDUFS3;CARD19;SLC9A3R1;ADIPOR1;ARRB2;CASP8;GSK3A;PSMD10;PYCARD;RNF34;NMI;RELA;MCL1
gsea,cellular response to organonitrogen compound (GO:0071417),0.6082557362590159,1.9970566827536582,0.0,0.0016050865711208682,0.14,10/28,17.57%,RAP1A;RAP1B;LAMTOR5;LAMTOR2;LAMTOR4;LAMTOR1;CTNNB1;RRAGA;LAMTOR3;RELA
gsea,ERAD pathway (GO:0036503),0.5154150551826742,1.994047866866856,0.0019120458891013384,0.0016591298900138266,0.146,18/35,30.37%,SEC61B;AUP1;TOR1A;DERL1;UBXN8;UBE2J2;UBE2J1;UFD1;FBXO6;RNF121;DNAJB9;WFS1;DNAJC18;FAF2;JKAMP;UBXN4;UGGT2;SGTA
gsea,regulation of protein secretion (GO:0050708),0.5324274695539845,1.9940154961554166,0.0,0.0016535623400473372,0.146,5/29,8.87%,RAP1A;ARF6;IER3IP1;DPH3;TMED10
gsea,negative regulation of protein ubiquitination (GO:0031397),0.6365035515226366,1.9921170933501156,0.0021008403361344537,0.0016748729437782973,0.149,7/17,11.40%,RPS3;VPS28;SVBP;SQSTM1;UBXN1;ARRB2;CHP1
gsea,regulation of protein binding (GO:0043393),0.5009318907195004,1.9894618245830253,0.0,0.0017174426310993288,0.153,10/38,16.88%,B2M;FKBP1A;PPP1CA;TMBIM6;PPP2CA;DERL1;RPL11;NMD3;ITGB1BP1;BTBD1
gsea,cellular amide metabolic process (GO:0043603),0.542348760290317,1.9872014944874083,0.0019569471624266144,0.0017703944904057418,0.159,12/28,23.14%,PLAAT3;PPP2CA;ORMDL2;ORMDL1;PANK2;MTHFS;ACOT13;PPP2R1A;DNPEP;ACOT2;ACOT9;SMPD2
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.6566755824471505,1.9830355609150438,0.0015552099533437014,0.0018283105313429758,0.164,4/19,6.23%,RAC1;CDC42;CIB1;ILK
gsea,recombinational repair (GO:0000725),0.609849254086362,1.9807875970131361,0.0,0.00184346576485169,0.166,8/20,22.12%,SEM1;SWI5;MORF4L1;NABP2;SFR1;NSMCE2;RNF138;AP5S1
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.6883977808492203,1.9801722875992165,0.0018656716417910447,0.0018374017327304675,0.166,5/15,9.68%,CSNK2B;FKBP1A;CALM1;CALM3;PPP1R2
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.4875103448388425,1.9795909869390291,0.0,0.001831377464754302,0.166,17/57,25.29%,SUB1;NDFIP1;CD3E;PDCD10;LGALS9;ID2;SDCBP;NDFIP2;MAP2K1;SNX12;CNPY2;CD28;CD46;SFMBT2;ERP29;EMILIN1;CNOT7
gsea,regulation of actin filament polymerization (GO:0030833),0.5841763964466574,1.9782521811696778,0.003795066413662239,0.0018516194758355115,0.168,6/23,15.64%,VASP;COTL1;ARF6;TWF2;PYCARD;MTPN
gsea,iron ion homeostasis (GO:0055072),0.6267367501098073,1.9771231950558044,0.001968503937007874,0.0018665013221177522,0.169,9/19,18.19%,FTH1;B2M;NDFIP1;NEDD8;ISCU;ATP6V1G1;ATP6V0D1;FBXL5;ATP6AP1
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),0.5598737557710577,1.9766548278825102,0.0017006802721088435,0.0018708638929623106,0.17,10/30,19.28%,RBM3;RPS4X;EIF3E;ELAVL1;CIRBP;PCIF1;CD28;NMD3;MTPN;LDB1
gsea,positive regulation of protein polymerization (GO:0032273),0.614540173736678,1.9747486997187451,0.0,0.0019063649566387012,0.172,6/22,12.32%,RAC1;VASP;RPS3;ARF6;MAPRE1;PYCARD
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.48167982110913804,1.970747579947198,0.002347417840375587,0.001967525474277193,0.179,27/39,35.42%,SNX3;VPS29;PLEKHJ1;TMED9;VAMP3;SURF4;SNX1;SNX2;VTI1B;SNX12;SNX6;TRIM27;ARFRP1;RAB29;VPS51;TBC1D10A;VPS26A;GOSR1;PHETA1;YKT6;SNX8;RAB6A;BET1L;VTI1A;SNX32;GGA1;STX6
gsea,response to tumor necrosis factor (GO:0034612),0.5545109494603812,1.97032495727667,0.0,0.001971521125942674,0.18,8/23,17.57%,RPS3;CIB1;ZFAND6;CASP8;PYCARD;IGBP1;ASAH1;RELA
gsea,regulation of cellular metabolic process (GO:0031323),0.6381592885379695,1.96887840657048,0.0,0.001970346656215681,0.18,8/17,17.31%,ARF1;ARF4;LAMTOR1;PDK3;MBOAT7;PANK2;RNF34;NPC2
gsea,defense response to bacterium (GO:0042742),0.6104611279698329,1.9632077952437677,0.0,0.002056356916995106,0.191,9/21,24.05%,RPL39;RPL30;ROMO1;HMGB2;PYCARD;PPP1R11;MYD88;RAB1A;TIRAP
gsea,cellular transition metal ion homeostasis (GO:0046916),0.5541320869097224,1.9629321558734125,0.0,0.0020549197502885003,0.192,11/28,18.19%,FTH1;NDFIP1;ARF1;NEDD8;ISCU;LCK;ATP6V1G1;ATP6V0D1;ATOX1;FBXL5;ATP6AP1
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.6440118873180778,1.9614211850064485,0.0015822784810126582,0.002084064785995032,0.194,4/19,6.23%,RAC1;CDC42;CIB1;ILK
gsea,regulation of Rho protein signal transduction (GO:0035023),0.6380523354085292,1.9582908723377292,0.0,0.0021435016867500205,0.2,3/16,3.16%,RAC1;ARHGDIB;PDCD10
gsea,peptidyl-lysine modification (GO:0018205),0.5323075287717344,1.9534133319858085,0.0,0.0022228170495964075,0.21,8/29,16.42%,UBE2I;SUMO1;EEF1AKMT1;SIRT2;EEF1AKMT2;NSMCE2;BLOC1S1;VCPKMT
gsea,regulation of Wnt signaling pathway (GO:0030111),0.5488733856751001,1.9528881570760939,0.0,0.0022208745009219557,0.21,9/33,15.05%,SNX3;PPP1CA;ATP6V0C;EMD;PPP2CA;ATP6AP2;GSKIP;CTNNB1;PPP2R1A
gsea,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6620266765103334,1.9508233110244468,0.0,0.0022642287053429174,0.214,5/15,7.31%,RHOA;CDC42;WDR1;MSN;SLC9A3R1
gsea,mRNA catabolic process (GO:0006402),0.6200385514348051,1.9491384316516855,0.0,0.0022872483638472375,0.217,9/17,17.56%,LSM5;LSM6;DDX5;RNH1;NBDY;NUDT16L1;YTHDF2;DCP2;XRN2
gsea,toll-like receptor signaling pathway (GO:0002224),0.5531284544358641,1.9485706821971727,0.0,0.002280122979536187,0.217,13/25,26.23%,UBE2D3;LGALS9;CTSB;HMGB1;CASP8;BCL10;NMI;ITGB2;UBC;MYD88;LY96;TIRAP;UBA52
gsea,negative regulation of cellular process (GO:0048523),0.41760847355719305,1.9474094670071027,0.0,0.0023029502976951587,0.219,52/143,27.34%,FTH1;ARHGDIB;CSNK2B;SNX3;TMBIM6;CIB1;BTG3;PDCD5;NDUFS3;PPP2CA;SIRT2;SLC9A3R1;BECN1;BNIP3L;BTG1;VAMP3;PTPN2;MAP2K1;ATG5;CTNNB1;CRLF3;CTBP1;PIP4P2;NMI;SP100;CD164;PPP2R1A;ITGB1BP1;RTN4;NR4A1;CHMP1A;LPCAT3;COPS8;CHMP2A;WFS1;TXNDC12;ANXA6;VPS4B;PTPN14;RNF167;MALSU1;IGFBP6;NDRG3;IFI35;EMILIN1;AQP11;INCA1;TES;CNOT7;RPS6KA2;TMEM115;PDE12
gsea,regulation of viral transcription (GO:0046782),0.6223400019615146,1.9420222501012885,0.0023094688221709007,0.002425022435625337,0.233,7/16,17.00%,POLR2K;POLR2G;POLR2D;POLR2I;TRIM27;POLR2J;CDK9
gsea,small GTPase mediated signal transduction (GO:0007264),0.5147040865591472,1.941597223205312,0.0,0.002427445740275387,0.233,17/36,26.56%,RAC1;RHEB;GNB1;RAB18;LAT;CHP1;RGS19;GRB2;RRAS;ARL3;KRAS;RUNDC3A;RIT1;TIAM2;G3BP2;RRAGC;ARHGAP1
gsea,response to reactive oxygen species (GO:0000302),0.5619540073779532,1.940301461683661,0.0,0.0024446703160148605,0.235,8/24,16.82%,GSTP1;RPS3;PDCD10;PRDX5;ROMO1;GLRX2;CAT;STK26
gsea,positive regulation of protein phosphorylation (GO:0001934),0.4581860566561235,1.9400080897008525,0.0,0.002447018484193471,0.236,20/86,18.89%,RAC1;RAP1A;CSNK2B;CALM1;PDCD10;CIB1;CALM3;SDCBP;ILK;JTB;UBE2K;LAT;NPTN;MAD2L2;HDAC3;PRKAG1;KRAS;CDK9;RPS6KA4;IL15
gsea,phagosome maturation (GO:0090382),0.6157313392627805,1.939502111767709,0.0,0.0024493522904871965,0.237,9/17,19.38%,ATP6V1F;ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V1C1;ATP6V0A1
gsea,chromosome organization (GO:0051276),0.5607908256810272,1.9375407836294314,0.0,0.0024908203192089084,0.241,15/24,31.94%,RBX1;COPS6;CETN2;HMGB2;EZH2;HDAC3;UBC;FAM50A;COPS8;LDB1;GATAD1;UBA52;XPA;HDAC8;PADI1
gsea,multivesicular body assembly (GO:0036258),0.5476364602534097,1.935258801454861,0.0,0.0025486829189919243,0.246,14/25,28.52%,VPS28;CHMP5;RAB11A;TSG101;VPS36;CHMP3;VTA1;CHMP1A;CHMP2A;VPS4B;CHMP2B;VPS25;MVB12A;CHMP1B
gsea,multivesicular body organization (GO:0036257),0.5476364602534097,1.935258801454861,0.0,0.0025486829189919243,0.246,14/25,28.52%,VPS28;CHMP5;RAB11A;TSG101;VPS36;CHMP3;VTA1;CHMP1A;CHMP2A;VPS4B;CHMP2B;VPS25;MVB12A;CHMP1B
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5592368076956977,1.9352273819036268,0.0017241379310344827,0.002540982970596178,0.246,7/24,13.06%,PDCD10;ARL6IP5;SDCBP;HMGB1;PYCARD;EMC10;CD27
gsea,cellular response to insulin stimulus (GO:0032869),0.5022651434654275,1.9350005454931052,0.0017761989342806395,0.002542998603643303,0.247,20/45,27.63%,ATP6V1F;ATP6V0C;ATP6V1D;RAB8A;RAB10;ATP6V1G1;PTPN2;GSK3A;ATP6V0D1;GRB2;ATP6V1E1;ATP6V0B;APPL1;ATP6V1C1;ATP6AP1;ATP6V0A1;INSIG2;IGF1R;SOGA1;LPIN3
gsea,regulation of cell growth (GO:0001558),0.4561272422391582,1.9345670052572632,0.0,0.00253536197119993,0.247,22/55,26.26%,CDC42;CIB1;DCUN1D5;NDUFS3;LAMTOR2;SDCBP;PPP2CA;LAMTOR1;BTG1;PSMD10;MAD2L2;CRLF3;PPP2R1A;MTPN;SGK3;RTN4;LTBP4;OGFR;NDRG3;TAF9B;CSNK2A1;RPS6KA1
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.5860366715738772,1.9339678470981743,0.003484320557491289,0.0025325767155110705,0.247,12/24,27.33%,SUMO1;BRK1;RPS3;SH3GLB1;SDCBP;TSG101;ERCC1;CHMP2A;VPS4B;TIRAP;EMILIN1;HAS3
gsea,proteolysis (GO:0006508),0.44657588006144555,1.9336377395783915,0.0,0.0025298080882143834,0.248,25/75,26.42%,SRGN;SPCS1;NEDD8;PSENEN;APH1A;SVBP;CTSB;CTSW;CTSC;CASP8;CTSA;TPP1;ATG4B;FBXO6;CPQ;CASP6;NCSTN;CTSO;CTSE;XPNPEP1;FBXL6;CNDP2;SPPL2A;CPA2;BMP1
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.5564032057408209,1.9299751922324884,0.008385744234800839,0.0025652722877735307,0.256,14/23,27.53%,POLR2K;POLR2G;CCNH;POLR2D;ELOB;WDR61;POLR2I;TCEA1;POLR2J;GTF2H5;CDK9;PAF1;NELFA;ELL3
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.6435121893045009,1.927850492777643,0.0,0.0026243403581234378,0.262,7/15,15.05%,DYNLL1;MAPRE1;SSNA1;CETN2;DCTN2;DCTN3;PPP2R1A
gsea,positive regulation of cellular component organization (GO:0051130),0.5585712432900056,1.9272803903627926,0.0014245014245014246,0.002621324814374909,0.262,6/29,9.90%,SUMO1;BRK1;RPS3;SH3GLB1;TMED9;SURF4
gsea,regulation of protein-containing complex assembly (GO:0043254),0.5535891617086304,1.926555201229746,0.0,0.002632531367384079,0.265,9/27,17.44%,CDC42;SUMO1;BRK1;RPS3;SAR1B;SH3GLB1;NAPA;LCMT1;SAR1A
gsea,protein autophosphorylation (GO:0046777),-0.4726208693892406,-1.9247172182966934,0.0,0.055561166355914654,0.44,22/46,27.99%,SMG1;MKNK2;SIK1;MARK2;UHMK1;STK11;TYRO3;DAPK3;INSRR;MARK3;GSK3B;IRAK1;PRKX;ULK3;STK24;FER;ITK;CAMK2B;DDR1;NTRK1;CDKL5;STK4
gsea,positive regulation of apoptotic process (GO:0043065),0.41188413054339956,1.9245055097926127,0.0,0.0026814387423430975,0.271,32/91,26.32%,SAP18;PSENEN;RPS3;ARL6IP5;APH1A;PDCD5;PDCD2;SQSTM1;SIRT2;HMGB1;BNIP3L;BTG1;MTCH1;CASP8;STK17B;CTNNB1;PYCARD;BCL10;RPS6;BAD;TNFRSF12A;UBC;RNF122;ING3;DIABLO;NCSTN;TIAM2;CDK5;TRADD;RASGRF2;UBA52;RPS6KA2
gsea,positive regulation of cellular metabolic process (GO:0031325),0.5542987364286631,1.9233245841177082,0.0,0.002711231275559003,0.273,13/26,27.67%,CHCHD2;GHITM;ROMO1;VAMP3;ARRB2;IL10RB;DHRS4;GRB2;RAB1B;RAB29;RAB1A;ATAD1;F2
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5530945062724916,1.9177287798979075,0.0,0.002858180473136283,0.289,11/30,24.05%,RAP1A;CIB1;LGALS9;DDT;HMGB1;ARRB2;MAP2K1;PYCARD;ATP6AP1;PRXL2C;TIRAP
gsea,cellular calcium ion homeostasis (GO:0006874),0.5773776423185784,1.9128599280098655,0.0,0.002971515955282074,0.302,12/28,22.06%,TPT1;SELENOK;SMDT1;MAIP1;NPTN;TMCO1;TMEM165;WFS1;VAPB;ANXA6;SLC24A1;MICU1
gsea,intracellular pH reduction (GO:0051452),0.6286969020343935,1.912855711775065,0.0,0.002962877827505091,0.302,9/15,19.38%,ATP6V1F;ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V1C1;ATP6V0A1
gsea,cellular response to organic substance (GO:0071310),0.5206695160229323,1.9118648491214043,0.0,0.0029822043248941346,0.305,11/36,21.94%,RHOA;CIB1;ARL6IP5;DCPS;EMD;TWF2;PTPN2;CTNNB1;CDK9;PTPN18;PTPN14
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.5931164698937523,1.9110259055588892,0.0,0.0030060580869546894,0.31,3/17,5.83%,GABARAPL2;PSME1;COMMD1
gsea,insulin receptor signaling pathway (GO:0008286),0.5648453240601936,1.9099516843925741,0.0017064846416382253,0.003029774363354953,0.312,14/30,19.38%,ATP6V1F;ATP6V0C;ATP6V1D;ATP6V1G1;PTPN2;GSK3A;ATP6V0D1;GRB2;ATP6V1E1;ATP6V0B;APPL1;ATP6V1C1;ATP6AP1;ATP6V0A1
gsea,negative regulation of neuron projection development (GO:0010977),0.6227928551874047,1.9096184000562495,0.0017421602787456446,0.0030302927506506046,0.312,6/15,20.18%,RHOA;THY1;CIB1;RTN4;RAB29;RTN4RL1
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.5628831281289725,1.9066740533834734,0.008620689655172414,0.0031043937980131404,0.321,14/22,27.53%,POLR2K;POLR2G;CCNH;POLR2D;ELOB;WDR61;POLR2I;TCEA1;POLR2J;GTF2H5;CDK9;PAF1;NELFA;ELL3
gsea,cellular protein catabolic process (GO:0044257),0.5562795413955193,1.9064326153507152,0.0,0.003095524101447389,0.321,12/20,30.46%,CLTA;CTSB;BNIP3L;CTSW;CTSC;CASP8;UBE2G1;AP2M1;CTSO;CPA2;SIAH2;AP2S1
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.6179517879061949,1.9036536627209946,0.0017094017094017094,0.003191881557385658,0.331,6/16,14.62%,CST7;LAMTOR5;BEX3;DNAJB6;IGBP1;TRIAP1
gsea,protein-containing complex subunit organization (GO:0043933),0.48983827095475607,1.9031979036448825,0.0,0.003196493427146956,0.333,8/35,15.05%,CD3E;CD3G;CAPZA1;ELOB;SLC9A3R1;VAMP3;WAS;PPP2R1A
gsea,membrane lipid biosynthetic process (GO:0046467),0.5914300575492718,1.902752329695503,0.0020920502092050207,0.003201079167334536,0.336,7/18,23.89%,SPTSSA;VAPA;DEGS1;CERS2;ELOVL1;VAPB;ACER2
gsea,fatty acid beta-oxidation (GO:0006635),0.5716044333919514,1.8992366172471562,0.00702576112412178,0.003328060856504851,0.345,7/20,19.30%,ETFA;SCP2;ECHS1;HADHB;ACAT1;HSD17B4;ECI2
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.511336238778559,1.898982136159766,0.0,0.0033232074078136283,0.345,11/28,16.52%,LSM5;LSM6;DCPS;POLR2D;LSM1;LSM4;NT5C3B;WDR61;CNOT8;DCP2;CNOT11
gsea,cellular response to growth factor stimulus (GO:0071363),0.4839682527672051,1.8944869558040247,0.0017391304347826088,0.0034626586702832213,0.36,12/44,17.59%,RAP1A;CIB1;EMD;PDCD5;CORO1B;SIRT2;TWF2;CTNNB1;APPL1;ITGB1BP1;RELA;NR4A1
gsea,protein tetramerization (GO:0051262),0.6537490199729522,1.892299800381857,0.001644736842105263,0.003542880162586118,0.37,6/16,15.47%,B2M;NUDT21;SSBP1;ACOT13;OXA1L;CUTC
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.606736045962381,1.8921782185508549,0.0016501650165016502,0.0035419508133672792,0.372,6/19,15.22%,POLR2K;POLR2G;POLR2D;POLR2I;GRB2;POLR2J
gsea,regulation of DNA binding (GO:0051101),0.6051718372037312,1.8918677332320981,0.0038684719535783366,0.003541026641581414,0.374,7/18,14.33%,CSNK2B;SUMO1;SIRT2;HMGB1;HMGB2;EDF1;SP100
gsea,negative regulation of cell migration (GO:0030336),0.5533758508515445,1.8894747997289747,0.0,0.0036069862112132842,0.38,6/30,16.82%,RAC1;ARHGDIB;THY1;ADIPOR1;ITGB1BP1;STK26
gsea,mitotic cytokinetic process (GO:1902410),0.5955573977111618,1.8848152253779844,0.002079002079002079,0.0037081501393761884,0.386,9/16,28.52%,RHOA;CHMP5;CHMP3;CHMP1A;CHMP2A;VPS4B;CHMP2B;KLHDC8B;CHMP1B
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4890024142159206,1.882543923742999,0.0021929824561403508,0.003764415742766898,0.39,11/25,26.23%,NEDD8;CTSB;CTSW;CTSC;CASP8;UBE2W;UBC;VPS4B;NGLY1;CTSO;UBA52
gsea,positive regulation of hydrolase activity (GO:0051345),0.50500266635932,1.8823283165459292,0.0018796992481203006,0.0037628889036469943,0.392,14/36,25.36%,RAP1A;RHOA;CALM1;THY1;RPS3;CALM3;HMGB2;EZH2;NDEL1;FNTA;PSAP;ZC3H15;LIMS1;MTMR9
gsea,integrin-mediated signaling pathway (GO:0007229),0.5715434115204863,1.8822998054003275,0.0,0.0037569608752609333,0.392,8/21,16.62%,CDC42;THY1;CD47;ILK;LAT;ZYX;ITGB2;ITGB1BP1
gsea,cellular response to lipopolysaccharide (GO:0071222),0.5229529423152821,1.8789857872816458,0.004228329809725159,0.003830220283414455,0.398,12/27,23.37%,RHOA;GSTP1;CHMP5;STAP1;HMGB1;HMGB2;PYCARD;BCL10;RELA;MYD88;LY96;PAF1
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5682085310336221,1.8761301242168502,0.0,0.003946934191280824,0.41,8/23,17.59%,POLR2K;POLR2G;POLR2D;POLR2I;GRB2;POLR2J;ITGB1BP1;NR4A1
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.6124608650820402,1.8748904640472641,0.004081632653061225,0.003958047266660452,0.413,8/16,18.09%,CDC42;RNF115;TSG101;PTPN2;SNX6;ZGPAT;GRB2;ZFYVE28
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.4773773761029898,1.8744728031939744,0.0,0.0039690999448912774,0.415,14/53,26.56%,RAC1;RHOA;RAC2;ARHGDIB;CDC42;RHOG;SQSTM1;DEPDC7;ARHGAP9;RHOD;TIAM2;RHOV;RASGRF2;ARHGAP1
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.49451798715937806,1.8737644332529912,0.0,0.003975742888901013,0.416,12/30,19.06%,RBM3;SAP18;PRDX6;DDX5;HNRNPL;CIRBP;PUF60;WTAP;SF1;RBM7;TRA2B;KHDRBS1
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.5663864142598853,1.8669822951136528,0.0035460992907801418,0.004255648449377221,0.436,13/22,30.13%,RBX1;ERCC1;UBC;GTF2H5;XRN2;POLD4;TREX1;PNRC2;DNASE1L2;UBA52;PDE12;XPA;SETMAR
gsea,regulation of ion transport (GO:0043269),0.5894065425975531,1.8663681595369765,0.004754358161648178,0.004274462351125116,0.437,6/19,13.13%,B2M;YWHAH;TOR1A;VAMP3;SNX6;RAB11B
gsea,regulation of MAP kinase activity (GO:0043405),0.5293994837147793,1.8641054441249623,0.0,0.004366525833264297,0.445,6/22,15.73%,GSTP1;PDCD10;TSG101;LIME1;EZH2;PTPN1
gsea,negative regulation of transport (GO:0051051),0.5936331902112105,1.8620511251970384,0.003590664272890485,0.0044322765904946234,0.45,6/19,13.82%,NDFIP1;SNX3;ARL6IP5;NDFIP2;SNX12;PIP4P2
gsea,positive regulation of protein modification process (GO:0031401),0.4742958595555517,1.8608635437195944,0.0,0.004463342336806692,0.452,12/53,18.61%,RAC1;CALM1;CIB1;CALM3;ILK;CAMTA1;CNEP1R1;NPTN;CHP1;HDAC3;KRAS;FAM161A
gsea,negative regulation of multicellular organismal process (GO:0051241),0.4537329665256998,1.85496731488579,0.0,0.004691133018529257,0.465,14/52,18.89%,SRGN;ARHGDIB;RHEB;PPP2CA;ADIPOR1;NPTN;GSK3A;MAD2L2;IFNGR1;PGAM5;ACOT13;PPP1R11;RPS6KA4;IL15
gsea,mitotic sister chromatid segregation (GO:0000070),0.4882502925813605,1.851060995506111,0.0,0.0048878301168441335,0.476,13/26,28.52%,CSNK2B;CHMP5;RAB11A;BECN1;DCTN2;CHMP3;CHMP1A;TUBG2;CHMP2A;VPS4B;CSNK2A1;CHMP2B;CHMP1B
gsea,DNA metabolic process (GO:0006259),0.42224733564882455,1.850202653122884,0.0020964360587002098,0.004942985435202461,0.481,25/63,31.53%,UBE2A;SUMO1;UBE2B;POLE4;HMGB1;NABP2;HMGB2;GLRX2;ERCC1;ALKBH3;SP100;NSMCE3;UBC;ORC4;POLD4;FBXO6;ACD;TREX1;DNASE1L2;DFFB;UBA52;XPA;EID3;SETMAR;USP3
gsea,double-strand break repair via homologous recombination (GO:0000724),0.539229838229384,1.8494174295725567,0.0,0.004985110144169046,0.486,8/24,22.12%,SEM1;SWI5;MORF4L1;NABP2;SFR1;NSMCE2;RNF138;AP5S1
gsea,cytoplasmic microtubule organization (GO:0031122),0.6060494490167113,1.849273711884745,0.0,0.004980426933082167,0.486,6/17,12.61%,RHOA;CIB1;RAB11A;CRIPT;CHP1;KATNA1
gsea,sphingolipid biosynthetic process (GO:0030148),0.5413758333840152,1.8484074352565711,0.007207207207207207,0.005005335754679549,0.489,9/24,23.89%,SPTSSA;VAPA;DEGS1;CERS2;ASAH1;ELOVL1;VAPB;SMPD2;ACER2
gsea,peptide metabolic process (GO:0006518),0.5549593961332429,1.8459453473481637,0.0,0.005139647288103567,0.499,12/26,22.03%,SPCS1;GSTP1;SPCS2;SEC11C;SEC11A;GLRX2;LTA4H;DNPEP;TPP1;ETHE1;CPQ;GSTM4
gsea,regulation of cytoskeleton organization (GO:0051493),0.5176845823230712,1.8446670463463652,0.002976190476190476,0.005168210687116931,0.504,8/39,15.28%,RAC1;RHOA;RAC2;CDK2AP2;RHOG;TWF2;PFDN2;KATNBL1
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.5284583837050468,1.844372972269417,0.0050933786078098476,0.00517147997066097,0.504,8/23,16.65%,CIB1;MAPRE1;TWF2;PFDN1;PFDN5;PFDN2;EML2;CHADL
gsea,response to calcium ion (GO:0051592),0.5896529093494289,1.8438599015290473,0.001607717041800643,0.005199811704360313,0.505,5/21,8.31%,CALM1;PDCD6;CALM3;ANXA11;PEF1
gsea,positive regulation of protein secretion (GO:0050714),0.5660769512230884,1.8432298992715792,0.003663003663003663,0.005215489092135601,0.508,5/16,17.01%,ARF6;IER3IP1;TMED10;BAD;GLUD1
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.5499691782641164,1.8427405209196062,0.0018450184501845018,0.005214452228460022,0.508,8/25,15.05%,DYNLL1;RAB11A;MAPRE1;SSNA1;CETN2;DCTN2;DCTN3;PPP2R1A
gsea,regulation of protein kinase activity (GO:0045859),0.47680009402211065,1.8426900337368224,0.001834862385321101,0.005209273212733361,0.508,12/36,16.62%,RAP1A;GSTP1;RTRAF;THY1;JTB;SLC9A3R1;LAT;GSKIP;CHP1;TRIM27;PRKAG1;ITGB1BP1
gsea,regulation of lipid metabolic process (GO:0019216),0.5394738468098554,1.8419331781232382,0.001763668430335097,0.005216531356142822,0.508,11/26,20.85%,ID2;SIN3B;ADIPOR1;CERS2;EDF1;MBOAT7;PANK2;HDAC3;NPC2;PSAP;SMARCD3
gsea,protein lipidation (GO:0006497),0.5154831319081776,1.8406425272813,0.006521739130434782,0.0052650140482011,0.511,9/26,23.65%,SELENOK;DPM1;DPM3;DPM2;PIGP;ATG5;ZDHHC3;MPPE1;ZDHHC20
gsea,response to UV (GO:0009411),0.4919679571320467,1.8399385987279282,0.0069124423963133645,0.005280323258328395,0.512,8/26,17.57%,UBE2A;COPS9;UBE2B;CIRBP;CAT;TRIAP1;NSMCE3;RELA
gsea,positive regulation of protein kinase B signaling (GO:0051897),0.5655223052542215,1.83870495845857,0.0,0.00533249988717649,0.514,8/33,16.92%,RAC1;RAC2;RHOG;LCK;CD28;GRB2;ITGB1BP1;RTN4
gsea,import into nucleus (GO:0051170),0.5457736753844658,1.8330317345289215,0.0,0.005576856912925057,0.525,8/19,18.83%,SNRPG;SEC13;SNRPD2;GEMIN7;FAM53A;PTTG1IP;APPL1;GEMIN4
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4895914751559087,1.8326250740522914,0.0,0.005574919006564847,0.526,10/34,15.01%,RBX1;SUMO1;GABARAP;ELOB;SIRT2;DDA1;FBXO22;GSK3A;PSMD10;RCHY1
gsea,regulation of protein localization to plasma membrane (GO:1903076),0.5271635550501774,1.8304098699872104,0.002008032128514056,0.005670762708122458,0.531,10/24,22.48%,CIB1;ARF6;TMEM59;RHOG;SQSTM1;STX8;VTI1B;APPL1;AP2M1;CDK5
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.4693915108274948,1.8298189184242781,0.002109704641350211,0.005705168470515694,0.533,12/35,19.06%,DYNLL1;CCNH;ARPP19;MAPRE1;SSNA1;CETN2;DCTN2;DCTN3;LCMT1;PPP2R1A;PPP2R2A;KHDRBS1
gsea,regulation of signal transduction (GO:0009966),0.40923973136210623,1.8186996527088026,0.0034482758620689655,0.0062865890702234,0.577,26/73,31.38%,CD3E;SNX3;PPP2CA;ILK;CSK;MTCH1;PTPN2;GLRX2;MFNG;GSKIP;ZDHHC3;SP100;SYNJ2BP;PPP2R1A;PTPN1;ELF1;ITGB1BP1;CD46;TSPEAR;IGFBP6;DTNBP1;SNW1;SHARPIN;CBFB;LFNG;NCK1
gsea,glycerophospholipid metabolic process (GO:0006650),0.5810236815427988,1.8178405124019505,0.0,0.006311184225490367,0.578,4/25,8.95%,PRDX6;PIGX;DPM2;PIGP
gsea,regulation of intracellular signal transduction (GO:1902531),0.37637493661137267,1.8149445017323003,0.0016233766233766235,0.006420346284483473,0.582,41/137,26.56%,RAC1;RHOA;RAC2;ARHGDIB;CDC42;CSNK2B;PRKAR1A;TMBIM4;RHOG;TAF10;SQSTM1;ZFAND6;ATP6AP2;TAF12;LIME1;RPL11;PAK1IP1;PYCARD;TAF11;RNF34;DEPDC7;PRKAG1;RRAS;TAF13;RELA;FBXO9;PRKAB1;ARHGAP9;VRK2;RHOD;TIAM2;TCP11;GNA12;CDK5;RHOV;TAF9B;CSNK2A1;ULK4;RASGRF2;RRAGC;ARHGAP1
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.5643877838463763,1.8132473096575257,0.008223684210526315,0.0065128700717911915,0.589,6/22,13.30%,GSTP1;PDCD10;LGALS9;ARL6IP5;MAP2K1;IGBP1
gsea,histone modification (GO:0016570),0.4823907347821062,1.813037795310228,0.001697792869269949,0.00652467691160633,0.589,17/37,31.94%,UBE2A;UBE2B;MORF4L1;ENY2;SIN3B;TAF10;SIRT2;EZH2;RPS6KA4;MSL3;MRGBP;USP51;USP21;USP16;USP3;NEK11;PADI1
gsea,positive regulation of T cell activation (GO:0050870),0.5817538352184355,1.8127664607927338,0.0018552875695732839,0.006536424864439845,0.59,11/21,20.65%,CD3E;THY1;PNP;CD47;LGALS9;LCK;PYCARD;CD28;IL15;ZAP70;CD46
gsea,positive regulation of interleukin-8 production (GO:0032757),0.6114177593669747,1.8118328351119768,0.00539568345323741,0.006556099875075785,0.593,10/15,24.05%,LAMTOR5;CD2;LGALS9;HMGB1;PYCARD;BCL10;RELA;MYD88;RAB1A;TIRAP
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.4228090770425714,1.8066775113258393,0.0,0.006858459244342767,0.61,34/101,25.81%,RPS7;CD3E;RPL23;LAMTOR5;RPS3;PDCD10;PDCL3;LGALS9;ID2;PDCD5;MSN;STAP1;RPL11;VAMP3;ARRB2;MAP2K1;GSK3A;IFNGR1;CD28;PRKAG1;MTPN;PTPN1;KRAS;KLF2;RAB29;PRKAB1;MYD88;WFS1;CD46;ERP29;POU3F1;EMILIN1;LIMS1;DTNBP1
gsea,substrate adhesion-dependent cell spreading (GO:0034446),0.5959178871952406,1.806309676830712,0.005338078291814947,0.0068613477928854945,0.61,4/15,9.59%,RAC1;RHOA;ILK;VAMP3
gsea,positive regulation of autophagy (GO:0010508),0.5171509229146649,1.8043067516395865,0.006507592190889371,0.006967264671680213,0.613,9/24,20.30%,SH3GLB1;TMEM59;HMGB1;BNIP3L;GSK3A;GNAI3;BAD;TRIM27;FBXO7
gsea,negative regulation of protein binding (GO:0032091),0.5530262254453654,1.8032767531323277,0.0,0.0070252188100536515,0.616,5/19,16.62%,B2M;PPP1CA;TMBIM6;ARRB2;ITGB1BP1
gsea,receptor metabolic process (GO:0043112),0.5480098902932584,1.7994168612207906,0.0055248618784530384,0.007213030315921543,0.625,9/21,19.52%,SH3GLB1;PLEKHJ1;BECN1;ARRB2;SNX1;RAB11B;GRB2;ITGB2;AP2M1
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5694294964742469,1.7991082510176222,0.009478672985781991,0.007199285355762718,0.625,5/17,9.41%,RPS7;RPL23;PDCL3;COMMD1;RPL11
gsea,positive regulation of growth (GO:0045927),0.5887919185782006,1.7969015776361943,0.005780346820809248,0.007334735455806608,0.634,9/16,26.26%,CDC42;CIB1;SDCBP;PSMD10;MTPN;WFS1;TAF9B;CSNK2A1;RPS6KA1
gsea,cell cycle G2/M phase transition (GO:0044839),0.45767915507837853,1.794201952520518,0.004282655246252677,0.007485184204836829,0.646,12/36,19.06%,DYNLL1;CCNH;ARPP19;MAPRE1;SSNA1;CETN2;DCTN2;DCTN3;LCMT1;PPP2R1A;PPP2R2A;KHDRBS1
gsea,monocarboxylic acid metabolic process (GO:0032787),0.5108230259519069,1.7941949098402856,0.0048,0.007466972077817762,0.646,7/28,19.39%,SCP2;GLO1;HAGH;PDHB;PANK2;MTHFS;ACOT2
gsea,histone acetylation (GO:0016573),0.500712551847398,1.7941042307941468,0.004878048780487805,0.007456640041566363,0.647,9/23,18.90%,MORF4L1;TAF10;TAF12;DR1;YEATS4;NAA60;ING3;TADA1;MSL3
gsea,cellular response to interferon-gamma (GO:0071346),0.5536852874920031,1.7927617723316462,0.006147540983606557,0.007570723100589469,0.655,6/20,17.24%,B2M;CD47;LGALS9;IFNGR1;SP100;IRF9
gsea,cellular iron ion homeostasis (GO:0006879),0.577938706107508,1.7911908411031245,0.007619047619047619,0.007695886095833149,0.664,8/18,18.19%,FTH1;NDFIP1;NEDD8;ISCU;ATP6V1G1;ATP6V0D1;FBXL5;ATP6AP1
gsea,negative regulation of protein phosphorylation (GO:0001933),0.4567933628341335,1.7909621127341104,0.0,0.00769281250592628,0.664,19/47,31.38%,GSTP1;RTRAF;CALM1;THY1;CIB1;CALM3;SIRT2;GSKIP;CHP1;FKBP8;TRIM27;ITGB1BP1;EMILIN1;DTNBP1;DBNDD2;SAMSN1;PAK2;DMD;NCK1
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.5449401846982804,1.7905322589384836,0.005357142857142857,0.007701328836435705,0.664,5/20,13.11%,RAC1;RHOA;ILK;VAMP3;YTHDF2
gsea,cell junction assembly (GO:0034329),0.5631967269122373,1.790143680061578,0.007587253414264037,0.007717502578171081,0.667,10/26,25.10%,RHOA;CDC42;VASP;CAPZA1;ILK;VMP1;RAB29;OBSL1;CDK5;LIMS1
gsea,cellular response to reactive oxygen species (GO:0034614),0.5841958997957236,1.7900128885597224,0.004273504273504274,0.007702879573369526,0.668,5/15,17.57%,RPS3;PRDX5;ROMO1;OSER1;RELA
gsea,Golgi to plasma membrane protein transport (GO:0043001),0.5980931670855416,1.785932794586968,0.00967741935483871,0.008025432855604342,0.681,5/18,15.76%,VAMP4;GOLGA7;RAB10;SYS1;ARFRP1
gsea,regulation of Ras protein signal transduction (GO:0046578),0.49359833993133395,1.7833014651035648,0.0036900369003690036,0.008185941512716427,0.686,6/29,13.65%,ARHGDIB;GABARAP;PDCD10;ARF6;SQSTM1;GRB2
gsea,positive regulation of endothelial cell migration (GO:0010595),0.5223997665759476,1.7832542124677704,0.0017761989342806395,0.008170310028294585,0.687,6/21,16.62%,RAC1;PDCD6;HMGB1;EMC10;RRAS;ITGB1BP1
gsea,regulation of protein catabolic process (GO:0042176),0.4776375548753896,1.7822660961528718,0.0034423407917383822,0.008208001944262638,0.69,9/36,12.42%,OAZ1;SNX3;VPS28;SIRT2;SEC22B;CTSA;GSK3A;MAD2L2;SNX12
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5705965127237966,1.7801351827450491,0.0013054830287206266,0.008370735167594883,0.698,5/24,11.79%,CD52;BCAP31;HMGB1;NPTN;FIS1
gsea,response to lipopolysaccharide (GO:0032496),0.4589439110521867,1.7689477205850295,0.0017543859649122807,0.00916489289783873,0.722,14/42,24.05%,RHOA;GSTP1;LGALS9;CHMP5;STAP1;HMGB1;HMGB2;PYCARD;BCL10;RELA;MYD88;LY96;PAF1;TIRAP
gsea,regulation of neurogenesis (GO:0050767),0.5459966860486688,1.7679085049751344,0.00597609561752988,0.009245298649656201,0.724,6/17,17.70%,B2M;BHLHE40;HMGB2;CTNNB1;YTHDF2;FAIM
gsea,positive regulation of viral process (GO:0048524),0.5122359707917998,1.7664975458594416,0.017777777777777778,0.009340398145090686,0.727,12/21,27.34%,POLR2K;POLR2G;POLR2D;POLR2I;CD28;POLR2J;CDK9;VAPB;STAU1;CNOT7;NELFA;PDE12
gsea,mitotic metaphase plate congression (GO:0007080),0.5411170125896552,1.7639697957855318,0.007142857142857143,0.009521508863346975,0.736,10/18,28.52%,CHMP5;RAB11A;BECN1;DCTN2;CHMP3;CHMP1A;CHMP2A;VPS4B;CHMP2B;CHMP1B
gsea,regulation of angiogenesis (GO:0045765),0.46867817824851865,1.7620594886006888,0.005110732538330494,0.00966802144941495,0.742,10/32,15.09%,PDCD6;PDCL3;NAXE;RNH1;BTG1;CTNNB1;EMC10;SP100;SYNJ2BP;RRAS
gsea,regulation of tumor necrosis factor production (GO:0032680),0.5236411527029059,1.7620566755154456,0.005190311418685121,0.009645485268880183,0.742,10/27,14.75%,GSTP1;CD47;CD2;LGALS9;DDT;HMGB1;CYBA;IFNGR1;PYCARD;TRIM27
gsea,regulation of interferon-gamma production (GO:0032649),0.5560599031738671,1.760675683128787,0.0045662100456621,0.00974623497022462,0.746,7/15,16.95%,CD47;CD2;LGALS9;HMGB1;PYCARD;TRIM27;IL12RB2
gsea,negative regulation of cell population proliferation (GO:0008285),0.42516428740709106,1.7541928914987381,0.0,0.01026361621811859,0.759,32/92,26.65%,FTH1;B2M;CSNK2B;GSTP1;CIB1;BTG3;EMD;PDCD5;SIRT2;SLC9A3R1;BTG1;PTPN2;MAP2K1;ATRAID;CTNNB1;CTBP1;NMI;CD164;ITGB1BP1;COPS8;CDKN1C;PTPN14;IGFBP6;IFI35;AQP11;MED25;INCA1;TES;CNOT7;CTNNBIP1;RPS6KA2;TMEM115
gsea,regulation of gene silencing by miRNA (GO:0060964),0.5880316643499468,1.7517733519690981,0.009416195856873822,0.01049622584124179,0.769,7/17,15.22%,SEC13;POLR2K;POLR2G;ELAVL1;POLR2D;POLR2I;POLR2J
gsea,mRNA 3'-end processing (GO:0031124),0.4926898383623139,1.7497190584619267,0.013921113689095127,0.010642502414983863,0.776,14/24,32.25%,NUDT21;POLR2D;SSU72;THOC7;CLP1;U2AF1L4;TENT2;CHTOP;PAF1;PAPOLA;CDC40;SRSF11;SLU7;PABPN1
gsea,regulation of heart contraction (GO:0008016),0.628278803682552,1.7477126428309997,0.0040595399188092015,0.0108435802454525,0.78,5/19,11.25%,SRI;CALM1;CALM3;ATP1B3;GSK3A
gsea,histone deacetylation (GO:0016575),0.5709818464623626,1.74684192293783,0.006,0.010874000287570572,0.785,5/16,18.90%,MORF4L1;SIN3B;SIRT2;HDAC3;MSL3
gsea,mitotic nuclear division (GO:0140014),0.5927419532334988,1.7457296714346686,0.00998003992015968,0.010992634177447046,0.791,7/15,20.10%,RHOA;RAB11A;MZT1;NDEL1;TUBG2;LSM14A;CHMP2A
gsea,membrane fusion (GO:0061025),0.5314793163596745,1.7435520157760154,0.015037593984962405,0.011176838526134557,0.794,7/15,21.05%,VAPA;VAMP3;CHP1;VTI1B;NAPA;RABIF;UBXN2A
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),0.5115941848172023,1.740900415692853,0.0077279752704791345,0.01138585382756287,0.797,6/24,12.08%,SDCBP;PPP2CA;ADIPOR1;EZH2;MAD2L2;CTNNB1
gsea,regulation of protein targeting to membrane (GO:0090313),0.6105205810865328,1.7375030142251313,0.01107011070110701,0.011718228839276498,0.808,7/15,21.04%,CIB1;MFF;CHP1;FIS1;ITGB2;ITGB1BP1;KCNB1
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5756306656123852,1.734121727654558,0.0055248618784530384,0.01204544513145706,0.816,8/16,27.73%,CDC42;RNF115;TSG101;PTPN2;GRB2;ZFYVE28;DOK1;MVB12A
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.5858273567875895,-1.7336562782907718,0.017241379310344827,0.2081748498031904,0.871,5/15,16.55%,SMG1;SOCS4;PI4K2A;TMEM150A;PIP4K2A
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.543835607398452,1.732170093682624,0.004601226993865031,0.012196474149265371,0.818,8/26,17.02%,RHOA;FKBP1A;ARRB2;ZYX;UBC;APPL1;FNTA;PARD6A
gsea,positive regulation of cell differentiation (GO:0045597),0.4181791268674763,1.7316126228683237,0.0016260162601626016,0.01221245732732914,0.82,23/68,26.55%,RAP1A;RHOA;NUDT21;CDC42;ID2;SDCBP;BTG1;ATRAID;EZH2;CTNNB1;AKIRIN1;CCDC71L;RRAS;ATP6AP1;ZC4H2;PKDCC;AAMDC;TCF3;SMYD1;BNIP2;CTNNBIP1;RPS6KA1;TACSTD2
gsea,regulation of phosphorylation (GO:0042325),0.4426582426042622,1.7312222072302976,0.009689922480620155,0.01221749868582295,0.822,13/36,23.43%,DYNLL1;SEC13;SDCBP;PPP2CA;ILK;SIRT2;NDUFS4;STAP1;BCL10;PRKAG1;LDB1;CDKN1C;ROPN1L
gsea,protein methylation (GO:0006479),0.598029338256113,1.7302005909673353,0.0072992700729927005,0.012294818532392055,0.826,8/16,16.42%,TRMT112;EEF1AKMT1;PCMT1;EEF1AKMT2;SETD3;EZH2;LCMT1;VCPKMT
gsea,regulation of cellular component organization (GO:0051128),0.47826531624628155,1.7273403010663484,0.007662835249042145,0.012620669465959366,0.831,14/33,20.79%,RAP1A;RAP1B;DCUN1D5;LAMTOR2;LAMTOR1;SNX17;MAD2L2;SNX12;PTPN1;RAB4B;SGK3;RAB5C;LTBP4;OGFR
gsea,regulation of intracellular protein transport (GO:0033157),0.5391176145063508,1.7245915376351377,0.015053763440860216,0.012851489115409462,0.838,8/16,22.39%,OAZ1;PDCD10;ZFAND1;NDEL1;PTPN1;RAB29;PTPN14;B3GAT3
gsea,regulation of gene expression (GO:0010468),0.3385951410514086,1.7236999944913416,0.0,0.012944825702216398,0.84,94/258,38.12%,RPS7;NUDT21;NDFIP1;CD3E;RPL23;LAMTOR5;RPS3;PDCD10;MLF2;C1D;PDCL3;TBX21;LGALS9;ID2;BHLHE40;PDCD5;HNRNPL;PPP2CA;MSN;RNF187;STAP1;NDFIP2;MLX;RPL11;BTG1;UBE2L3;GLRX2;MAP2K1;CASP8;EDF1;ATRAID;GSK3A;PFDN5;EZH2;IFNGR1;SNX12;CREM;CNPY2;YTHDF2;CD28;YAF2;METTL18;TRAPPC2;TRIM27;PPP2R1A;PRKAG1;KRAS;FAM50A;RELA;RPS6KA4;MSL3;TRA2B;PRKAB1;LDB1;PQBP1;MYD88;CD46;SFMBT2;TCF3;ERP29;POU3F1;EMILIN1;NFIA;LIMS1;CNOT7;ANKRA2;DTNBP1;IRF2;HES6;TCF7;TAPBP;SPIN1;STOX1;KLF1;TESMIN;DDRGK1;UBE2V1;DRAP1;PABPN1;ZFP64;POU5F1;SLC39A8;CITED1;RHOH;FGF23;SOX12;ZFPL1;ARNTL2;LEF1;TLR6;SERTAD3;NOS3;DHH;THAP7
gsea,endosome organization (GO:0007032),0.5758243957244569,1.7188919818388155,0.007476635514018692,0.013392441077789743,0.847,4/15,9.00%,SNX3;PLEKHJ1;SQSTM1;LAMTOR1
gsea,positive regulation of mitochondrion organization (GO:0010822),0.5261973656985794,1.7180963717802722,0.01991150442477876,0.013462708300314452,0.848,7/16,20.30%,PDCD5;MFF;GSK3A;FIS1;PYCARD;BAD;FBXO7
gsea,cellular amino acid catabolic process (GO:0009063),0.5963781585034696,1.717889011328784,0.0112,0.013450625465992875,0.848,13/17,37.41%,ECHS1;QDPR;ACAT1;GLUD1;HMGCL;PRODH;AUH;KYAT1;ALDH5A1;AMDHD1;DAO;ALDH6A1;NOS3
gsea,regulated exocytosis (GO:0045055),0.41206068664446105,1.7168517108785712,0.0019047619047619048,0.013534687871336278,0.849,15/45,26.09%,SRGN;CALM1;WDR1;RAB10;CTSW;TMED10;VTI1B;RAB11B;APOOL;TEX264;PSAP;SNAPIN;CDK5;RIMS3;SYT5
gsea,protein homooligomerization (GO:0051260),0.46882139195858724,1.7146563777751447,0.006339144215530904,0.013781727837433826,0.851,12/29,29.89%,B2M;ELAVL1;SSBP1;PYCARD;BCL10;ACOT13;CHMP2A;MICU1;G3BP2;AQP11;GSDMD;USP16
gsea,positive regulation of programmed cell death (GO:0043068),0.37560012629863304,1.7107631114463877,0.0,0.014215468704938021,0.861,30/81,29.04%,SAP18;PSENEN;ARL6IP5;APH1A;PDCD5;PDCD2;SQSTM1;HMGB1;BNIP3L;MTCH1;CASP8;STK17B;CTNNB1;PYCARD;BCL10;RPS6;BAD;TNFRSF12A;UBC;RNF122;ING3;DIABLO;NCSTN;TIAM2;TRADD;RASGRF2;UBA52;RPS6KA2;MAP3K10;HTATIP2
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5066842722875984,1.7097936619738936,0.0,0.014304672628340925,0.864,4/30,7.99%,CD3G;GNB1;PRKAR1A;GNG2
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5066842722875984,1.7097936619738936,0.0,0.014304672628340925,0.864,4/30,7.99%,CD3G;GNB1;PRKAR1A;GNG2
gsea,negative regulation of inflammatory response (GO:0050728),0.43213796595954546,1.7096857444320637,0.002777777777777778,0.01428738243899036,0.864,9/46,22.41%,GSTP1;CD3G;GNB1;PRKAR1A;GNG2;PTPN2;LPCAT3;CD247;FNDC4
gsea,positive regulation of vasculature development (GO:1904018),0.5359807312397189,1.7073274235001368,0.006932409012131715,0.014519535853421594,0.868,5/17,15.09%,PDCD6;PDCL3;BTG1;EMC10;RRAS
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.5539621086143283,1.7061014178725766,0.01956521739130435,0.014719134494994861,0.872,6/15,22.48%,CCNH;PPP6C;CRLF3;MAX;KHDRBS1;CDK5
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),0.5100066248399033,1.705320403953069,0.006259780907668232,0.014784980441610088,0.874,13/32,28.97%,RHOA;FKBP1A;PDCD5;ARRB2;ZYX;UBC;APPL1;FNTA;PARD6A;LIMS1;UBA52;TGFBR3L;ITGB5
gsea,positive regulation of cytokine production (GO:0001819),0.39335297543490805,1.705217812226192,0.007380073800738007,0.014756328498413372,0.874,26/72,24.05%,TIGIT;LAMTOR5;PNP;POLR2K;RPS3;CD2;LGALS9;CRLF2;HMGB1;TMED10;CYBA;CTNNB1;PYCARD;BCL10;CD28;TRIM27;S100A13;APPL1;IL12RB2;RELA;IL15;PQBP1;MYD88;CD46;RAB1A;TIRAP
gsea,regulation of autophagosome assembly (GO:2000785),0.5591261337822644,1.7001721199395343,0.016913319238900635,0.015364961037649437,0.881,4/15,14.37%,SH3GLB1;IFT20;SEC22B;RAB1B
gsea,protein localization to membrane (GO:0072657),0.4156144813044777,1.6926286792211591,0.0030349013657056147,0.016301009072941804,0.899,32/70,40.08%,RAP1A;THY1;SH3GLB1;RAB11A;ATP1B3;SLC9A3R1;RAB8A;RAB10;ABHD17A;TM9SF1;ZDHHC3;RAB11B;ITGB2;SYNJ2BP;ARL3;ITGB1BP1;RAB29;KCNB1;TSPAN17;HPS6;SLC9A3R2;PDZK1;TSPAN14;CAPN3;LRRC4;RAB3A;MAGI2;PIGW;EHD1;LIN7C;CRB3;SCN3B
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5323308346638098,1.692526428839122,0.013961605584642234,0.016279668548560684,0.9,4/17,12.08%,CALM1;GNB1;GNG2;CTNNB1
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4638180513455845,1.6919375232446008,0.003937007874015748,0.01633798249009453,0.901,12/28,25.10%,RHOA;RPS3;LGALS9;ILK;ADIPOR1;LIME1;CD27;NMI;RELA;TRADD;IFI35;LIMS1
gsea,establishment of protein localization to plasma membrane (GO:0061951),0.5551111120462133,1.690013718041795,0.01361573373676248,0.01655828017562754,0.904,5/20,15.76%,VAMP4;GOLGA7;RAB10;SYS1;ARFRP1
gsea,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5468512903424788,1.687567743845447,0.015521064301552107,0.016870630955686722,0.905,4/15,10.47%,RAC1;ARF6;SDCBP;UNC119
gsea,regulation of exocytosis (GO:0017157),0.5262329941844596,1.6851454627744413,0.014675052410901468,0.017167895980190015,0.908,5/16,18.19%,RAB8A;RAB10;CHMP3;RAB21;ATP6AP1
gsea,positive regulation of T cell proliferation (GO:0042102),0.5518336655712648,1.6813218132167798,0.0056925996204933585,0.01772454572553984,0.913,8/17,20.65%,CD3E;PNP;RPS3;HMGB1;PYCARD;CD28;IL15;CD46
gsea,endocytic recycling (GO:0032456),0.44940044285587777,1.6772631534422293,0.02506265664160401,0.018282244057415093,0.916,16/28,39.69%,SNX3;VPS29;ARF6;SNX17;SNX12;VPS35L;RAB11B;VPS51;VPS26C;VPS26A;SNX4;RAB35;CCDC22;STX6;EHD1;ACAP2
gsea,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5401720070581861,1.6751684274963838,0.013232514177693762,0.018543872513162373,0.92,5/17,9.41%,EIF3H;GABARAPL2;SDCBP;UBXN1;RPL11
gsea,negative regulation of cytokine production (GO:0001818),0.3891714346069274,1.6747273046867075,0.006085192697768763,0.018572657776239343,0.921,14/52,18.53%,SRGN;RAC1;TIGIT;TBX21;LGALS9;HMGB1;NPTN;PYCARD;TRIM27;PPP1R11;TAX1BP1;UFD1;RPS6KA4;CUEDC2
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.5317664409126706,1.671589063094164,0.027426160337552744,0.019022996353496052,0.929,7/18,16.51%,SUMO1;HMGB1;HMGB2;ERCC1;NSMCE2;BABAM2;BABAM1
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.46535374271471164,1.668235988760408,0.004291845493562232,0.019498578092305513,0.935,17/43,25.81%,RAC1;VAPA;CORO1B;TOR1A;RAB11A;SLC9A3R1;HMGB1;BLOC1S4;ATXN10;BLOC1S1;BLOC1S3;FAM161A;PQBP1;SNAPIN;CDK5;ATP1B2;DTNBP1
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5414914113708648,1.6670141786532213,0.01054481546572935,0.019623368522458717,0.935,8/19,12.90%,CD2;LGALS9;DDT;HMGB1;CYBA;IFNGR1;PYCARD;BCL10
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3321337988447599,1.6634317425923237,0.0017482517482517483,0.0202680194812273,0.938,46/154,27.95%,SAP18;UBE2I;SUMO1;RPS3;TBX21;ID2;BHLHE40;PAIP2;MBD2;SIRT2;EIF4E2;MLX;HMGB2;GSK3A;PFDN5;EZH2;COMMD7;CTNNB1;PCIF1;CTBP1;SMARCE1;SNX6;HDAC3;ZGPAT;CNOT8;YAF2;MTERF3;RELA;CHMP1A;KHDRBS1;LDB1;LSM14A;DPF2;CDKN1C;SFMBT2;PHC2;MALSU1;CDK5;YWHAQ;ID3;LIMS1;CNOT7;SNW1;CPEB3;EID1;MAP3K10
gsea,positive regulation of angiogenesis (GO:0045766),0.5052998137276751,1.6620974851189039,0.010526315789473684,0.020434505506286685,0.939,5/20,15.09%,PDCD6;PDCL3;BTG1;EMC10;RRAS
gsea,response to endoplasmic reticulum stress (GO:0034976),0.4534923846376331,1.6606302491817013,0.012681159420289856,0.02068105254949446,0.944,10/32,20.50%,BCAP31;SELENOK;ERP44;DERL1;UFC1;UFM1;TMCO1;TMX1;DNAJB9;WFS1
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.49476622031829254,1.6597265474740668,0.004665629860031105,0.020805682834026985,0.944,11/27,24.61%,GSTP1;TMBIM6;GHITM;NDUFS3;PSMD10;TRIAP1;RELA;MCL1;NR4A2;CSNK2A1;TMEM14A
gsea,cell chemotaxis (GO:0060326),0.5719662847132079,1.6584244997354787,0.006069802731411229,0.020959950944386286,0.946,5/17,17.59%,RHOG;CORO1B;HMGB2;ARRB2;NR4A1
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5339434146691769,1.6578757247169973,0.024469820554649267,0.02099988263883136,0.947,11/19,29.14%,LAMTOR5;BEX3;DNAJB6;RNF34;IGBP1;TRIAP1;BCL2L12;CSNK2A1;RPS6KA1;PAK2;SIAH2
gsea,histone H3 acetylation (GO:0043966),0.5347680258975512,1.654442318682355,0.023094688221709007,0.02150015130505562,0.95,6/15,19.28%,TAF10;TAF12;DR1;NAA60;TADA1;LDB1
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5184746711458097,1.64967501386539,0.019189765458422176,0.02236132017650753,0.954,10/18,23.89%,BEX3;PDCD2;LCK;MTCH1;CASP8;PYCARD;BAD;DIABLO;TRADD;ACER2
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4060060888912253,1.6486067415640842,0.007952286282306162,0.022467888835089423,0.955,24/47,31.06%,SUMO1;ID2;BHLHE40;COMMD1;ARRB2;CHP1;PSMD10;MAD2L2;COMMD7;PYCARD;COMMD6;SP100;TAX1BP1;WFS1;AIM2;ID3;CTNNBIP1;RWDD3;HES6;MAP3K10;FOXJ1;RNF2;PEX14;OTULIN
gsea,positive regulation of cell growth (GO:0030307),0.489611893253602,1.6467402599282994,0.012367491166077738,0.022769678506850993,0.957,9/26,26.26%,CDC42;CIB1;SDCBP;TWF2;PSMD10;MTPN;TAF9B;CSNK2A1;RPS6KA1
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.4353220351251418,1.6450380273535141,0.026804123711340205,0.023010653461862672,0.962,10/27,23.63%,GABARAP;CIB1;CASP8;GSK3A;CD27;BAD;APPL1;MCL1;DIABLO;TRADD
gsea,regulation of organelle organization (GO:0033043),0.4479255241583013,1.642310189830539,0.009836065573770493,0.023462006175396396,0.964,9/39,17.44%,PDCD10;SAR1B;MSN;SQSTM1;TMED9;MFF;SURF4;FIS1;SAR1A
gsea,negative regulation of neuron death (GO:1901215),-0.420432573067695,-1.6398945985570117,0.007692307692307693,0.3351115254471377,0.977,10/30,26.24%,SOD1;SORL1;TNFRSF1B;TYRO3;CPEB4;GSK3B;POU4F1;SIX1;FGF20;NTRK1
gsea,phosphatidylcholine metabolic process (GO:0046470),0.5203801767531278,1.6336239404221082,0.0243531202435312,0.025078241724145148,0.967,9/23,27.63%,CSNK2B;PLAAT3;LPCAT4;MBOAT7;CEPT1;LPCAT3;CSNK2A1;PEMT;LPIN3
gsea,platelet degranulation (GO:0002576),0.44308390941263553,1.6326105982914345,0.0149812734082397,0.0252373550414148,0.967,8/28,20.11%,SRGN;CALM1;WDR1;CTSW;VTI1B;APOOL;TEX264;PSAP
gsea,long-chain fatty acid metabolic process (GO:0001676),0.5058009619034296,1.6310085976557402,0.008278145695364239,0.025497571542877105,0.968,7/20,22.03%,GSTP1;SCP2;HSD17B4;LTA4H;ELOVL1;ACOT2;GSTM4
gsea,calcium ion homeostasis (GO:0055074),0.5612184594376112,1.6304837752014705,0.02321981424148607,0.02556018472337987,0.968,7/17,21.45%,TPT1;NPTN;TMCO1;TMEM165;WFS1;VAPB;SLC24A1
gsea,regulation of cation channel activity (GO:2001257),0.552270841045338,1.6224822196879112,0.009887005649717515,0.027152442076843038,0.975,2/19,2.24%,FKBP1A;CALM1
gsea,regulation of axonogenesis (GO:0050770),0.5149665832497237,1.6197710918950192,0.02336448598130841,0.027615971188085668,0.978,6/17,33.11%,RHOA;THY1;RTN4;TIAM2;PAK2;PLXNA3
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.47068393191088453,1.6183595794437595,0.01929824561403509,0.027807392300087903,0.978,9/26,22.52%,DDX5;ARL6IP5;SELENOK;GSKIP;PYCARD;BAD;MCL1;DIABLO;PRODH
gsea,regulation of apoptotic signaling pathway (GO:2001233),0.530099041157511,1.613505897598983,0.025597269624573378,0.028826575018186928,0.983,6/16,24.31%,TMBIM6;RPS3;PYCARD;BCL2L12;NR4A2;CSNK2A1
gsea,regulation of ATP metabolic process (GO:1903578),0.5128206150196861,1.6118073643919877,0.02576112412177986,0.029180149603064028,0.984,6/15,15.19%,COX7A2;SEC13;FIS1;COX7A2L;PRKAG1;UQCC2
gsea,positive regulation of immune response (GO:0050778),0.5461219687389733,1.6096023740738412,0.013671875,0.029600255778311657,0.985,9/16,24.44%,SKAP1;LGALS9;CYBA;PYCARD;NMI;ITGB2;IL15;CD46;IFI35
gsea,protein import (GO:0017038),0.438162730202413,1.609523667165749,0.009671179883945842,0.029543927470047693,0.985,12/28,29.98%,TOMM22;SEC13;FIS1;FAM53A;PTTG1IP;PXMP4;APPL1;PEX13;PEX11B;ATAD1;PEX19;PEX14
gsea,actomyosin structure organization (GO:0031032),0.5558122359432882,1.599426616747409,0.013020833333333334,0.031850332320916504,0.989,4/20,11.44%,RHOA;PDCD10;WDR1;ZYX
gsea,regulation of cell adhesion (GO:0030155),0.4355251669336522,1.5990556623094208,0.014727540500736377,0.03188300219028065,0.989,9/35,21.50%,RAC2;ARHGDIB;PPP2CA;CYTIP;YTHDF2;CD164;PPP2R1A;ITGB1BP1;RHOD
gsea,regulation of cellular response to stress (GO:0080135),0.47207410612129186,1.5950509683569924,0.02197802197802198,0.03278549830171485,0.99,6/20,17.92%,CHCHD2;SEC13;HSBP1;DNAJB6;BAG1;MCL1
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.5280672983447771,1.5939428080865707,0.020654044750430294,0.03294752554372656,0.99,7/18,12.32%,CD2;LGALS9;DDT;HMGB1;CYBA;IFNGR1;PYCARD
gsea,response to ionizing radiation (GO:0010212),0.49207481583914736,1.5931203037027837,0.03469387755102041,0.033086525573623,0.99,5/17,16.51%,SWI5;NABP2;GRB2;BABAM2;BABAM1
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3129320977140502,1.5926604543609773,0.0017513134851138354,0.033138815191034225,0.99,73/175,41.00%,UBE2D3;UBE2I;SUMO1;RPL23;DDX5;TBX21;ID2;BHLHE40;HSBP1;RPS14;SIN3B;SDCBP;MBD2;SIRT2;HMGB1;MLX;DR1;EZH2;PSMD10;MAD2L2;CTBP1;MAX;CREM;UXT;HDAC3;IGBP1;ZGPAT;SP100;VPS72;TRIM27;UBC;RELA;KLF2;LDB1;DPF2;PER3;WFS1;TCF3;TAF9B;PAF1;NR4A2;ID3;MED25;THAP11;UBA52;HESX1;IRF2;SNW1;CPEB3;EID1;FOXJ1;RNF2;CBFB;HDAC8;DRAP1;LIN37;POU5F1;PPM1A;NR1I3;UBE2D1;ZGLP1;SMAD2;CBX8;SNAI1;THAP7;PHF6;LEFTY1;BRMS1;TLE6;MAP2K5;SIRT7;HEXIM2;CNOT2
gsea,positive regulation of cell projection organization (GO:0031346),0.46790480483078994,1.591243492853748,0.014884979702300407,0.03343930356501809,0.99,5/36,11.10%,RAP1A;RHOA;SNX3;TWF2;NPTN
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),0.5026596056374312,1.589570153844322,0.013123359580052493,0.033811704838779794,0.99,5/27,11.79%,CD52;BCAP31;HMGB1;NPTN;FIS1
gsea,negative regulation of type I interferon production (GO:0032480),-0.5182712597699978,-1.5877246259047038,0.030456852791878174,0.40088194382787296,0.99,11/19,27.60%,NLRC5;ILRUN;YY1;ITCH;RNF216;CYLD;RNF135;UBA7;IRF3;OTUD5;PCBP2
gsea,positive regulation of MAP kinase activity (GO:0043406),0.4979770939062965,1.5873077328370624,0.017857142857142856,0.03430000216112638,0.99,3/18,11.50%,RPS3;PDCD10;EZH2
gsea,activation of GTPase activity (GO:0090630),-0.40331297324521354,-1.5869904493089573,0.010830324909747292,0.35268865237207375,0.99,18/32,33.53%,ARHGAP45;TBC1D2B;SLC27A4;RALGAPA1;RABGAP1L;TBC1D22A;RAP1GAP2;TBC1D9B;GMIP;SIPA1;RUNDC1;TBC1D2;RAP1GAP;TBC1D12;SYDE1;PIP5K1A;TBC1D10C;TBC1D16
gsea,water-soluble vitamin metabolic process (GO:0006767),0.5520230748380631,1.585649857555025,0.028523489932885907,0.034653407509840285,0.99,9/16,33.49%,CYB5A;PANK2;MTHFS;RFK;CYB5R3;MMAA;TPK1;SLC46A1;THTPA
gsea,bicellular tight junction assembly (GO:0070830),-0.48977708996790303,-1.585299973426199,0.02830188679245283,0.31671960960338835,0.99,9/15,15.73%,APC;DLG1;PDCD6IP;F11R;PATJ;GRHL2;TBCD;PARD6B;OCLN
gsea,regulation of calcium ion transport (GO:0051924),0.5574170873798623,1.5852840351279303,0.022082018927444796,0.03469577881393357,0.99,4/15,20.50%,SRI;SARAF;CTNNB1;WFS1
gsea,regulation of protein phosphorylation (GO:0001932),0.37245284038016774,1.584572517303807,0.011235955056179775,0.034854659863652174,0.991,23/68,41.09%,RAC1;PDCL3;CIB1;PPP2CA;ILK;NDUFS4;SLC9A3R1;NPTN;CHP1;FKBP8;HDAC3;ITGB2;KRAS;ERP29;ROPN1L;F2;PPIL4;FGF23;ANKRD54;PIP5KL1;RARRES2;DVL2;TWF1
gsea,peroxisome organization (GO:0007031),0.5060611601423842,1.583688345215231,0.03508771929824561,0.03500977062185987,0.991,8/15,33.46%,PLAAT3;MFF;FIS1;PEX11B;PEX19;PEX14;LONP2;ACOT8
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4540410877240208,1.5830940349242808,0.015384615384615385,0.03510145290073523,0.991,13/39,28.97%,RHOA;FKBP1A;DDX5;ARRB2;ZYX;UBC;APPL1;FNTA;PARD6A;BMP8A;UBA52;TGFBR3L;ITGB5
gsea,negative regulation of kinase activity (GO:0033673),0.45442804303066003,1.579632088477203,0.023008849557522124,0.03589813735528332,0.992,11/26,28.70%,GSTP1;RTRAF;THY1;GSKIP;CHP1;TRIM27;ITGB1BP1;CDKN1C;DTNBP1;DBNDD2;PAK2
gsea,positive regulation of neurogenesis (GO:0050769),0.4849000235009405,1.5792646982441287,0.026687598116169546,0.03592828283855931,0.992,8/22,27.11%,RHOA;NPTN;CTNNB1;FAIM;SMARCD3;TIAM2;OBSL1;SNW1
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.47050413318214407,1.5787392729076346,0.028985507246376812,0.03601452028158944,0.992,10/21,25.10%,RHOA;RPS3;LGALS9;ILK;CD27;NMI;RELA;TRADD;IFI35;LIMS1
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3055332029998514,1.5784707594321843,0.0,0.036044322708762795,0.992,100/247,41.00%,SAP18;UBE2D3;UBE2I;SUMO1;RPL23;DDX5;TBX21;ID2;BHLHE40;HSBP1;PRDX5;RPS14;SIN3B;SDCBP;MBD2;SIRT2;HMGB1;MAF1;MLX;HMGB2;DR1;PFDN5;EZH2;PSMD10;MAD2L2;COMMD7;CTNNB1;CTBP1;MAX;CREM;SMARCE1;UXT;SNX6;HDAC3;IGBP1;ZGPAT;YAF2;SP100;VPS72;TRIM27;UBC;MTERF3;RELA;KLF2;CHMP1A;KHDRBS1;LDB1;DPF2;PER3;CDKN1C;WFS1;SFMBT2;PHC2;CDK5;TCF3;TAF9B;PAF1;NR4A2;YWHAQ;ID3;MED25;LIMS1;CNOT7;THAP11;UBA52;HESX1;IRF2;SNW1;CPEB3;EID1;MAP3K10;FOXJ1;RNF2;CBFB;PEX14;HDAC8;DRAP1;CAPN3;LIN37;POU5F1;PPM1A;NR1I3;CITED1;UBE2D1;ZGLP1;SMAD2;CBX8;LEF1;SNAI1;THAP7;DPF1;PHF6;LEFTY1;BRMS1;TLE6;MAP2K5;SIRT7;SAMD13;HEXIM2;CNOT2
gsea,fat cell differentiation (GO:0045444),-0.46015624985751424,-1.5778025793438724,0.040160642570281124,0.2985575927076859,0.991,12/22,32.81%,EP300;NR4A3;ZBTB7A;OSBPL8;OSBPL11;FAM120B;FOXO1;BBS9;SENP2;AKT2;PER2;BBS2
gsea,axon guidance (GO:0007411),0.4547113549920193,1.5754362576354526,0.011890606420927468,0.03684544657931528,0.992,6/49,13.65%,RAC1;RAC2;VASP;RHOG;NPTN;GRB2
gsea,negative regulation of cell adhesion (GO:0007162),0.47885553092034855,1.5731179176009988,0.03225806451612903,0.03738268356453844,0.993,6/23,23.89%,RHOA;ARHGDIB;CD164;ITGB1BP1;SPINT2;ACER2
gsea,positive regulation of secretion by cell (GO:1903532),0.4584597043609623,1.5731138270670146,0.03508771929824561,0.03731051622174976,0.993,6/19,25.81%,ARF6;IER3IP1;TMED10;ATP6AP1;KCNB1;DTNBP1
gsea,response to interleukin-1 (GO:0070555),0.4946314158628799,1.5696121725033576,0.028716216216216218,0.03812312555338524,0.995,6/18,20.14%,CD47;LGALS9;PYCARD;IGBP1;RELA;MYD88
gsea,negative regulation of phosphorylation (GO:0042326),0.45202346287390593,1.5692725136348757,0.025594149908592323,0.038108459244342766,0.995,6/22,20.37%,DYNLL1;CIB1;STAP1;CHP1;FKBP8;CDKN1C
gsea,cilium assembly (GO:0060271),0.36579491511763046,1.5679235934116635,0.007772020725388601,0.038417331174428464,0.995,45/108,40.98%,ACTR3;DYNLL1;DYNLRB1;ARF4;RAB11A;ATP6V1D;MAPRE1;IFT20;RAB8A;SSNA1;CETN2;DCTN2;DCTN3;ATP6V0D1;ARL6;PPP2R1A;CFAP20;ARL3;BBIP1;BBS5;FAM161A;TTC8;TXNDC15;B9D2;RAB1A;RSPH9;DYNC2LI1;ZMYND10;BBS7;FOXJ1;IFT52;TTC26;CPLANE2;PRKACA;BBS1;SNAP29;DISC1;BBOF1;RILP;RSPH1;EHD1;STK36;KIF17;WDPCP;TCTN1
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.32519789076116556,1.567751361060819,0.006666666666666667,0.03838985793188513,0.995,37/133,27.95%,SAP18;UBE2I;SUMO1;TBX21;ID2;BHLHE40;MBD2;SIRT2;MLX;HMGB2;PFDN5;EZH2;COMMD7;CTNNB1;CTBP1;SMARCE1;SNX6;HDAC3;ZGPAT;YAF2;MTERF3;RELA;CHMP1A;KHDRBS1;LDB1;DPF2;CDKN1C;SFMBT2;PHC2;CDK5;YWHAQ;ID3;LIMS1;CNOT7;SNW1;EID1;MAP3K10
gsea,tight junction assembly (GO:0120192),-0.4775111495745462,-1.5649967679287227,0.03215434083601286,0.29462964009266057,0.991,9/16,15.73%,APC;DLG1;PDCD6IP;F11R;PATJ;GRHL2;TBCD;PARD6B;OCLN
gsea,negative regulation of cell cycle process (GO:0010948),0.5284971253841555,1.5642403685363553,0.03868471953578337,0.03926170650927202,0.996,6/16,20.10%,AURKAIP1;EZH2;MAX;UXT;YAF2;CHMP2A
gsea,regulation of transcription by RNA polymerase II (GO:0006357),0.2841629322047947,1.56341313221112,0.0,0.03943183097335675,0.996,184/490,41.35%,SAP18;SUB1;UBE2D3;UBE2I;CHCHD2;ACTR3;SUMO1;RTRAF;RPL23;METTL23;ARF4;PRKAR1A;LAGE3;SKAP1;DDX5;MED10;TBX21;LITAF;ID2;BHLHE40;HSBP1;CCNH;ENY2;MED21;RPS14;SIN3B;SDCBP;SSBP4;MBD2;SSU72;SQSTM1;IER2;SIRT2;SRA1;HMGB1;CAMTA1;MLX;HMGB2;DR1;LIME1;CCNQ;YEATS4;WAS;SETD3;EZH2;PSMD10;MAD2L2;MED31;CTNNB1;CCNC;CRLF3;CTBP1;MAX;WBP2;CREM;MED18;SMARCE1;UXT;HDAC3;IGBP1;ZGPAT;GLMP;SP110;MED19;SP100;AKIRIN1;TRIAP1;VPS72;TRIM27;TCEA1;UBC;MEIS3;BCL2L12;ELF1;GTF2H5;ITGB1BP1;MED6;CDK9;IRF9;RELA;NR4A1;KLF2;TADA1;FIZ1;RPS6KA4;RNF4;ZFP3;LDB1;DPF2;REPIN1;PER3;WFS1;SMARCD3;CREG1;ZIK1;RFXAP;TCF3;TAF9B;PAF1;NR4A2;MTF1;ID3;CRTC2;POU3F1;NFIA;MED25;NPAS4;MRGBP;HOXC4;THAP11;UBA52;RPS6KA1;DACH2;HESX1;IRF2;SNW1;BBS7;ELL3;HES6;CPEB3;LPIN3;TCF7;EID1;ZBTB24;PPIL4;MED17;FOXJ1;RNF2;FSTL3;SMARCD2;MED29;HTATIP2;CBFB;ZBTB10;ZFP14;KLF1;USP16;DDRGK1;HBP1;ZBTB8A;HDAC8;NCK1;DRAP1;ZFP64;PSMC3;LIN37;NOD2;POU5F1;PPM1A;NR1I3;CITED1;SOX12;UBE2D1;BATF;ZGLP1;GCM2;PITX2;SMAD2;CBX8;ARNTL2;LEF1;PPM1D;KLF5;SNAI1;DBX1;THAP7;DPF1;PHF6;LEFTY1;BRMS1;RFX4;TLE6;MAP2K5;TOX2;CRTC1;DMRT2;SIRT7;TIAL1;ELK1;DVL2;HEXIM2;CNOT2;TEAD3;PRDM15
gsea,cellular response to metal ion (GO:0071248),0.49232102729280214,1.5629862986202163,0.03412462908011869,0.03948512964957336,0.996,2/23,1.95%,B2M;SUMO1
gsea,protein localization to cell periphery (GO:1990778),0.40953616302944706,1.5617099101403102,0.01694915254237288,0.039782345299815135,0.996,21/49,40.08%,RAP1A;RAB11A;ATP1B3;SLC9A3R1;RAB8A;RAB10;ZDHHC3;ARL3;ITGB1BP1;RAB29;KCNB1;TSPAN17;SLC9A3R2;PDZK1;TSPAN14;RAB3A;PIGW;EHD1;LIN7C;CRB3;SCN3B
gsea,epithelial cell differentiation (GO:0030855),0.5224578073200256,1.561530638249466,0.0237741456166419,0.039752542554591215,0.996,5/16,19.25%,CTSB;RAB10;EDF1;TPP1;CASP6
gsea,regulation of protein localization (GO:0032880),0.48724339445223097,1.561054005776123,0.03556485355648536,0.03978061149562061,0.996,4/18,14.75%,FKBP1A;SUMO1;DNAJB6;TRIM27
gsea,positive regulation of defense response (GO:0031349),0.5087131357613285,1.5606493211779129,0.02040816326530612,0.03982374526646766,0.996,8/18,24.44%,CD47;DDT;CYBA;NMI;GPSM3;IL15;TRADD;IFI35
gsea,kidney development (GO:0001822),-0.443245942971669,-1.5583054489516557,0.01838235294117647,0.28090946757820595,0.991,8/17,16.71%,NIPBL;PKD1;TGFBR1;GREB1L;PRKX;SOX4;BAG6;SIX1
gsea,negative regulation of binding (GO:0051100),0.4386270516514092,1.553918950963179,0.02766798418972332,0.041732250849142574,0.996,10/25,36.78%,PPP1CA;SUMO1;TMBIM6;SP100;ITGB1BP1;CTNNBIP1;PEX19;PEX14;DISC1;LEF1
gsea,"positive regulation of transcription, DNA-templated (GO:0045893)",0.28733793366170857,1.5509231143879922,0.004754358161648178,0.04256351037279274,0.996,127/314,42.10%,YWHAH;CHCHD2;ACTR3;RTRAF;METTL23;ARF4;LAGE3;SKAP1;MED10;TBX21;LITAF;ID2;ENY2;RHOG;MED21;ILK;SSBP4;SQSTM1;RNF187;IER2;SIRT2;HMGB1;MLX;HMGB2;DR1;SFR1;YEATS4;PCBD2;MAP2K1;WAS;EDF1;SETD3;MAD2L2;CTNNB1;CCNC;CRLF3;MAX;WBP2;SERTAD1;BCL10;HDAC3;GLMP;YAF2;MED19;SP100;AKIRIN1;TRIAP1;TCEA1;UBC;MEIS3;BCL2L12;ELF1;ITGB1BP1;MED6;CDK9;RELA;NR4A1;KLF2;FIZ1;RPS6KA4;RNF4;LDB1;DPF2;CDKN1C;SMARCD3;RFXAP;TCF3;NR4A2;MTF1;CRTC2;POU3F1;NFIA;MED25;NPAS4;HOXC4;UBA52;RPS6KA1;IRF2;SNW1;HAS3;ELL3;LPIN3;MED17;FOXJ1;FSTL3;USP21;SPIN1;SMARCD2;HTATIP2;KLF1;USP16;DDRGK1;HDAC8;UBE2V1;NCK1;DRAP1;ZFP64;CAPN3;PSMC3;SEC14L2;NOD2;POU5F1;CAMK4;PPM1A;NR1I3;CITED1;SOX12;ZGLP1;PITX2;SMAD2;ARNTL2;LEF1;SERTAD3;KLF5;SNAI1;MSANTD1;DPF1;RFX4;MAP2K5;TOX2;CRTC1;SIRT7;ELK1;DVL2;PRDM15;GALR2;PSMD9
gsea,myeloid leukocyte differentiation (GO:0002573),0.4782335538916219,1.5508372206801653,0.03821656050955414,0.042531777054682106,0.996,5/20,18.89%,CDC42;LGALS9;GLO1;CASP8;IL15
gsea,positive regulation of cell adhesion (GO:0045785),0.48183103172271613,1.5504079594699922,0.02538787023977433,0.04256340261955413,0.996,8/21,29.48%,RAC1;CIB1;CD47;P2RY12;RHOD;LIMS1;FSTL3;RELL2
gsea,organic substance transport (GO:0071702),0.4500829451989164,1.550380396540037,0.0183206106870229,0.04248670165317129,0.996,14/33,31.81%,CD3G;ARL6IP5;SCAMP3;SLC50A1;CHMP3;SCAMP2;CHMP1A;CHMP2A;SLC18A2;CHMP2B;CHMP1B;PEX19;SNX4;PPT1
gsea,response to cytokine (GO:0034097),0.4324840000598477,1.5485081028552479,0.02607361963190184,0.04298931864970266,0.996,12/38,21.94%,RHOA;LGALS9;PTPN2;CASP8;IGBP1;SP100;CDK9;RELA;MCL1;MYD88;PTPN18;PTPN14
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),0.4959446062339129,1.546274578450866,0.025157232704402517,0.043564924322138786,0.996,7/20,21.45%,TPT1;LCK;NPTN;TMCO1;TMEM165;VAPB;SLC24A1
gsea,calcium ion transport (GO:0006816),0.43328807697922667,1.5460324432472305,0.02564102564102564,0.043555533546318984,0.996,7/33,22.06%,TPT1;FKBP1A;SELENOK;TMCO1;TMEM165;SLC24A1;MICU1
gsea,cellular response to DNA damage stimulus (GO:0006974),0.3288925864961906,1.539338988501507,0.02102803738317757,0.045685298631178164,0.996,34/75,44.02%,UBE2A;SUMO1;UBE2B;RPS3;CIB1;DCUN1D5;NABP2;ERCC1;ALKBH3;OTUB1;GRB2;BABAM2;NSMCE3;FAAP20;MCL1;FBXO6;HMCES;TREX1;ACER2;XPA;EID3;TOPORS;USP16;USP3;MOAP1;BATF;RAD51B;PAXX;SIRT7;CDKN2AIP;BCL2L2;POLB;INIP;PNKP
gsea,regulation of MAPK cascade (GO:0043408),0.4264895895427614,1.535334003440111,0.029850746268656716,0.04686316766183508,0.997,12/34,28.70%,YWHAZ;GSTP1;ATP6AP2;HMGB1;LAMTOR1;MAP2K1;PSMD10;RRAS;VRK2;ULK4;IGF1R;PAK2
gsea,cellular metal ion homeostasis (GO:0006875),0.496099937682682,1.5349378402232903,0.03234880450070324,0.04691608599735515,0.997,8/23,25.71%,TPT1;ATP1B3;NPTN;TMCO1;TMEM165;VAPB;SLC24A1;ATP1B2
gsea,intraciliary transport involved in cilium assembly (GO:0035735),0.5488070959690916,1.5323749511105205,0.040061633281972264,0.047594822132940785,0.997,3/15,7.66%,DYNLL1;DYNLRB1;IFT20
gsea,positive regulation of response to external stimulus (GO:0032103),0.423346664735499,1.5315072416036133,0.02388535031847134,0.04777945892705551,0.997,14/31,32.41%,CD47;DDT;CYBA;NMI;GPSM3;IL15;P2RY12;LY96;TRADD;IFI35;F2;SETD4;THBD;ZCCHC3
gsea,protein localization to plasma membrane (GO:0072659),0.4110183104741494,1.5289459594902182,0.027972027972027972,0.048554607766540296,0.997,20/46,40.08%,RAP1A;RAB11A;ATP1B3;SLC9A3R1;RAB8A;RAB10;ZDHHC3;ITGB1BP1;ASB3;KCNB1;TSPAN17;SLC9A3R2;PDZK1;TSPAN14;NECTIN3;RAB3A;PIGW;EHD1;CRB3;SCN3B
gsea,regulation of kinase activity (GO:0043549),-0.4155272051723262,-1.5289335506860184,0.04024767801857585,0.3098954598333094,0.995,11/23,26.24%,SOD1;NLRC5;TYRO3;INSRR;DSTYK;EPHB6;MAPT;LTK;CDKN1B;DDR1;NTRK1
gsea,positive regulation of intracellular transport (GO:0032388),0.4479491023795912,1.5131950919923831,0.028985507246376812,0.05394153068608771,0.999,5/17,22.39%,OAZ1;PDCD10;ZFAND1;RAB29;B3GAT3
gsea,cilium organization (GO:0044782),0.3627345836719442,1.51232909499984,0.017591339648173207,0.054157682488700266,0.999,33/82,40.98%,ACTR3;DYNLL1;ARF4;RAB11A;ATP6V1D;SLC9A3R1;IFT20;RAB8A;ATP6V0D1;ARL6;CFAP20;ARL3;BBIP1;BBS5;FAM161A;TTC8;TXNDC15;B9D2;RAB1A;BBS7;FOXJ1;IFT52;TTC26;CPLANE2;ARMC2;BBS1;SNAP29;DISC1;RILP;EHD1;STK36;WDPCP;TCTN1
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.49198784273244156,1.5113995886492522,0.05894308943089431,0.05436716308847864,0.999,6/16,16.62%,GSTP1;SLC9A3R1;PTPN2;SYNJ2BP;PTPN1;ITGB1BP1
gsea,Wnt signaling pathway (GO:0016055),0.4052174196677544,1.5079795105410345,0.03345070422535211,0.05545911552867351,0.999,14/34,37.51%,RBX1;SNX3;VPS29;ARL6;CTNNB1;UBC;NR4A2;VPS26A;UBA52;TCF7;FRAT1;LEF1;RAC3;FZD9
gsea,negative regulation of protein kinase activity (GO:0006469),0.41375182476929784,1.504434726667916,0.04259259259259259,0.05673746709704806,0.999,13/31,28.70%,GSTP1;RTRAF;THY1;GSKIP;CHP1;PYCARD;TRIM27;PTPN1;ITGB1BP1;CDKN1C;DTNBP1;DBNDD2;PAK2
gsea,erythrocyte differentiation (GO:0030218),0.48584195125913854,1.504082017241015,0.04462474645030426,0.05675983732557475,0.999,5/15,29.59%,ID2;RPS14;PTPN2;SLC25A38;KLF1
gsea,regulation of glycolytic process (GO:0006110),-0.42590514540301405,-1.5010220546978381,0.04773869346733668,0.3388961644322117,0.997,10/20,30.36%,EP300;GIT1;OGT;ZBTB7A;NCOR1;TPR;ACTN3;GAPDHS;PFKFB4;HIF1A
gsea,protein complex oligomerization (GO:0051259),0.4189419694943934,1.4966378045181499,0.0304,0.059455324933537175,0.999,12/31,28.84%,NUDT21;ELAVL1;PYCARD;BCL10;OXA1L;CUTC;CHMP2A;UGDH;MICU1;G3BP2;AQP11;GSDMD
gsea,positive regulation of inflammatory response (GO:0050729),0.5007153487553008,1.4959259240789924,0.0564373897707231,0.05963581176767044,0.999,9/16,30.67%,CD47;DDT;NMI;GPSM3;IL15;TRADD;IFI35;SETD4;SNX4
gsea,positive regulation of neuron projection development (GO:0010976),0.4561095954257133,1.4955280381546299,0.034482758620689655,0.05969061074632098,0.999,4/26,11.10%,RAP1A;SNX3;TWF2;NPTN
gsea,purine ribonucleotide metabolic process (GO:0009150),0.48367370243908614,1.494279908367959,0.07203389830508475,0.06005577982470504,0.999,10/16,33.46%,ACAT1;GNAI3;BAD;ACOT13;SULT4A1;ACOT2;ACOT9;AK3;ACOT7;ACOT8
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.40836067965316314,-1.493131056716159,0.03056768558951965,0.3302268489745183,0.998,12/20,29.88%,BTBD9;AKAP9;DGKZ;PTEN;EIF4EBP2;DLG4;AGER;LRRC4C;CHRNB2;NLGN3;NPTXR;MAPK8IP2
gsea,amide biosynthetic process (GO:0043604),0.5178932086097063,1.491467685569679,0.04597701149425287,0.06114394764789676,0.999,6/17,23.14%,SPTSSA;DEGS1;CERS2;ASAH1;PAM;SMPD2
gsea,hemopoiesis (GO:0030097),-0.3977119154841298,-1.489564613111021,0.04534005037783375,0.31591665371866584,0.998,11/26,28.94%,PTPRC;RUNX3;MKNK2;RUNX2;TGFBR2;CDK13;NOTCH4;PRKX;FUT10;TOX;RASGRP4
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.5057895763092634,1.4882686436922554,0.057724957555178265,0.06223976233710307,0.999,6/17,17.59%,PDCD6;PDCL3;HMGB1;HMGB2;EMC10;NR4A1
gsea,generation of neurons (GO:0048699),0.40737452712661887,1.487392856340417,0.021476510067114093,0.06248290241967639,0.999,16/44,28.86%,RAC1;BHLHE40;IER2;HMGB2;MAP2K1;NGRN;CTNNB1;YTHDF2;MTPN;PEX13;LDB1;CDK5;NR4A2;HES6;ITM2C;DNAAF4
gsea,regulation of endothelial cell proliferation (GO:0001936),0.46302907359367135,1.4867405584082363,0.05731225296442688,0.06267329952478952,0.999,6/17,17.59%,PDCD6;PDCL3;HMGB2;EMC10;SYNJ2BP;NR4A1
gsea,circulatory system development (GO:0072359),-0.3979916620454453,-1.4845939555851273,0.05,0.3057958298297566,0.998,13/28,15.84%,AKAP13;KDM6A;STK11;PKD1;TGFBR2;TAB2;PTEN;TCF25;TGFBR1;NOTCH4;POU4F1;HEY1;SOX4
gsea,glycoprotein biosynthetic process (GO:0009101),0.43808278942403334,1.4797591639967134,0.052805280528052806,0.06539145702740269,1.0,5/22,25.74%,DAD1;CHST12;ALG5;ATP7A;B3GNT2
gsea,cation transport (GO:0006812),0.40889481687090157,1.4792927238040243,0.03207810320781032,0.06548408647760737,1.0,20/36,54.23%,NDFIP1;NDUFA9;NDFIP2;CHP1;SLC18A2;KCNA3;SLC4A11;SLC25A29;SLC36A3;KCNIP2;SCN3B;MCOLN1;KCNH1;SLC38A7;TRPM6;KCNJ13;SLC5A2;SLC5A6;ASIC1;PANX1
gsea,regulation of interleukin-8 production (GO:0032677),0.46813526310576176,1.4779091589765574,0.06390328151986183,0.06594899449092868,1.0,10/20,24.05%,LAMTOR5;CD2;LGALS9;HMGB1;PYCARD;BCL10;RELA;MYD88;RAB1A;TIRAP
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31847451267988286,1.4655449354599652,0.00975609756097561,0.07117600468765391,1.0,42/112,38.12%,RBM3;MLF2;TBX21;BHLHE40;PPP2CA;MLX;BTG1;UBE2L3;GLRX2;EDF1;PFDN5;EZH2;PCIF1;CREM;YAF2;METTL18;TRAPPC2;PPP2R1A;MTPN;RELA;RPS6KA4;MSL3;LDB1;PQBP1;TCF3;NFIA;IRF2;HES6;TCF7;SPIN1;KLF1;TESMIN;UBE2V1;DRAP1;POU5F1;SLC39A8;RHOH;SOX12;ZFPL1;ARNTL2;SERTAD3;THAP7
gsea,regulation of vesicle-mediated transport (GO:0060627),0.38860215608282267,1.4640271311494377,0.03143418467583497,0.07180905988913165,1.0,17/37,34.55%,RAB11A;RAB8A;RAB10;MAP2K1;SNX17;CHMP3;SNX12;RAB11B;PTPN1;RAB4B;RAB21;RAB5C;ATP9A;AP2S1;BET1L;CPLANE2;CD22
gsea,regulation of RNA metabolic process (GO:0051252),-0.44963428470412437,-1.4639072871735197,0.08646616541353383,0.3234137260318118,1.0,9/20,15.71%,SON;MBNL1;CLK1;RC3H1;TNFRSF1B;MBNL2;CLK4;CLK3;PRX
gsea,regulation of receptor internalization (GO:0002090),0.49441205212493206,1.4613749860374878,0.07918968692449356,0.0728589563260478,1.0,3/15,10.07%,ARF1;SDCBP;ARRB2
gsea,nitrogen compound transport (GO:0071705),0.39406644431529303,1.4573129760672523,0.040419161676646706,0.07462229606624163,1.0,16/39,32.19%,CD3G;ARL6IP5;SCAMP3;CHMP3;SCAMP2;SLC43A1;CHMP1A;CHMP2A;SLC18A2;SLC25A47;CHMP2B;SLC7A4;CHMP1B;SNX4;PPT1;SLC25A29
gsea,fatty acid biosynthetic process (GO:0006633),0.4894373898359577,1.457280097327578,0.07880910683012259,0.07450442551188653,1.0,5/15,22.03%,DEGS1;TECR;LTA4H;ELOVL1;GSTM4
gsea,negative regulation of metabolic process (GO:0009892),0.42992866067722446,1.4511600324338263,0.0683453237410072,0.07727953029967276,1.0,6/19,18.89%,GSTP1;RHEB;FIS1;PGAM5;ACOT13;IL15
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4405355410866941,1.449734038140902,0.07095343680709534,0.07775186554216185,1.0,8/20,19.06%,SAP18;DDX5;HNRNPL;PUF60;WTAP;RBM7;TRA2B;KHDRBS1
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.28001554511199095,1.4483237102848228,0.01676829268292683,0.07826209962533881,1.0,97/242,41.35%,SUB1;CHCHD2;ACTR3;RTRAF;METTL23;ARF4;LAGE3;SKAP1;MED10;LITAF;MED21;SSBP4;SQSTM1;IER2;SIRT2;HMGB1;MLX;HMGB2;DR1;YEATS4;WAS;SETD3;CTNNB1;CCNC;CRLF3;MAX;WBP2;HDAC3;GLMP;MED19;AKIRIN1;TRIAP1;TCEA1;UBC;MEIS3;BCL2L12;ELF1;EAPP;ITGB1BP1;MED6;CDK9;RELA;NR4A1;KLF2;FIZ1;RPS6KA4;RNF4;LDB1;DPF2;SMARCD3;RFXAP;TCF3;NR4A2;MTF1;CRTC2;NFIA;MED25;NPAS4;HOXC4;UBA52;RPS6KA1;IRF2;SNW1;ELL3;LPIN3;MED17;FOXJ1;FSTL3;SMARCD2;HTATIP2;USP16;DDRGK1;HDAC8;NCK1;DRAP1;ZFP64;PSMC3;NOD2;POU5F1;NR1I3;CITED1;SOX12;ZGLP1;PITX2;SMAD2;ARNTL2;LEF1;KLF5;DPF1;RFX4;MAP2K5;TOX2;CRTC1;SIRT7;ELK1;DVL2;PRDM15
gsea,protein import into nucleus (GO:0006606),0.44812786662391113,1.4480145741759969,0.0659536541889483,0.07826278001612894,1.0,5/16,16.56%,RPL23;SEC13;FAM53A;PTTG1IP;APPL1
gsea,positive regulation of catalytic activity (GO:0043085),0.4761541758643889,1.4478794401603001,0.06806282722513089,0.07819305948576188,1.0,10/18,24.97%,PSENEN;CIB1;APH1A;SSBP1;YWHAB;NCSTN;CHTOP;B3GAT3;ATP7A;NHEJ1
gsea,inflammatory response (GO:0006954),0.38741318251157864,1.446765172686543,0.04671532846715328,0.07857896674100306,1.0,10/39,17.93%,RAC1;LGALS9;PRDX5;HMGB1;CYBA;LAT;IL10RB;ITGB2;RELA;TUSC2
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.49315556871394595,1.4456162516663869,0.08103130755064457,0.07905331972310682,1.0,6/15,14.28%,GSTP1;ROMO1;CYBA;DHRS4;GRB2;ITGB2
gsea,positive regulation of GTPase activity (GO:0043547),-0.33526558014482183,-1.4442926269945497,0.035483870967741936,0.340740134986316,1.0,35/57,35.51%,ARHGAP45;DOCK10;TBC1D2B;SEMA4D;SLC27A4;RAB11FIP2;SNX18;ARHGEF7;RALGAPA1;RALBP1;RABGAP1L;RIC1;GSK3B;TBC1D22A;RAP1GAP2;TBC1D9B;F11R;DVL3;RAPGEF6;PLXNB1;GMIP;SIPA1;TBC1D20;RUNDC1;TBC1D2;RAP1GAP;TBC1D12;AGRN;NTRK1;CDKL5;SYDE1;PIP5K1A;TBC1D10C;TBC1D16;ARHGAP29
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.3562775605890332,1.4435811724637817,0.03795066413662239,0.07990417878049348,1.0,11/46,32.92%,ARF1;DPM1;DPM3;DPM2;PIGP;MBOAT7;IMPA1;MPPE1;MTMR9;PIK3C2B;PLEKHA3
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.40533958546726745,1.4399261023106098,0.06748466257668712,0.0817223955418247,1.0,13/26,27.67%,RPS3;CSTB;PAIP2;EIF4E2;ATRAID;PCIF1;CNOT8;LSM14A;MALSU1;CDK5;CNOT7;CPEB3;F2
gsea,negative regulation of immune response (GO:0050777),0.368651831320811,1.4376671135369359,0.03551136363636364,0.082627065226396,1.0,13/45,37.69%,CD3G;GNB1;PRKAR1A;SIRT2;GNG2;PDCD1;NMI;TRIM27;CD247;SAMSN1;PRKACA;ADCY9;PPM1B
gsea,external encapsulating structure organization (GO:0045229),-0.3243312960745857,-1.437245421143248,0.03821656050955414,0.33547260203024654,1.0,18/36,33.33%,ITGAL;ITGAV;MMP11;F11R;ADAM15;ICAM5;COMP;ADAMTS10;ITGAD;AGRN;DDR1;ADAMTSL5;ITGA2;MMP17;NID2;COL11A2;COL18A1;COL23A1
gsea,extracellular structure organization (GO:0043062),-0.3227987749937721,-1.436949339714394,0.03184713375796178,0.31989182870164845,1.0,19/37,33.33%,ITGAL;ITGAV;MMP11;F11R;TGFBR1;ADAM15;ICAM5;COMP;ADAMTS10;ITGAD;AGRN;DDR1;ADAMTSL5;ITGA2;MMP17;NID2;COL11A2;COL18A1;COL23A1
gsea,regulation of smoothened signaling pathway (GO:0008589),-0.4479846576335288,-1.4344394363038853,0.0668693009118541,0.30960011865077125,1.0,10/15,26.68%,HERC4;IFT122;INTU;FBXL17;GLIS2;ULK3;SUFU;TTC23;MOSMO;KIF7
gsea,regulation of hydrolase activity (GO:0051336),-0.4034917261636426,-1.4341071831565977,0.05,0.29667900667441294,1.0,11/23,24.70%,SOD1;RALBP1;RAPGEF6;PLXNB1;OCRL;VAV1;ARHGAP15;FGD6;FBXW11;CRK;RAP1GAP
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.4727416566614535,1.4336050963751976,0.06576402321083172,0.08463487732306077,1.0,6/17,32.32%,LAMTOR5;HDAC3;NMD3;RBM22;F2;ORMDL3
gsea,establishment of protein localization to extracellular region (GO:0035592),0.49000146834594327,1.4318754317931326,0.07086614173228346,0.08532551195145649,1.0,3/17,8.11%,SVBP;RAB8A;RAB10
gsea,positive regulation of interleukin-1 production (GO:0032732),0.4763601378422927,1.431175005703454,0.06842105263157895,0.08551945682394162,1.0,8/18,22.67%,LGALS9;HMGB1;TMED10;CASP8;PYCARD;S100A13;MYD88;AIM2
gsea,protein K63-linked ubiquitination (GO:0070534),0.4292568104184188,1.4311737455641127,0.0947867298578199,0.08537175482597281,1.0,7/16,32.49%,UBE2B;RNF115;UBE2G1;TRIM27;RNF4;UBE2V1;TRAF3IP2
gsea,negative regulation of response to stimulus (GO:0048585),0.4471952588952474,1.4304033277370323,0.08013355592654424,0.08562029900673886,1.0,6/17,24.70%,THY1;PDCD1;PTPN1;LPCAT3;WFS1;AQP11
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4089243722755317,1.4297409027486307,0.08131868131868132,0.08581273506395251,1.0,10/24,29.23%,SUB1;MED10;MED31;CTNNB1;CCNC;MED6;RELA;MED25;MED17;CBFB
gsea,positive regulation of mRNA catabolic process (GO:0061014),-0.48107845982258657,-1.427992145901984,0.1,0.29348629238312274,1.0,8/15,10.68%,GTPBP1;DHX36;TNRC6B;TNRC6C;RC3H1;YTHDF3;ZC3HAV1;PUM1
gsea,regulation of interleukin-6 production (GO:0032675),0.44765763683292836,1.4278520931875276,0.07608695652173914,0.08667743272123328,1.0,12/20,36.83%,CD47;LGALS9;HMGB1;CYBA;PYCARD;BCL10;MYD88;TIRAP;FOXJ1;SETD4;NOD2;TLR6
gsea,positive regulation of developmental growth (GO:0048639),0.4827878253842356,1.4269593234834954,0.0784,0.08702157176670396,1.0,2/16,7.37%,PPIB;TWF2
gsea,fatty acid catabolic process (GO:0009062),0.3883133009250204,1.424381537436917,0.06639004149377593,0.08829900046301394,1.0,14/30,34.73%,SCP2;ECHS1;HADHB;ACAT1;PHYH;HSD17B4;PEX13;ECI2;NUDT7;MMAA;LPIN3;AUH;ACOT8;ACADVL
gsea,anterograde trans-synaptic signaling (GO:0098916),0.4182250893547549,1.4231098219189096,0.04,0.08890807735145403,1.0,13/43,26.32%,CALM1;GABARAP;PRKAR1A;SDCBP;CNP;UNC119;SNCB;SYNJ2BP;SLC18A2;CDK5;SYT5;RPS6KA1;RPS6KA2
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.424849347244199,1.4218905786448297,0.08149405772495756,0.08945755531195829,1.0,11/23,29.14%,GSTP1;CASP8;PYCARD;BCL10;SP100;TNFRSF12A;BCL2L12;RELA;TRADD;PAK2;SIAH2
gsea,lysosome localization (GO:0032418),0.42278342800945407,1.4207248164479152,0.08590308370044053,0.08987117603582552,1.0,9/17,26.46%,KXD1;LAMTOR1;S100A13;NDEL1;BLOC1S1;TMEM106B;SNAPIN;ARL8B;HPS6
gsea,positive regulation of synaptic transmission (GO:0050806),0.49087430651359215,1.4205069049714636,0.07849293563579278,0.08985482085303677,1.0,6/15,25.81%,SQSTM1;NPTN;ZDHHC3;SLC24A1;RIMS3;DTNBP1
gsea,regulation of insulin secretion (GO:0050796),0.42934318983439784,1.4184616666010343,0.07285714285714286,0.09078685758385692,1.0,6/23,25.96%,RAP1A;BAD;UQCC2;GLUD1;KCNB1;BMP8A
gsea,regulation of cytokine production (GO:0001817),0.38685200276833476,1.417346288342414,0.07337883959044368,0.09121788598251307,1.0,12/31,24.15%,SRGN;CD47;LGALS9;CASP8;NPTN;CD28;S100A13;PPP1R11;RPS6KA4;IL15;TREX1;PLD3
gsea,negative regulation of cell differentiation (GO:0045596),0.3629048123839486,1.4152486589746154,0.049679487179487176,0.09219063224483565,1.0,12/42,34.38%,ID2;PPP2CA;SIRT2;SRA1;ADIPOR1;MAD2L2;WDR61;YTHDF2;CHADL;PAF1;CITED1;FGF23
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.47375482195746893,1.4138544639442523,0.08225806451612903,0.09284558199571455,1.0,8/17,26.23%,CTSB;HMGB1;BCL10;UBC;MYD88;LY96;ALPK1;UBA52
gsea,regulation of cell death (GO:0010941),0.4166088440840935,1.4099748292611196,0.0805921052631579,0.09485439089099446,1.0,15/28,34.53%,BECN1;BNIP3L;CHP1;ATG5;SNCB;RAB29;CHMP2A;TXNDC12;VPS4B;PRODH;ACER2;PDE12;SARM1;NCK1;TRIM13
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),0.38423273211065334,1.4087403085027033,0.0661764705882353,0.09537294701634856,1.0,15/27,31.06%,SUMO1;PTPN2;CASP8;IFNGR1;PYCARD;PTPN1;ELF1;TAX1BP1;VRK2;TRADD;SPPL2A;IL7;SHARPIN;CBFB;OTULIN
gsea,regulation of cell cycle (GO:0051726),-0.30438270985153715,-1.4028980606820658,0.043933054393305436,0.32218417236378705,1.0,83/83,99.78%,SON;PTPRC;STAT3;RUNX3;IQGAP1;EP300;SIK1;CDK11B;XIAP;UHMK1;APC;NOP53;STK11;UHRF2;PKD1;DAPK3;FOXM1;WHAMM;ADAM10;CYLD;TGFBR1;RNF20;CDC14B;FBXL3;PUM1;FBXL17;SIPA1;CDK10;APBB2;RASSF1;POU4F1;SRPK2;ASAH2;PRDM11;ING4;AKT2;CDKN1B;PPP1R13B;ZBTB49;IRF6;PER2;PKD2;BIN1;TMEM8B;CDK5RAP3;FBXL22;ADARB1;IL12A;TGFB1;TRIM32;HMGA2;MLXIPL;LIN52;MAGI2;FZD9;PRKACA;LIN37;HBP1;SETMAR;PRCC;USP51;RPS6KA2;MED25;CSNK2A1;FBXL6;CDK5;RNF167;EVI2B;CHMP1A;NR4A1;CDK9;MAEA;CTBP1;CRLF3;MAP2K1;DYNLT3;CDC26;SRA1;SIRT2;SDCBP;ID2;RPL23;RPS15A
gsea,regulation of epithelial cell migration (GO:0010632),0.4656845925121942,1.3959971229198471,0.08444444444444445,0.10255289258442173,1.0,4/15,26.55%,RAB11A;ADIPOR1;RTN4;TACSTD2
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2816150304200476,1.390777658095682,0.033444816053511704,0.10544018361161783,1.0,62/140,51.05%,YWHAH;SKAP1;TBX21;ID2;ENY2;RHOG;ILK;RNF187;HMGB2;SFR1;YEATS4;PCBD2;MAP2K1;EDF1;SETD3;MAD2L2;CTNNB1;CRLF3;WBP2;BCL10;YAF2;SP100;ELF1;RELA;KLF2;RNF4;CDKN1C;SMARCD3;TCF3;POU3F1;RPS6KA1;HAS3;MED17;USP21;SPIN1;KLF1;USP16;UBE2V1;CAPN3;SEC14L2;CAMK4;PPM1A;CITED1;SMAD2;ARNTL2;LEF1;SERTAD3;SNAI1;MSANTD1;ELK1;PSMD9;CASZ1;MLXIPL;ZFHX3;HMGA2;FOXC1;ATOH8;EGR1;DYRK1B;NAT14;TGFB1;TRIM16
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.35790440362933806,-1.3902981658705622,0.09090909090909091,0.32981864830839347,1.0,24/24,92.64%,PTPRC;STAT3;SEMA4D;DGKQ;DLG3;DLG4;HGF;SRC;HCLS1;CNTF;TNFRSF14;ERBB3;TREM2;IL12A;TGFB1;IL18;IL11;FGFR3;CRLF1;PAK2;IL15;PTPN1;UNC119;ARL2BP
gsea,phosphorylation (GO:0016310),-0.27824080939638646,-1.3826869133920054,0.03439153439153439,0.3291611997329834,1.0,139/139,99.55%,STAT3;PRKCH;RUNX3;MKNK2;SIK1;PKN1;CDK11B;MARK2;CSNK1G2;STK11;PKN2;PRPF4B;LIMD1;DGKZ;IKBKB;TGFBR2;CDK13;DAPK3;MARK3;SIK3;LIPE;FNIP2;GSK3B;STK38;ADAM10;CDC42BPA;BMPR2;TGFBR1;MAML1;DGKQ;BRAF;AKT3;CCNT1;CLK3;MAP3K6;MORC3;MAP4K2;MAP4K3;GK5;MARK4;IRAK1;CDK10;MAP4K5;SHPK;LIMK2;SRPK2;JAK1;TLK1;CDC42BPG;STK24;FER;STK19;CAMK2B;TESK2;CDC42BPB;GRK6;LTK;NTRK1;CSNK1D;PRKACB;CDKL5;STK4;NEK3;TOLLIP;PRAG1;MAP3K12;JAK3;TAOK3;MKNK1;TOP1;ACVR2B;INSR;CDK17;GLYCTK;MAP3K9;CDKL4;BMPR1A;FASTK;CDK20;TTBK1;TBK1;MAPK3;ACVR1B;ACVR2A;TSSK6;FYN;PRKCD;CSNK1A1;MAPK1;TGFB1;DYRK1B;GRK3;PNKP;NIM1K;DMPK;BRSK2;RSKR;FGFR1;STK36;MAPK9;FGGY;GRK4;PXK;TSSK4;PRKACA;FAM20C;CAMK4;NRBP2;NEK11;STK25;PAK2;XYLB;CSNK2A1;STRADB;CDK5;PKN3;VRK2;ZAP70;PRKAB1;COPS8;RPS6KA4;NRBP1;CDK9;STK26;SGK3;PRKAG1;CTBP1;STK17B;PANK2;GNPTG;GSK3A;PDK3;MAP2K1;HCST;CSK;LCK;ILK;GMFG;YWHAZ
gsea,protein localization to nucleus (GO:0034504),0.3724072820398252,1.3810490691202528,0.05952380952380952,0.11144731749765868,1.0,12/30,29.82%,SEC13;TOR1A;ARL2BP;RPL11;CNEP1R1;FAM53A;PTTG1IP;APPL1;TOR1AIP2;PAF1;XPA;TOPORS
gsea,positive regulation of JNK cascade (GO:0046330),0.4513203022507474,1.3806732756582831,0.093603744149766,0.11151862350657163,1.0,7/17,33.27%,SDCBP;HMGB1;PYCARD;CD27;TIRAP;MAP3K10;NOD2
gsea,cytosolic transport (GO:0016482),0.329695047781178,1.3775062278804355,0.07627118644067797,0.11336359345215266,1.0,26/48,35.42%,VPS29;PLEKHJ1;BECN1;VAMP3;SNX1;SNX2;STX8;VTI1B;SNX6;TRIM27;SYS1;ARFRP1;RAB29;VPS51;TBC1D10A;VPS26A;GOSR1;MYO1D;PHETA1;YKT6;RAB6A;BET1L;VTI1A;SNX32;GGA1;STX6
gsea,central nervous system development (GO:0007417),0.339972813128612,1.3745366377252164,0.04827586206896552,0.11523986551790795,1.0,26/66,35.48%,GSTP1;COX7B;IER3IP1;NDUFS4;RAB18;ATP6AP2;UFC1;UFM1;DNAJC30;EIF2B2;TPP1;MEIS3;PTS;TMX2;CDK5;NR4A2;MTF1;NHEJ1;TAGLN3;HESX1;FOXJ1;PPT1;ALDH5A1;SH3GL1;SOX12;PAFAH1B2
gsea,purine ribonucleotide biosynthetic process (GO:0009152),0.4392846260309274,1.374350420554236,0.09598603839441536,0.1151789826168547,1.0,10/16,37.84%,ACAT1;PANK2;SLC35B2;NUDT2;SLC25A16;PAPSS1;ACOT7;AK5;ADCY9;PANK1
gsea,cellular response to peptide (GO:1901653),0.46942599163040477,1.3732499135895795,0.0886426592797784,0.11568621467502219,1.0,7/18,36.83%,RPL23;CHMP5;SNX6;CDK5;IGF1R;NOD2;TLR6
gsea,protein O-linked glycosylation (GO:0006493),0.4054433578485058,1.3732221642732116,0.0926517571884984,0.11550234907807083,1.0,6/23,25.74%,DPM1;DPM3;DPM2;C1GALT1C1;GALNT9;B3GNT2
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3679749650180699,-1.3652932373706443,0.064,0.34552942525674035,1.0,28/28,99.00%,EP300;RBPJ;RNF111;ZEB2;STK11;SH2B1;RNF165;BMPR2;TGFBR1;FOXD1;SMAD4;TGFB1I1;ING2;ACVR2B;BMPR1A;ACVR1B;ACVR2A;TGFB1;FLCN;SLC2A10;LEFTY1;SMAD2;CITED1;SNW1;BMP8A;CDKN1C;SDCBP;CSNK2B
gsea,regulation of cell migration (GO:0030334),0.33254969742599166,1.364096898151459,0.07177033492822966,0.12146572349800108,1.0,43/91,52.08%,RAC1;RHOA;THY1;PDCD10;MIEN1;CIB1;SDCBP;MAPRE1;FAM89B;APPL1;SGK3;STK26;LDB1;RHOD;GNA12;TRADD;ULK4;IGF1R;FAM83H;DDRGK1;PTPRU;NKD1;CAMSAP3;PLXNA3;FGF23;FERMT3;LEF1;PIP5KL1;SNAI1;MAGI2;BEX4;RNF41;CBLL1;SEMA6C;SMO;EPHA1;TRIM32;FLCN;PODXL;TGFB1;SEMA3E;JAG1;RECK
gsea,"regulation of transcription, DNA-templated (GO:0006355)",0.24701850132963596,1.3635511650660765,0.016574585635359115,0.12168148030489029,1.0,177/483,43.02%,SAP18;SUB1;YWHAH;UBE2I;SUMO1;POLR2K;PRKAR1A;MLF2;SKAP1;DDX5;TBX21;LITAF;ID2;BHLHE40;CCNH;ENY2;RHOG;MED21;PPP2CA;ILK;MBD2;RNF187;SIRT2;SRA1;HMGB1;CAMTA1;MLX;HMGB2;SFR1;LIME1;BTG1;UBE2L3;CCNQ;YEATS4;PCBD2;GLRX2;MAP2K1;EDF1;SETD3;PFDN5;EZH2;MAD2L2;MED31;COMMD7;CTNNB1;CCNC;CRLF3;CTBP1;MAX;WBP2;CREM;MED18;SMARCE1;BCL10;UXT;SNX6;HDAC3;ZGPAT;SP110;YAF2;SP100;TRAPPC2;PPP2R1A;MEIS3;ELF1;MED6;MTERF3;IRF9;RELA;NR4A1;KLF2;TADA1;CHMP1A;RPS6KA4;RNF4;MSL3;KHDRBS1;ZFP3;LDB1;PQBP1;DPF2;REPIN1;CDKN1C;SMARCD3;CREG1;SFMBT2;PHC2;ZIK1;RFXAP;CDK5;TCF3;NR4A2;YWHAQ;MTF1;ID3;POU3F1;NFIA;NPAS4;LIMS1;CNOT7;MRGBP;HOXC4;THAP11;RPS6KA1;DACH2;HESX1;IRF2;SNW1;BBS7;HAS3;HES6;TCF7;EID1;MAP3K10;ZBTB24;MED17;FOXJ1;FSTL3;USP21;SPIN1;SMARCD2;MED29;HTATIP2;CBFB;ZBTB10;ZFP14;KLF1;TESMIN;USP16;PEX14;HBP1;ZBTB8A;UBE2V1;DRAP1;CAPN3;SEC14L2;POU5F1;CAMK4;SLC39A8;PPM1A;CITED1;RHOH;SOX12;BATF;ZGLP1;GCM2;PITX2;ZFPL1;SMAD2;ARNTL2;LEF1;SERTAD3;KLF5;SNAI1;DBX1;THAP7;MSANTD1;DPF1;PHF6;BRMS1;RFX4;TOX2;DMRT2;TIAL1;SAMD13;ELK1;DVL2;HEXIM2;CNOT2;TEAD3;PRDM15;SCML2;PSMD9;SOX5;TOX4;ONECUT3;CASZ1
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.39682577980204947,1.3582671466962108,0.10652173913043478,0.12526561764783883,1.0,13/24,27.57%,RPS3;PAIP2;ORMDL2;ORMDL1;EIF4E2;PCIF1;CNOT8;RTN4;LSM14A;MALSU1;CNOT7;RTN2;CPEB3
gsea,regulation of RNA splicing (GO:0043484),0.38443209249899346,1.357237909747662,0.09502262443438914,0.12578643015098612,1.0,9/23,19.43%,RPS13;TMBIM6;HNRNPL;FAM50A;SF1;RBM22;TRA2B;KHDRBS1;PQBP1
gsea,inositol phosphate metabolic process (GO:0043647),0.42152249065920633,1.3455928411351097,0.11524163568773234,0.13346729714542,1.0,5/18,19.03%,CALM1;IMPA1;IMPA2;MINPP1;INPP1
gsea,polyol metabolic process (GO:0019751),0.42152249065920633,1.3455928411351097,0.11524163568773234,0.13346729714542,1.0,5/18,19.03%,CALM1;IMPA1;IMPA2;MINPP1;INPP1
gsea,negative regulation of MAPK cascade (GO:0043409),0.3736500362302098,1.3441466578184083,0.11066398390342053,0.1343773214763469,1.0,9/28,24.64%,GSTP1;SLC9A3R1;PTPN2;PSMD10;IGBP1;SYNJ2BP;PTPN1;ITGB1BP1;EMILIN1
gsea,positive regulation of phosphorylation (GO:0042327),0.35151965639910127,1.3421898526209928,0.07115628970775095,0.1354498669289085,1.0,21/60,46.18%,RAC1;CIB1;SDCBP;ILK;NPTN;BCL10;HDAC3;KRAS;ERP29;PRXL2C;IGF1R;F2;PFKFB2;FGF23;ANG;RARRES2;FGFR1;DVL2;FGFR3;EPHA1;MLXIPL
gsea,regulation of neuron projection development (GO:0010975),0.36000116794288833,1.341274107888741,0.08586525759577279,0.13588683892633074,1.0,16/49,30.90%,RAP1A;SNX3;CIB1;TWF2;NPTN;GSK3A;NDEL1;RAB29;RTN4RL1;FBXO7;CDK5;ULK4;ATP1B2;ITM2C;PAK2;STYXL1
gsea,negative regulation of translation (GO:0017148),0.3753630076287727,1.3405120398552008,0.12666666666666668,0.1362255039953251,1.0,11/27,27.57%,RPS3;EIF3E;PAIP2;EIF4E2;PCIF1;YTHDF2;CNOT8;LSM14A;MALSU1;CNOT7;CPEB3
gsea,regulation of cellular component movement (GO:0051270),-0.394296913137235,-1.3393259247544416,0.12244897959183673,0.37773283184386675,1.0,13/21,34.27%,MYCBP2;ETS1;PKN1;PKN2;ABL2;DAPK3;TGFBR1;CADM4;ARHGAP18;ZSWIM5;NRG4;EGF;PRAG1
gsea,apoptotic process (GO:0006915),0.3174191296149479,1.3384238699137423,0.09259259259259259,0.13761133907226974,1.0,21/56,27.95%,CIB1;CD2;PPP2CA;GLRX2;CASP8;PYCARD;NUDT2;BAD;ITGB2;RFK;PPP2R1A;RTN4;CASP6;DPF2;DIABLO;MYD88;CDK5;TRADD;BNIP2;RRAGC;MAP3K10
gsea,sodium ion transport (GO:0006814),0.46350015541048173,1.3369338339449706,0.12247838616714697,0.1385150562424355,1.0,2/16,7.29%,NDUFA9;ATP1B3
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.42741369459355316,-1.3366055187783394,0.10913705583756345,0.3697748774255921,1.0,7/16,18.76%,STAT3;ETS1;NFATC3;NR3C1;TEAD1;PPARD;GATA2
gsea,anion transmembrane transport (GO:0098656),0.4097820316740382,1.3346410578379175,0.13027522935779817,0.13999429578995273,1.0,4/19,19.92%,ARL6IP5;SLC25A11;PRAF2;SLC25A38
gsea,nucleus organization (GO:0006997),0.38744745002252867,1.3340124956303927,0.1399548532731377,0.14023565930212747,1.0,8/22,28.52%,TOR1A;CHMP5;CHMP3;CHMP1A;CHMP2A;VPS4B;CHMP2B;CHMP1B
gsea,negative regulation of cell death (GO:0060548),0.38903888315244817,1.3308538558313077,0.12743362831858407,0.14241377338878733,1.0,12/27,31.38%,DCPS;BECN1;BNIP3L;ATG5;CHMP2A;NENF;WFS1;TXNDC12;VPS4B;CDK5;PDE12;NCK1
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3190894810684358,-1.324998345102447,0.0755813953488372,0.37864749360118155,1.0,14/33,34.15%,ITGAL;PKD1;TGFBR2;PCDHGC3;CD6;ATP2C1;CDH11;CDH24;LRRC4C;AMIGO3;LRFN4;CLDN12;TENM4;CELSR2
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.444909379792246,1.31824894972787,0.12272727272727273,0.15166382626540947,1.0,8/19,34.90%,UBE2D3;PDCD6;PTPN1;EMILIN1;DAND5;FSTL3;NBL1;UBE2D1
gsea,positive regulation of transferase activity (GO:0051347),0.35310847726032896,1.3140277745261306,0.11057692307692307,0.15482613288045727,1.0,16/35,51.02%,UBE2I;DCUN1D5;UBE2L3;GSK3A;CTNNB1;ACD;IGF1R;TOPORS;PABPN1;FGFR1;FGFR3;PNKP;EPHA1;PRKCQ;TGFB1;MAPK1
gsea,regulation of type I interferon production (GO:0032479),-0.3657464975228028,-1.3111692144641471,0.13275862068965516,0.3906929770043505,1.0,16/32,29.12%,NLRC5;EP300;ILRUN;DHX36;RNF26;ITCH;RNF216;CYLD;PTPN22;IRAK1;RNF135;UBA7;IRF3;OTUD5;PCBP2;LRRFIP1
gsea,mRNA export from nucleus (GO:0006406),0.3924502905950453,1.3093580394841782,0.15536105032822758,0.15842798933470792,1.0,13/22,39.24%,SEC13;POLR2D;ENY2;THOC7;U2AF1L4;CHTOP;CDC40;SRSF11;SLU7;PABPN1;AGFG1;NXF2;WDR33
gsea,protein secretion (GO:0009306),0.44711678342491556,1.3089359647211454,0.13530326594090203,0.15854229703621206,1.0,4/19,19.12%,SVBP;RAB8A;RAB10;CYB5R4
gsea,positive regulation of Ras protein signal transduction (GO:0046579),0.4402754886076322,1.3085917739334632,0.14165261382799327,0.1585377241635997,1.0,2/15,13.65%,RAC1;GRB2
gsea,protein dephosphorylation (GO:0006470),0.3195784729948327,1.3070251374778352,0.09915966386554621,0.15959550689934976,1.0,23/57,41.81%,PPP1CA;PPP1CC;PPP6C;PPP2CA;SSU72;PTPN2;PPP3CC;PPP2R1A;PTPN1;PPP2R2A;PTPN18;PTPN14;ILKAP;PHPT1;NCK1;TNS2;PTPRU;PP2D1;PPM1A;PPM1D;PPM1B;PPEF2;PTPRR
gsea,inositol lipid-mediated signaling (GO:0048017),0.4657601522589562,1.306949580504926,0.1413373860182371,0.1594274707977798,1.0,7/15,48.98%,RHOA;IGF1R;PIK3C2B;FGFR1;PLCD1;GAB2;KCNH1
gsea,histone H4 acetylation (GO:0043967),-0.43153312304587255,-1.3064280276728628,0.170018281535649,0.3872776867494083,1.0,7/16,24.04%,EP300;KANSL1;KANSL3;OGT;MSL2;EPC1;ING4
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3772375841942555,1.3059241239095911,0.1489795918367347,0.16008046309071752,1.0,16/25,39.76%,COMMD1;ARRB2;CHP1;PSMD10;COMMD7;PYCARD;COMMD6;TAX1BP1;AIM2;G3BP2;RWDD3;FOXJ1;OTULIN;CCDC22;BRMS1;MAP2K5
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4514494018376639,1.3052245761630628,0.13799283154121864,0.16037809983118226,1.0,6/15,28.78%,CCNH;CCNI;SERTAD1;CNPPD1;CDKN1C;STOX1
gsea,positive regulation of cellular catabolic process (GO:0031331),0.31829110076576433,1.3043670609530182,0.10611510791366907,0.16084347612612637,1.0,18/47,40.77%,SH3GLB1;TMEM59;MSN;HMGB1;GSK3A;CNOT8;BAD;TRIM27;PTPN1;PNPLA2;PTTG1IP;ABHD5;PRXL2C;CNOT7;ORMDL3;PFKFB2;NPRL2;LIN28B
gsea,mitotic cytokinesis (GO:0000281),-0.4367393938901887,-1.3028922022984242,0.16477272727272727,0.3817651019388488,1.0,7/15,11.51%,SON;APC;SNX18;TTC19;PDCD6IP;SPAST;ANK3
gsea,protein phosphorylation (GO:0006468),-0.25451589280221476,-1.295968918851552,0.05172413793103448,0.3832512060137915,1.0,164/164,99.55%,SMG1;PRKCH;RUNX3;MKNK2;SIK1;PKN1;CDK11B;MARK2;UHMK1;CSNK1G2;STK11;PKN2;PRPF4B;ABL2;TYRO3;IKBKB;PKD1;TGFBR2;CDK13;MAPK14;DAPK3;INSRR;MARK3;SIK3;LIPE;FNIP2;GSK3B;STK38;ADAM10;CDC42BPA;BMPR2;TGFBR1;MAML1;DGKQ;BRAF;AKT3;CCNT1;CLK3;MAP3K6;TNKS;MORC3;MAP4K2;MAP4K3;MARK4;IRAK1;CDK10;PRKX;MAP4K5;ULK3;CAB39;LIMK2;SRPK2;JAK1;TLK1;CDC42BPG;STK24;FER;CDK5R1;STK19;CAMK2B;TESK2;CDC42BPB;GRK6;ABI1;LTK;AKT2;DDR1;NTRK1;CSNK1D;PRKACB;CDKL5;STK4;NEK3;SBK1;SRC;PRAG1;RPS6KB1;MAP3K12;JAK3;CSNK1G3;TAOK3;RPS6KB2;MKNK1;EIF2AK1;TOP1;ACVR2B;INSR;CDK17;GLYCTK;MAP3K9;CDKL4;BMPR1A;PTK2;FASTK;CDK20;TTBK1;TBK1;MAPK3;ACVR1B;ACVR2A;TSSK6;FYN;PRKCD;CSNK1A1;MAPK1;TGFB1;DYRK1B;PRKCQ;EPHA1;GRK3;NIM1K;DMPK;FGFR3;BRSK2;RSKR;FGFR1;STK36;MAPK9;GRK4;PXK;SMAD2;TSSK4;PRKACA;FAM20C;CAMK4;NRBP2;NEK11;STK25;HTATIP2;PAK2;MAP3K10;IGF1R;RPS6KA2;RPS6KA1;CSNK2A1;STRADB;CDK5;PKDCC;PKN3;VRK2;ZAP70;PRKAB1;COPS8;RPS6KA4;NRBP1;CDK9;STK26;SGK3;GTF2H5;PRKAG1;STK16;CTBP1;STK17B;GSK3A;PDK3;MAP2K1;HCST;CSK;LCK;ILK;CCNH;GMFG;CSNK2B;YWHAZ
gsea,positive regulation of macroautophagy (GO:0016239),0.4362010380429335,1.2926481063150708,0.14967462039045554,0.17063422708697965,1.0,6/15,42.68%,SH3GLB1;BNIP3L;GNAI3;TRIM13;PAFAH1B2;SPTLC2
gsea,sterol homeostasis (GO:0055092),0.42723457629178874,1.2914595369153008,0.15123456790123457,0.17109561481257027,1.0,4/18,21.71%,RALY;LAMTOR1;NPC2;TTC39B
gsea,cholesterol homeostasis (GO:0042632),0.42723457629178874,1.2914595369153008,0.15123456790123457,0.17109561481257027,1.0,4/18,21.71%,RALY;LAMTOR1;NPC2;TTC39B
gsea,regulation of interleukin-1 beta production (GO:0032651),0.4278496158619734,1.2909048059082198,0.15559157212317667,0.17136838840656918,1.0,6/18,22.67%,GSTP1;LGALS9;CASP8;PYCARD;MYD88;AIM2
gsea,RNA 3'-end processing (GO:0031123),0.37206441026258463,1.2901559875007098,0.12719298245614036,0.17178736970031055,1.0,11/22,32.25%,NUDT21;THOC7;CLP1;U2AF1L4;TENT2;CHTOP;PAPOLA;CDC40;SRSF11;SLU7;PABPN1
gsea,positive regulation of epithelial cell proliferation (GO:0050679),0.414612540072391,1.2884792703030545,0.1344165435745938,0.1730278260303718,1.0,10/24,36.29%,PDCD6;PDCL3;HMGB2;EMC10;BAD;RTN4;NR4A1;MST1;NOD2;ANG
gsea,negative regulation of protein-containing complex assembly (GO:0031333),-0.3910931642807267,-1.2860044021378636,0.15776699029126215,0.389205395575812,1.0,18/18,99.31%,SORL1;EP300;NOP53;RPL13A;THRA;GSK3B;DACT1;SRC;RIOK3;JAM3;LDLRAD4;TREM2;GBA;RAF1;PPM1A;LCMT1;HMGB1;CDC42
gsea,positive regulation of cell motility (GO:2000147),0.3325019902263607,1.28550629776074,0.13573407202216067,0.1752830366525616,1.0,24/50,51.33%,PDCD10;MIEN1;CIB1;SDCBP;MAPRE1;FAM89B;CFAP20;RHOD;TRADD;IGF1R;PHPT1;FAM83H;DDRGK1;FERMT3;LEF1;SNAI1;CBLL1;SEMA6C;SMO;EPHA1;TRIM32;PODXL;TGFB1;SEMA3E
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.38723917463040913,1.2844320304586254,0.171875,0.17599925675601744,1.0,5/20,15.74%,RHOA;JTB;UNC119;DCTN3;ARL3
gsea,regulation of inflammatory response (GO:0050727),0.32108580487449334,1.2835198216357073,0.11973018549747048,0.17654188450932715,1.0,25/45,46.76%,CD47;DDT;VAMP3;PTPN2;SNX6;NMI;GPSM3;RELA;LPCAT3;IL15;MYD88;FNDC4;TRADD;IFI35;SHARPIN;SETD4;OTULIN;NOD2;IL1RL2;DNASE1;VAMP2;CEBPA;GBA;IL18;FOXP1
gsea,calcium-mediated signaling (GO:0019722),0.4418930455180974,1.279785453086284,0.15677966101694915,0.17946276718547963,1.0,5/18,20.76%,BCAP31;PPP3CC;LAT;FIS1;P2RY12
gsea,negative regulation of neuron apoptotic process (GO:0043524),-0.36264132930364096,-1.2755758004566697,0.12169312169312169,0.3970614337146345,1.0,8/21,30.36%,SOD1;TYRO3;CPEB4;POU4F1;SIX1;FGF20;NTRK1;HIF1A
gsea,regulation of cell differentiation (GO:0045595),0.3156633441920519,1.271465438320359,0.14890282131661442,0.1866547386751496,1.0,22/49,47.66%,YWHAH;DDX5;ID2;PPP2CA;PDCD2;OCIAD1;PPP2R1A;UQCC2;CDK9;LTBP4;PHLDB1;RPS6KA1;ELL3;CBFB;PRKACA;RAF1;FGFR1;TAF8;CASZ1;APC2;ZFHX3;MCRIP1
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.39482681825888716,1.2704115772643787,0.14948453608247422,0.1873763015439897,1.0,6/33,26.61%,CD3E;STAP1;LCK;CD8A;ZAP70;IGF1R
gsea,extracellular matrix organization (GO:0030198),-0.2686711704197832,-1.2689537349249183,0.06369426751592357,0.398822004514082,1.0,50/50,96.84%,ITGAL;ITGAV;MMP11;ADAM10;CAPNS1;P3H4;F11R;TGFBR1;ADAM15;WASHC1;ICAM5;COMP;ADAMTS10;ITGAD;AGRN;DDR1;ADAMTSL5;ITGA2;MMP17;NID2;QSOX1;COL11A2;COL18A1;COL23A1;JAM3;ICAM4;LAMB3;COL9A3;COL5A1;RECK;ITGA2B;TGFB1;LAMB2;COL8A2;MMP28;LOXL3;KIF9;CAPN1;ECM2;COL10A1;ITGA9;SLC39A8;ITGB5;HAS3;NOXO1;BMP1;ATP7A;ITGB2;CD47;PPIB
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.364671788164788,1.2668948357476724,0.16049382716049382,0.19021152280106612,1.0,10/19,31.06%,GSTP1;UBE2K;PTPN2;CASP8;PYCARD;TAX1BP1;TRADD;SPPL2A;SHARPIN;OTULIN
gsea,regulation of organelle assembly (GO:1902115),0.33476673004716906,1.2659484025681407,0.15120967741935484,0.19084029306354847,1.0,12/31,39.01%,MSN;TSG101;IFT20;ATG5;RAB1B;ATG3;RNF4;TBC1D10A;DYNC2LI1;TBC1D19;NPRL2;STX18
gsea,receptor-mediated endocytosis (GO:0006898),0.3546097634364423,1.2642622739416283,0.1629032258064516,0.1921061467190043,1.0,13/30,45.03%,CLTA;AP1S1;ARRB2;SNX1;GRB2;ITGB2;AP2M1;AP2S1;PPT1;GRK4;STAB2;GRK3;LRP1
gsea,establishment of protein localization to organelle (GO:0072594),0.3939168547624887,1.262383434009617,0.18456375838926176,0.19355499693583153,1.0,8/20,29.66%,SEC13;RAB11A;FAM53A;PTTG1IP;APPL1;NEURL1B;TSPAN17;PEX19
gsea,regulation of secretion by cell (GO:1903530),0.41577132371419084,1.258040208365052,0.1956521739130435,0.19741320571630772,1.0,9/15,46.30%,RAB8A;RAB10;VAMP3;RAB21;ARFIP1;CPLANE2;RAB3A;VAMP2;LLGL2
gsea,positive regulation of lymphocyte proliferation (GO:0050671),0.42420489286856833,1.2549392450102248,0.18845500848896435,0.20007925886389943,1.0,8/16,31.38%,CD3E;PNP;CD28;IL15;CD46;TIRAP;IL7;NCK1
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.39751880863727695,1.2541432298634065,0.17530487804878048,0.2005192231384197,1.0,8/22,48.98%,RHOA;SIRT2;IGF1R;PIK3C2B;FGFR1;PLCD1;GAB2;KCNH1
gsea,sulfur compound catabolic process (GO:0044273),0.43626874692608303,1.2528281400957015,0.18998527245949925,0.2014557035738138,1.0,6/16,26.03%,ACAT1;HEXB;GLB1;MPST;NUDT7;CSPG5
gsea,brain development (GO:0007420),0.33094548011723623,1.2526743535054197,0.1582608695652174,0.2013159428185496,1.0,13/38,35.48%,IER3IP1;NDUFS4;RAB18;UFC1;UFM1;DNAJC30;MEIS3;TMX2;VPS51;HESX1;FOXJ1;PPT1;PAFAH1B2
gsea,cellular response to peptide hormone stimulus (GO:0071375),0.34310573807564587,1.252335213212445,0.1705989110707804,0.20132724329766827,1.0,11/32,36.95%,PRKAR1A;RAB8A;RAB10;GSK3A;RELA;NR4A1;INSIG2;NR4A2;LPIN3;PRKACA;ADCY9
gsea,Notch signaling pathway (GO:0007219),-0.3694584860479563,-1.2507580018384015,0.18421052631578946,0.42108332934933307,1.0,20/20,97.55%,EP300;RBPJ;ITCH;DTX3;ADAM10;MAML1;APH1B;GALNT11;NOTCH4;HEY1;MDK;PSEN1;JAG1;TRAF7;SNAI1;DTX2;SNW1;NCSTN;APH1A;PSENEN
gsea,cell-matrix adhesion (GO:0007160),0.3503525007948383,1.2504880120308768,0.15491009681881052,0.20278333353057898,1.0,13/35,35.03%,RAC1;THY1;ILK;TIMM10B;ZYX;ITGB2;ITGB1BP1;PARVG;RHOD;EMILIN1;ITGB5;VWA2;FERMT3
gsea,calcium ion transmembrane transport (GO:0070588),0.3582822590707357,1.250071873312153,0.18478260869565216,0.2028785113690826,1.0,9/27,27.85%,FKBP1A;SMDT1;MAIP1;TMCO1;TMEM165;SLC24A1;MICU1;SLC25A23;MCOLN3
gsea,regulation of proteolysis (GO:0030162),0.37443085868370485,1.2495723507411747,0.17164179104477612,0.20296356562112147,1.0,11/22,32.53%,NEDD8;AURKAIP1;CSTB;CASP8;BAD;LTBP4;CDK5;TBC1D10A;F2;SPOP;CAPN3
gsea,negative regulation of protein modification process (GO:0031400),0.3782773886392727,1.2462148599108507,0.17061611374407584,0.20598856422132353,1.0,10/24,44.02%,CIB1;ARPP19;YWHAB;CHP1;FKBP8;DMD;SNTA1;PIP5KL1;BEX4;PNKP
gsea,positive regulation of organelle assembly (GO:1902117),0.4159353019522802,1.2448474680822805,0.18947368421052632,0.20697530071757367,1.0,5/15,41.00%,SH3GLB1;SDCBP;G3BP2;STX18;CNOT2
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),-0.37315791025276174,-1.2369500041354136,0.2106537530266344,0.43587826289620885,1.0,16/16,97.48%,RBPJ;PLCL2;LNPEP;STK11;ACOT11;ACTN3;NR1H2;IP6K1;ACVR2B;NR1D1;FLCN;LGR4;IL15;ACOT13;PGAM5;RHEB
gsea,positive regulation of signal transduction (GO:0009967),-0.26509552087227817,-1.2330434317565255,0.13109756097560976,0.4325497582197699,1.0,63/63,97.00%,ITGAV;PTPRC;SORL1;STAT3;EP300;RBPJ;ASXL2;MBD5;PTEN;ZRANB1;TGFBR1;MAML1;DSTYK;GPS2;NOTCH4;DLG4;ULK3;PDE6H;ZBTB7B;NLGN3;TTC23;KIF7;DACT1;CRADD;HIF1A;PKD2;ARMC9;TERT;SRC;TPD52L1;SASH1;TREM2;JAG1;TRIM16;TRAF7;SMO;LOXL3;LIMS2;CDKN2AIP;STK36;NOS3;DISC1;NOD2;TSPAN14;ERFE;SPIN1;SNW1;IL7;RWDD3;LIMS1;CSNK2A1;TXNDC15;LY96;KLF2;ITGB1BP1;NPTN;TM2D3;ATP6AP2;CRLF2;ILK;ATP6V0C;PDCD10;RPS3
gsea,inorganic cation transmembrane transport (GO:0098662),0.32296184501065184,1.2314238072147239,0.14335664335664336,0.22011707029142616,1.0,23/64,35.07%,FKBP1A;ATP6V1F;ATP6V0C;ATP1B3;UCP2;ATP6V0D1;TMCO1;TMEM165;KCNB1;SLC24A1;NNT;KCNA3;KCNK12;KCNG3;MCOLN3;SLC4A11;SLC30A5;TMEM175;SLC46A1;ATP6V1A;SLC36A3;SLC39A8;ATP6V1H
gsea,regulation of BMP signaling pathway (GO:0030510),-0.36748475437347006,-1.2301398880414667,0.1656441717791411,0.42753090256197773,1.0,10/19,25.34%,SORL1;RBPJ;XIAP;RNF165;BMPR2;SMURF1;SMURF2;LEMD2;FOXD1;SMAD4
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.2675564666101149,1.2277324290476954,0.14735099337748345,0.2235516692395967,1.0,47/107,47.79%,RALY;MLF2;TBX21;BHLHE40;PPP2CA;MLX;BTG1;UBE2L3;GLRX2;EDF1;PFDN5;EZH2;CREM;YAF2;TRAPPC2;PPP2R1A;RELA;RPS6KA4;MSL3;LDB1;PQBP1;TCF3;NFIA;IRF2;HES6;TCF7;SPIN1;KLF1;TESMIN;UBE2V1;DRAP1;POU5F1;SLC39A8;RHOH;SOX12;ZFPL1;ARNTL2;SERTAD3;THAP7;DVL2;CASZ1;CEBPA;MLXIPL;PRKCQ;ZFHX3;HMGA2;FOXC1
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.347944670556096,1.223919958172668,0.20553359683794467,0.22702949418574347,1.0,13/23,51.80%,GSK3A;ATP6V0D1;TPP1;YIF1A;DNAJB9;WFS1;VAPB;PDIA5;ACADVL;EXTL2;DNAJC3;TATDN2;EXTL1
gsea,neuron projection morphogenesis (GO:0048812),-0.2903134530885961,-1.2234866496904047,0.15441176470588236,0.4300821204368836,1.0,41/41,99.31%,IQGAP1;DOCK10;DNM2;NCKAP1L;MAP1S;PTEN;PLXNB1;DLG4;WASL;TRIO;ANK3;PARD6B;NTNG2;NYAP1;ZDHHC17;DVL1;POU4F1;ATL1;MAPK8IP2;MEF2A;DBN1;CELSR2;TAOK3;DBNL;MYO16;SLC9A6;CNTNAP1;MAP1B;SPTBN4;BRSK2;RAB3A;NBL1;DTNBP1;ATP7A;CDK5;GAS7;TMEM106B;CTNNB1;RAB10;RAB8A;CDC42
gsea,negative regulation of cell growth (GO:0030308),0.3087951052264042,1.216650901155203,0.18126272912423624,0.23449121340616327,1.0,15/35,52.46%,NDUFS3;PPP2CA;BTG1;GSK3A;CRLF3;PPP2R1A;RTN4;NDRG3;PPT1;SERTAD3;CDKN2AIP;FLCN;TGFB1;MAG;CCDC85B
gsea,regulation of mitochondrion organization (GO:0010821),0.3676559349010594,1.216141266316973,0.208984375,0.23466608864722113,1.0,9/20,53.70%,SQSTM1;MFF;GSK3A;FIS1;STOX1;SIRT7;FLCN;GOLPH3;TREM2
gsea,chemical synaptic transmission (GO:0007268),0.32585905334249615,1.2103534787624035,0.17494089834515367,0.24040360168548894,1.0,21/66,39.29%,CALM1;GABARAP;PRKAR1A;SDCBP;CNP;UNC119;NAPA;SNCB;SYNJ2BP;SLC18A2;SNAPIN;CDK5;SYT5;RPS6KA1;RPS6KA2;SLC17A7;CAMK4;PRKACA;RAB3A;KCNIP2;LIN7C
gsea,second-messenger-mediated signaling (GO:0019932),0.458279608942867,1.209558349017807,0.2378449408672799,0.24096180303796694,1.0,7/15,39.56%,PPP2CA;LAT;PPP2R1A;P2RY12;NMUR1;NOS3;PTGDR2
gsea,negative regulation of cellular component organization (GO:0051129),-0.354791339033046,-1.2068683905835198,0.20754716981132076,0.4501710313200369,1.0,13/21,35.95%,SORL1;EP300;DNM2;NOP53;GSK3B;WASL;LRSAM1;CARMIL1;SCAMP5;APOA2;RUBCN;SRC;RIOK3
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3793979127712085,1.2055201630814825,0.23228346456692914,0.24488101320580233,1.0,5/15,25.29%,GSTP1;STAP1;PTPN2;YTHDF2;CNOT7
gsea,regulation of macromolecule metabolic process (GO:0060255),0.31340260333483794,1.2039799329333063,0.2061328790459966,0.24624783721914414,1.0,13/42,37.86%,ARF1;C1D;RNF187;LAMTOR1;ATRAID;TRIM27;ANKRA2;MTMR9;TAPBP;STOX1;ZFP64;POU5F1;DHH
gsea,synapse organization (GO:0050808),0.3775387657273964,1.2009257081277367,0.21486486486486486,0.24919632774256079,1.0,6/26,22.48%,CDC42;SNCB;RAB29;ZC4H2;OBSL1;CDK5
gsea,phosphate-containing compound metabolic process (GO:0006796),0.28724573590940333,1.1985586033559643,0.18227424749163879,0.25131414033534816,1.0,26/59,46.69%,PPP1CA;CALM1;PLAAT3;LPCAT4;PANK2;IMPA1;IMPA2;MINPP1;NT5C;INPP1;NUDT14;CDK5;PLPPR2;XYLB;PLPPR3;DUSP28;PAK2;PFKFB2;THTPA;PPM1A;PLB1;EPHX2;PLCD1;PNKP;NUDT3;PIP4P1
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.27803078714595564,1.193882350242528,0.17703349282296652,0.25612801978598143,1.0,33/70,40.80%,LAMTOR5;RPS3;CIB1;LGALS9;TAF12;CTNNB1;PYCARD;BCL10;TRIM27;UBC;MTPN;RELA;RPS6KA4;MYD88;TCF3;AIM2;TRADD;TIRAP;CRTC2;UBA52;DDRGK1;UBE2V1;CAPN3;RIPK4;NOD2;TRIM13;TRIM62;TSSK4;TLR6;RNF25;STK36;CRTC1;DVL2
gsea,cognition (GO:0050890),0.38871280634982386,1.1924553593294847,0.2235294117647059,0.25738332071669767,1.0,5/15,30.10%,METTL23;TUSC3;TTC8;CHMP2B;RP9
gsea,protein localization to cilium (GO:0061512),0.41902174438579415,1.1903436869217485,0.2306525037936267,0.25930425475874613,1.0,12/19,43.41%,ATP6V1D;IFT20;ARL6;ARL3;RAB29;TTC26;TULP1;BBS1;INVS;EHD1;TCTN1;RABEP1
gsea,visual perception (GO:0007601),0.3790126290077229,1.1886074096497652,0.23477157360406092,0.2608912504003057,1.0,8/25,25.08%,DNAJC19;UNC119;PITPNA;EML2;WFS1;SLC24A1;RDH10;CRYGN
gsea,phosphatidylinositol metabolic process (GO:0046488),0.31473117862465894,1.1855590534269929,0.21489001692047377,0.2639637824688773,1.0,16/38,56.86%,ARF1;PLAAT3;MBOAT7;IMPA1;PIP4P2;MTMR9;PIK3C2B;PLEKHA3;PIGW;PLCD1;MTMR7;PIP4P1;PLEKHA4;MTMR2;MTMR10;PIK3C3
gsea,phospholipid metabolic process (GO:0006644),0.38586589403162613,1.184851906613427,0.23623188405797102,0.26439501920186514,1.0,13/22,51.75%,PLAAT3;LPCAT4;SMPD2;PLPPR2;PLPPR3;ABHD12;AGPAT3;PLB1;PLCD1;PNPLA3;PIP4P1;FITM2;GPX4
gsea,regulation of cell motility (GO:2000145),0.3476567045926977,1.1813047192908568,0.20765027322404372,0.26803753251410084,1.0,13/39,34.38%,RAC1;RHOA;WAS;CFAP20;SGK3;LDB1;SPINT2;TACSTD2;PHPT1;NRG2;CAMSAP3;PLXNA3;FGF23
gsea,neuron development (GO:0048666),0.3156423933120747,1.1808569727233498,0.22108345534407028,0.26814947760861985,1.0,20/43,38.93%,VAPA;TOR1A;RAB11A;HMGB1;BLOC1S4;ATXN10;ARL3;BLOC1S1;BLOC1S3;PQBP1;UGDH;SNAPIN;CDK5;ATP7A;DTNBP1;RAB35;PPT1;LGI4;EHD1;NRTN
gsea,positive regulation of protein metabolic process (GO:0051247),0.30967618827382626,1.1774726213271651,0.2168458781362007,0.27171618847743445,1.0,20/42,47.70%,OAZ1;VPS28;SEC22B;GSK3A;BCL10;RAB1B;MTPN;KLF2;LDB1;WFS1;RAB1A;CSNK2A1;NKD1;RILP;MAP2K5;RNF41;APC2;GBA;IL18;TRIM32
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.34985313510175203,1.17718591429937,0.228099173553719,0.27162528633592464,1.0,11/23,39.76%,GSTP1;CASP8;RNF34;RELA;FAIM;MCL1;TRADD;SIAH2;UNC5B;NOS3;MAP2K5
gsea,actin cytoskeleton reorganization (GO:0031532),0.39640838485425095,1.1769932939560448,0.2698907956318253,0.2714658971836623,1.0,5/17,25.81%,RHOA;GRB2;PTPN1;PARVG;DTNBP1
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3599477866987223,1.1750314435629483,0.23529411764705882,0.27331215272762993,1.0,6/20,25.00%,GSTP1;PRKAR1A;PYCARD;PTPN1;CDKN1C;INCA1
gsea,negative regulation of cell cycle (GO:0045786),0.34954677359088987,1.1687628136948465,0.2545454545454545,0.28011242758694904,1.0,9/21,26.32%,BTG3;SLC9A3R1;BTG1;NR4A1;CHMP1A;CDKN1C;RNF167;INCA1;RPS6KA2
gsea,cholesterol metabolic process (GO:0008203),0.3788963770529291,1.1672513809428662,0.27411167512690354,0.2815085803603191,1.0,8/18,50.92%,EBP;SNX17;INSIG2;SOAT2;GBA;PIP4P1;PLPP6;ACAA2
gsea,regulation of cellular catabolic process (GO:0031329),0.3500329567154592,1.1669567947717883,0.2508710801393728,0.28147938877549145,1.0,11/26,30.73%,VPS29;CISD2;RAB8A;RRAGA;PSAP;DCAF12;ACER2;RRAGC;SOGA1;RMC1;LONP2
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2949237182845118,1.165120311005975,0.23421926910299004,0.2832271748216989,1.0,25/50,37.12%,LAMTOR5;RPS3;CIB1;LGALS9;PYCARD;BCL10;TRIM27;UBC;MTPN;RELA;RPS6KA4;MYD88;AIM2;TRADD;TIRAP;UBA52;DDRGK1;UBE2V1;CAPN3;RIPK4;NOD2;TRIM13;TRIM62;TLR6;RNF25
gsea,phospholipid transport (GO:0015914),-0.3601942375085484,-1.1631834834221122,0.2597701149425287,0.5247213590221669,1.0,17/17,95.04%,ATP11B;ATP9B;PITPNC1;OSBPL8;PITPNM1;MTTP;ATP8A2;ABCA3;APOA2;SCARB2;TMEM30B;TMEM30A;ATP9A;NPC2;TRIAP1;PITPNA;SCP2
gsea,neuron projection development (GO:0031175),0.29117797139510254,1.1624514119175453,0.23348694316436253,0.2859169144785495,1.0,20/56,38.93%,CDC42;VAPA;SVBP;TOR1A;RAB11A;HMGB1;BLOC1S4;ATXN10;BLOC1S1;BLOC1S3;PQBP1;GAS7;SNAPIN;CDK5;ATP7A;DTNBP1;RAB35;NBL1;EHD1;NRTN
gsea,activation of protein kinase activity (GO:0032147),-0.31242114897816325,-1.1624096931091614,0.24022346368715083,0.515044788823736,1.0,16/29,36.83%,MARK2;STK11;ADCY7;TGFBR2;OSBPL8;TRAF6;ADCY3;MAPKAP1;ADCY5;IRAK1;CARD10;PRKACB;STK4;TOM1L1;PRRC1;TAOK3
gsea,cellular response to UV (GO:0034644),-0.3169754320059395,-1.162094844014143,0.25481798715203424,0.5048062979076031,1.0,24/24,98.17%,EP300;YY1;DHX36;STK11;N4BP1;KDM1A;HYAL1;BMF;ACTR5;OPN3;USP28;CASP9;PRKCD;RPL26;MME;TMEM161A;HYAL3;OPN1SW;SDE2;XPA;NSMCE3;TRIAP1;ERCC1;COPS9
gsea,organonitrogen compound catabolic process (GO:1901565),0.4056827342610247,1.1614163839169527,0.25524475524475526,0.28678016060918315,1.0,9/15,32.53%,GNPDA2;MPST;LTA4H;TPP1;CPQ;SMPD2;AMDHD2;PPT1;CAPN3
gsea,nuclear export (GO:0051168),0.3524159185839851,1.1607069871545246,0.26422764227642276,0.28722145493179946,1.0,9/18,31.42%,THOC7;CHP1;U2AF1L4;PHAX;CHTOP;STRADB;CDC40;SRSF11;SLU7
gsea,glycolipid metabolic process (GO:0006664),0.35658158831698544,1.1593816992267545,0.2560483870967742,0.28832127961069987,1.0,7/19,23.14%,GLTP;CTSA;HEXB;GLB1;ASAH1;PSAP;SMPD2
gsea,cell-cell junction assembly (GO:0007043),0.3620985982486504,1.1593480520364332,0.2720897615708275,0.28793664353931137,1.0,9/22,54.70%,RHOA;WDR1;CTNNB1;PAK2;GJB1;GJA5;FLCN;ARVCF;CNTNAP1
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.35380548804060824,1.1587652140333553,0.2509090909090909,0.2882226893255602,1.0,6/24,27.95%,CSNK2B;MAP2K1;GSK3A;CDK5;CSNK2A1;MAP3K10
gsea,myeloid cell differentiation (GO:0030099),0.3897283534399515,1.156820233156938,0.26489028213166144,0.2899592385112804,1.0,6/17,29.59%,RPS14;PTPN2;SLC25A38;EVI2B;TIRAP;KLF1
gsea,response to molecule of bacterial origin (GO:0002237),0.35046006568108007,1.1519989033480909,0.2845786963434022,0.2954150203085848,1.0,10/24,51.32%,LGALS9;SIRT2;HMGB2;LY96;TIRAP;CITED1;NOS3;PALM3;FOXP1;IL12A
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3730265775729623,1.1510017473856513,0.2806201550387597,0.2962186105580573,1.0,7/20,31.01%,CALM1;YWHAB;ZDHHC3;FNTA;CAMKMT;GUCA1A;CNGA1
gsea,positive regulation of cell migration (GO:0030335),0.2832887914706644,1.1508293301004855,0.24822695035460993,0.29592275987018996,1.0,26/64,54.22%,PDCD10;MIEN1;CIB1;SDCBP;RAB11A;MAPRE1;FAM89B;RTN4;RHOD;TRADD;IGF1R;FAM83H;DDRGK1;FERMT3;LEF1;SNAI1;CBLL1;SEMA6C;SMO;EPHA1;TRIM32;INSL3;PODXL;TGFB1;SEMA3E;PTP4A1
gsea,positive regulation of protein catabolic process (GO:0045732),0.3170641048167648,1.1492814021975888,0.25735294117647056,0.2974065602472528,1.0,13/33,50.05%,OAZ1;VPS28;MSN;SEC22B;GSK3A;PTTG1IP;CSNK2A1;NKD1;RILP;RNF41;APC2;TRIM32;GPLD1
gsea,organic anion transport (GO:0015711),0.3381435779630798,1.148674028515168,0.27580645161290324,0.2976973028457706,1.0,9/20,39.86%,SLC9A3R1;MFSD10;SLC35B2;CYB5R4;SLC4A11;SLC39A8;SLC26A6;SLCO5A1;SLC2A10
gsea,RNA transport (GO:0050658),0.37868330153696267,1.1477951486526492,0.27977315689981097,0.29822970386841885,1.0,7/16,31.42%,RTRAF;THOC7;U2AF1L4;CHTOP;CDC40;SRSF11;SLU7
gsea,carbohydrate homeostasis (GO:0033500),0.3475654717439749,1.1430781708617797,0.26973684210526316,0.3035227930625028,1.0,10/22,27.07%,ADIPOR1;PTPN2;RPS6;BAD;CYB5R4;WFS1;KCNB1;CRTC2;IGF1R;SELENOT
gsea,positive regulation of catabolic process (GO:0009896),0.32140813632625415,1.1419427043207282,0.26607142857142857,0.3045887810844659,1.0,10/28,47.70%,OAZ1;VPS28;SEC22B;GSK3A;CSNK2A1;NKD1;RILP;RNF41;APC2;TRIM32
gsea,lipid homeostasis (GO:0055088),0.35611995147904774,1.1356390904540001,0.3036565977742448,0.3117317274416721,1.0,12/19,53.70%,ORMDL2;ORMDL1;PNPLA2;ABHD5;RBP1;ORMDL3;PNPLA3;CEBPA;MLXIPL;FITM2;DGAT2;TREM2
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3516206068178942,-1.1342794697238177,0.2786458333333333,0.5500636610040743,1.0,16/16,87.71%,STAT3;ADCY7;MAPK14;CD6;CARD9;HIF1A;TICAM1;TREM2;TLR6;NOD2;F2;PLD3;MYD88;CUEDC2;APPL1;PYCARD
gsea,negative regulation of signal transduction (GO:0009968),0.2765315178488917,1.1327589047784774,0.24516129032258063,0.3148748155435609,1.0,33/79,46.26%,TMBIM6;PDCD6;CD47;SLC9A3R1;YWHAB;PTPN2;GSK3A;EZH2;YTHDF2;PTPN1;APPL1;LEPROT;PTPN18;NR4A2;CSNK2A1;EMILIN1;CTNNBIP1;FSTL3;SIAH2;NCK1;TNS2;NKD1;CITED1;GRB14;SLC2A10;GPR108;KCTD6;LGR4;DKK3;LRP1;GBA;PALM3;PRKCQ
gsea,negative regulation of growth (GO:0045926),0.30368824324641686,1.1325608478456397,0.2619047619047619,0.31466575736416674,1.0,14/33,52.46%,NDUFS3;PPP2CA;BTG1;CRLF3;PPP2R1A;RTN4;NDRG3;PPT1;SERTAD3;CDKN2AIP;FGFR3;FLCN;TGFB1;CCDC85B
gsea,positive regulation of type I interferon production (GO:0032481),0.34440953465136837,1.1306650631755901,0.2795969773299748,0.31657298749871626,1.0,6/16,28.15%,POLR2K;CTNNB1;RELA;PQBP1;MYD88;CRCP
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2931257913601588,-1.1296343166765415,0.296,0.5484803803435607,1.0,26/26,96.87%,NSD1;AKAP9;PTEN;FNIP2;PDE4D;MTCP1;BRAF;CAPRIN2;ARAF;CREBL2;STK4;INPP5K;HCLS1;TBK1;TENM1;TGFB1;MLXIPL;IL11;SPTBN4;RAPGEF3;RAF1;NCK1;DMD;STOX1;MAD2L2;PDCD10
gsea,positive regulation of cellular protein localization (GO:1903829),0.3407585471800085,1.121812071394714,0.3129251700680272,0.32741250957948004,1.0,8/24,32.32%,LAMTOR5;VPS28;RTN4;PARD6A;PDZK1;F2;DDRGK1;ORMDL3
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3623003812689406,-1.1199792276118827,0.31002331002331,0.5573058835715766,1.0,8/15,36.91%,NOP53;WAC;UIMC1;CDC14B;EME2;RAD9B;TAOK3;CDK5RAP3
gsea,heart development (GO:0007507),0.2940591917919821,1.1188785654868618,0.2972972972972973,0.33068664797765424,1.0,16/39,52.14%,FKBP1A;NDUFV2;ID2;CASP8;PDLIM2;PRICKLE4;BORCS8;DAND5;DNAAF4;LEFTY1;DVL2;MESP2;FOXC1;TGFB1;TBX19;NDRG4
gsea,cellular macromolecule catabolic process (GO:0044265),0.3694338161534069,1.1184383361642793,0.3154471544715447,0.3307983105169414,1.0,8/19,29.14%,RNASEH2C;UBE2G1;XRN2;FBXO6;NGLY1;DNASE1L2;DFFB;SIAH2
gsea,regulation of fat cell differentiation (GO:0045598),0.3311690041245732,1.11704521323763,0.30401529636711283,0.3321732350730988,1.0,9/20,54.93%,ID2;SIRT2;CCDC71L;AAMDC;RARRES2;TAF8;TGFB1;CCDC85B;NR1D1
gsea,JNK cascade (GO:0007254),-0.3332047012008728,-1.1154151650124104,0.3157894736842105,0.5562249925866348,1.0,11/21,26.17%,TRAF6;TAB2;CRKL;GPS2;MAP4K2;MAP4K3;IRAK1;IRAK2;DUSP9;MAP2K4;ARHGEF6
gsea,glycosphingolipid metabolic process (GO:0006687),0.36126000662320773,1.11356103108268,0.325187969924812,0.33624517520628067,1.0,7/18,23.14%,GLTP;CTSA;HEXB;GLB1;ASAH1;PSAP;SMPD2
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.36921743906137555,1.1105856872190738,0.3171745152354571,0.3396472157837463,1.0,11/22,39.86%,FKBP1A;FAM89B;SNX6;UBC;EMILIN1;DAND5;UBA52;PPM1A;WFIKKN1;SMAD2;SLC2A10
gsea,response to insulin (GO:0032868),0.3327383132460817,1.10999400761267,0.3161397670549085,0.3398838826491282,1.0,9/25,50.05%,RAB8A;RAB10;GSK3A;INSIG2;LPIN3;CITED1;VAMP2;GCK;GPLD1
gsea,regulation of Notch signaling pathway (GO:0008593),-0.2753469384967849,-1.1086072199128154,0.3069908814589666,0.559145969785342,1.0,33/33,96.87%,STAT3;EP300;RBPJ;ZBTB7A;HIF1AN;WWP2;MAML1;GALNT11;NOTCH4;HEY1;RFNG;GATA2;ARRDC1;BEND6;EGF;SRC;PRAG1;JAG1;LLGL2;NOS3;YJEFN3;NOD2;TSPAN14;LFNG;SNW1;TSPEAR;CD46;ITGB1BP1;SYNJ2BP;YTHDF2;MFNG;TM2D3;PDCD10
gsea,determination of left/right symmetry (GO:0007368),0.4034208677192106,1.1045197826462305,0.3424283765347885,0.34660135278586185,1.0,9/15,38.71%,ARL6;ENKUR;DNAH11;DAND5;BBS7;FOXJ1;DNAAF4;PITX2;LEFTY1
gsea,negative regulation of cellular catabolic process (GO:0031330),-0.3292466382388562,-1.1015958872853098,0.32129277566539927,0.5632565052710579,1.0,20/20,93.10%,SORL1;STAT3;TAB2;RIC1;PTPN22;BMF;WASHC1;HGF;FOXK1;RUBCN;CDK5RAP3;MTMR2;TREM2;GPLD1;MTMR9;MCL1;RRAGA;GSK3A;ATRAID;SIRT2
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3399257960202102,1.1014680134086878,0.31341301460823373,0.3501507658326731,1.0,16/34,39.86%,FKBP1A;UBE2D3;FAM89B;SNX6;UBC;EMILIN1;DAND5;UBA52;FSTL3;NBL1;PPM1A;UBE2D1;WFIKKN1;SMAD2;MAGI2;SLC2A10
gsea,negative regulation of autophagy (GO:0010507),-0.33722754710852576,-1.1000468331776472,0.3277310924369748,0.5559767971825149,1.0,10/17,31.77%,STAT3;SMG1;TAB2;PTPN22;BMF;WASHC1;HGF;FOXK1;QSOX1;RUBCN
gsea,cellular response to light stimulus (GO:0071482),0.35152509866418225,1.0964554807324056,0.33125,0.35643532155795044,1.0,10/21,54.31%,COPS9;GNB1;TRIAP1;NSMCE3;CNGA1;SDE2;OPN1SW;TMEM161A;RPL26;PRKCD
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3588059425196431,-1.0959770979718366,0.35135135135135137,0.5542993954460703,1.0,15/15,98.31%,ITCH;NCOR1;FOXM1;DLG1;FOXO1;CYLD;PTPN22;GPS2;ZMYND11;DACT1;TAOK3;TREM2;IGBP1;HDAC3;GSTP1
gsea,peptidyl-threonine modification (GO:0018210),0.32209584775139405,1.0955257810414223,0.32604735883424407,0.3571520510900394,1.0,6/27,27.95%,CSNK2B;MAP2K1;GSK3A;CDK5;CSNK2A1;MAP3K10
gsea,regulation of GTPase activity (GO:0043087),-0.26147944689685315,-1.0938656477113191,0.3047858942065491,0.5483785403533694,1.0,45/45,99.61%,SOD1;DOCK10;SEMA4D;RAB11FIP2;SNX18;ARHGEF7;RALBP1;RIC1;GSK3B;F11R;DVL3;RAPGEF6;PLXNB1;GMIP;OCRL;VAV1;TBC1D20;ARHGAP15;FGD6;TBC1D2;CRK;RAP1GAP;AGRN;NTRK1;CDKL5;CHN1;MAPRE2;PTK2;TBC1D15;FGD4;FLCN;EPHA1;FICD;FGD1;RAPGEF3;PLXNA3;LIMS1;ZC3H15;ARHGAP9;ITGB1BP1;NDEL1;EZH2;KLRK1;THY1;RAP1A
gsea,positive regulation of proteolysis (GO:0045862),0.3624570073754719,1.0931452604591232,0.3374485596707819,0.35985005384806557,1.0,9/16,50.05%,AURKAIP1;CTSC;CASP8;BAD;TBC1D10A;CAPN3;GBA;TRIM32;GPLD1
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3295278218393859,-1.088576053818066,0.34688346883468835,0.5491566989776077,1.0,18/18,89.68%,DNM2;NCKAP1L;MAP1S;PLXNB1;TRIO;NYAP1;DBN1;TAOK3;DBNL;MYO16;SLC9A6;CNTNAP1;NBL1;DTNBP1;ATP7A;GAS7;SNX2;SNX1
gsea,regulation of endocytosis (GO:0030100),0.3311889797935029,1.0883134172624171,0.3494539781591264,0.36575966439926977,1.0,12/22,56.43%,SNX17;SNX12;PTPN1;RAB4B;RAB5C;AP2S1;CD22;CBLL1;LRP1;CALY;MTMR2;SNX33
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3467241001490684,-1.0875672514409198,0.35335689045936397,0.5416232685397513,1.0,9/17,27.47%,EP300;CNOT6;WAC;CNOT6L;SOX4;CNOT3;CNOT4;CDKN1B;CRADD
gsea,neuron differentiation (GO:0030182),0.31201515364867666,1.0839897475367613,0.35269709543568467,0.37117907566710484,1.0,14/34,35.87%,ID2;IER2;MAP2K1;NGRN;CTNNB1;MTPN;LDB1;UGDH;CDK5;NR4A2;ITM2C;PPT1;NRBP2;PITX2
gsea,apical junction assembly (GO:0043297),0.3619634540116202,1.0818207877455273,0.3424242424242424,0.3736847777743324,1.0,8/19,39.73%,RHOA;WDR1;PARD6A;CLDN7;PAK2;PARD6G;CLDN23;CRB3
gsea,sensory perception of light stimulus (GO:0050953),0.3423834879596709,1.0813146459535123,0.35877862595419846,0.37381503637185237,1.0,13/26,45.82%,DNAJC19;UNC119;PITPNA;EML2;WFS1;SLC24A1;RDH10;CRYGN;TULP1;BEST1;DRAM2;GNAT2;RD3
gsea,regulation of epithelial cell proliferation (GO:0050678),0.36062189735507905,1.078310703176646,0.3582554517133956,0.3772534671254502,1.0,6/16,25.10%,B2M;BAD;NR4A1;CDKN1C;AQP11;LIMS1
gsea,skeletal system development (GO:0001501),-0.2674567115409023,-1.0737895341731603,0.34527687296416937,0.55929806912389,1.0,32/32,96.84%,AKAP13;ANKRD11;TRIP11;PKD1;DEAF1;TGFBR1;CDH11;HYAL1;EXT1;SOX4;SUFU;COMP;SLC10A7;COL11A2;RAB33B;EXTL1;HYAL3;PAPSS2;FGFR3;SOX5;FGFR1;COL10A1;DDRGK1;BMP1;ATP7A;PKDCC;PAPSS1;GNAS;UFD1;TRAPPC2;EBP;PPIB
gsea,organic acid transport (GO:0015849),0.36794455140084553,1.0736959274953572,0.3920529801324503,0.3830375021502932,1.0,10/19,35.80%,SLC25A11;SLC43A1;SLC10A1;SFXN5;SLC25A47;SLC7A4;SLC51A;SLC46A1;SLC25A29;SLC26A6
gsea,mesenchymal cell differentiation (GO:0048762),-0.3095693411835404,-1.0656662774384789,0.3181818181818182,0.5652877045784132,1.0,19/19,96.15%,DDX17;RBPJ;GSK3B;TGFBR1;NOTCH4;FBXL17;HGF;HIF1A;TGFB1;FOXC1;HMGA2;LOXL3;FGFR1;SNAI1;LEF1;TGFBR3L;LIMS1;CTNNB1;DDX5
gsea,dephosphorylation (GO:0016311),0.26601734294461654,1.0635788531414767,0.3421875,0.3967372732168006,1.0,28/59,44.68%,PPP1CA;PPP1CC;PPP6C;PPP2CA;PPP3CC;PPP2R1A;PTPN1;NT5C;PPP2R2A;PTPN18;PTPN14;PLPPR2;ILKAP;PLPPR3;DUSP28;PHPT1;PTPRU;THTPA;PP2D1;SGPP1;PPM1A;PPM1D;PPM1B;PPEF2;PTPRR;EPHX2;PNKP;MTMR7
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.31047081013723393,1.0599418067614312,0.3786610878661088,0.4011113567426016,1.0,11/23,37.31%,MED10;MED31;CTNNB1;CCNC;MED6;RELA;MED25;MED17;CBFB;LEF1;PPM1D
gsea,glycosaminoglycan catabolic process (GO:0006027),0.3642109033460181,1.0573342138056308,0.3737931034482759,0.40445291547173223,1.0,9/16,50.69%,CHP1;HEXB;GLB1;CSPG5;OMD;STAB2;OGN;TGFB1;HYAL3
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3656175774829651,1.0571801418284152,0.3820375335120643,0.4041177298952613,1.0,8/18,49.52%,GNB1;GNG2;GNAS;ADCY9;PTGER1;LGR4;LGR5;PTGER3
gsea,regulation of insulin receptor signaling pathway (GO:0046626),-0.3350236766827086,-1.0488988244462782,0.3736842105263158,0.5895690905324218,1.0,18/18,90.20%,SORL1;OGT;SLC27A4;PIP4K2A;ZBTB7B;INPP5K;PIP4K2C;RPS6KB1;PRKCD;PRKCQ;GRB14;VWA2;TNS2;ERFE;NCK1;PTPN1;GSK3A;PTPN2
gsea,positive regulation of kinase activity (GO:0033674),0.30915986734745965,1.0474106984029887,0.3892128279883382,0.41767722375576183,1.0,11/28,56.08%,RAP1A;JTB;LAT;PRKAG1;IGF1R;F2;FGFR1;FGFR3;EPHA1;TREM2;ERBB3
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3171120742621806,1.045810331300345,0.3783783783783784,0.4195009984031264,1.0,8/18,52.45%,PDCD10;MAD2L2;STOX1;RAF1;RAPGEF3;IL11;TGFB1;TENM1
gsea,glucose homeostasis (GO:0042593),0.29129509448168905,1.0443946041730923,0.39522998296422485,0.42101243891456724,1.0,10/27,27.07%,ADIPOR1;PTPN2;RPS6;BAD;CYB5R4;WFS1;KCNB1;CRTC2;IGF1R;SELENOT
gsea,regulation of response to external stimulus (GO:0032101),0.2920502424501741,1.0431784063622551,0.40224358974358976,0.42225478276912043,1.0,15/30,41.26%,CALM1;CASP8;APPL1;FNTA;RELA;MYD88;P2RY12;TIRAP;F2;CAMKMT;GUCA1A;CNGA1;NOD2;GRK4;IL1RL2
gsea,plasma membrane organization (GO:0007009),0.3277682735126948,1.0410767575916244,0.3980952380952381,0.42479453924627275,1.0,10/16,52.65%,DEGS1;SLC9A3R1;ANXA6;ARL8B;RAB3A;BIN2;BIN3;PLSCR2;COL5A1;MYOF
gsea,regulation of osteoblast differentiation (GO:0045667),-0.3073311355486952,-1.0408347600607635,0.3850746268656716,0.5961689789290082,1.0,21/21,96.15%,SUCO;SEMA4D;RUNX2;LIMD1;NBR1;BMPR2;SUFU;TRPM4;LRP5;HGF;ACVR2B;BMPR1A;PTK2;ACVR2A;PRKACA;FGF23;CITED1;CTNNBIP1;ATP6AP1;ATRAID;DDX5
gsea,lipid transport (GO:0006869),0.3026498287225383,1.0236452085800578,0.41515650741350907,0.4502609105544822,1.0,9/23,32.92%,GLTP;SCP2;PITPNA;TRIAP1;NPC2;SLC10A1;PEX19;SLC51A;PLEKHA3
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3112679084527144,1.023552202563653,0.41825613079019075,0.4497672447153429,1.0,13/32,59.86%,SLC9A3R1;BECN1;LIME1;HCST;IGF1R;UNC5B;FGFR1;IL18;MAPK1;TREM2;ERBB3;MAPK3;PTK2
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2984568749704777,1.0231043953579657,0.4207650273224044,0.4498546051230629,1.0,9/24,44.93%,CCNH;CCNI;PSMD10;SERTAD1;CNPPD1;CDKN1C;INCA1;HEXIM2;CEBPA
gsea,neurotransmitter transport (GO:0006836),-0.29311037447343846,-1.0209597323262327,0.4169278996865204,0.6266272554184301,1.0,11/20,35.84%,SLC28A2;STXBP2;SLC29A4;DVL1;TSPOAP1;SNPH;NRXN2;DNAJC5;STXBP1;SLC1A1;CASK
gsea,defense response to virus (GO:0051607),-0.3437295916224795,-1.0139701419854767,0.43859649122807015,0.6312019305469235,1.0,15/15,91.88%,NLRC5;PTPRC;SERINC5;RNF135;ZMYND11;IRF3;ZDHHC1;PDE12;IRF2;CNOT7;MYD88;PQBP1;RELA;PYCARD;BNIP3L
gsea,regulation of defense response (GO:0031347),-0.28956625611751363,-1.0106890410137133,0.44243792325056436,0.6282432949275708,1.0,21/21,89.31%,XIAP;BRD4;N4BP1;CYLD;PTPN22;RNF135;SHPK;GGT1;BCL6B;DAGLB;NR1D2;TREM2;MGLL;FOXP1;IL1RL2;NOD2;TIRAP;MYD88;RELA;APPL1;CASP8
gsea,positive regulation of interleukin-1 beta production (GO:0032731),0.35783900246085604,1.010267616166879,0.4520766773162939,0.4687707956747713,1.0,8/15,36.83%,LGALS9;CASP8;PYCARD;MYD88;AIM2;GSDMD;NOD2;TLR6
gsea,stress-activated MAPK cascade (GO:0051403),-0.2809117105897097,-1.006943880859993,0.43724696356275305,0.6260050002825018,1.0,16/29,36.46%,IKBKB;MAPK14;TRAF6;TAB2;CRKL;GPS2;MAP4K2;MAP4K3;IRAK1;IRAK2;DUSP9;FBXW11;MAP2K4;ARHGEF6;MAP3K12;NOD1
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.24447107303768864,1.006107993679099,0.45304777594728174,0.4743851973820652,1.0,19/58,44.68%,CSNK2B;ARF1;LPCAT4;MBOAT7;IMPA1;CEPT1;LPCAT3;ABHD5;CSNK2A1;MTMR9;PEMT;PIK3C2B;LPIN3;PLEKHA3;PTDSS1;AGPAT3;PNPLA3;HDHD5;MTMR7
gsea,gland development (GO:0048732),-0.3121502136502546,-1.0047961287885063,0.4405594405594406,0.6208906523937182,1.0,15/15,93.48%,SOD1;ARID5B;TGFBR1;NOTCH4;SIX1;PKD2;MDK;CDK5RAP3;CEBPG;CEBPA;DKK3;GCM2;HESX1;SLC9A3R1;MSN
gsea,chromatin organization (GO:0006325),0.2700436671636971,0.9953466024906473,0.44197952218430037,0.4900674810730426,1.0,18/33,48.32%,HMGB2;DR1;EZH2;SMARCE1;HDAC3;CHRAC1;FAM50A;SMARCD3;GATAD1;SMARCD2;HDAC8;PADI1;SMARCAD1;SNAI1;HDAC11;PADI4;HMGA2;MPND
gsea,regulation of JNK cascade (GO:0046328),0.2963547441685557,0.9915571661580084,0.47398843930635837,0.4952663859015564,1.0,10/28,33.27%,SDCBP;HMGB1;PYCARD;HDAC3;CD27;TIRAP;ULK4;IGF1R;MAP3K10;NOD2
gsea,negative regulation of developmental process (GO:0051093),0.3391542100808499,0.9893148456780433,0.47002724795640327,0.4981940102806583,1.0,9/15,54.73%,THY1;FOXJ1;NOS3;RAPGEF3;FGFR3;FOXC1;TGFB1;HYAL3;ARPIN
gsea,epithelial to mesenchymal transition (GO:0001837),-0.2843905734064427,-0.9868498213065283,0.4380664652567976,0.6480477461338792,1.0,19/19,96.15%,DDX17;RBPJ;GSK3B;TGFBR1;NOTCH4;HEY1;EOMES;HGF;HIF1A;TGFB1;HMGA2;LOXL3;FGFR1;SNAI1;LEF1;TGFBR3L;LIMS1;CTNNB1;DDX5
gsea,BMP signaling pathway (GO:0030509),0.34019475971768914,0.9832328803641769,0.4754601226993865,0.5062308200643931,1.0,8/15,58.03%,DDX5;BMP8A;SMAD2;LEFTY1;TGFB1;RGMA;ACVR2A;MAPK3
gsea,cellular response to BMP stimulus (GO:0071773),0.34019475971768914,0.9832328803641769,0.4754601226993865,0.5062308200643931,1.0,8/15,58.03%,DDX5;BMP8A;SMAD2;LEFTY1;TGFB1;RGMA;ACVR2A;MAPK3
gsea,RNA export from nucleus (GO:0006405),-0.3030450308509831,-0.9824866500338406,0.4676113360323887,0.6473730945797042,1.0,20/20,97.14%,SMG1;SMG5;POLDIP3;YTHDC1;TPR;ZC3H11A;FIP1L1;NUP50;SRSF5;NUP62CL;WDR33;NXF2;AGFG1;SLU7;SRSF11;CDC40;CHTOP;U2AF1L4;THOC7;SEC13
gsea,regulation of DNA metabolic process (GO:0051052),0.31958929970212185,0.9817794252638713,0.4653284671532847,0.5078546038330496,1.0,9/16,45.53%,SUB1;WDR70;CDK9;STOX1;HDAC8;UBE2V1;SMARCAD1;SIRT7;MPV17
gsea,positive regulation of developmental process (GO:0051094),-0.23158237124334652,-0.9788327207858432,0.516260162601626,0.6449581224658913,1.0,46/46,94.43%,SORL1;NR2C2;ARHGEF7;RALBP1;BMPR2;DVL3;ANAPC2;DNM1L;MUL1;DLG4;MIEF1;SMURF2;DVL1;PPP1R13L;TRPM4;FOXD1;CAMK2B;TAPT1;SYDE1;SRC;RREB1;MDK;PSEN1;INSR;TMEM79;BMPR1A;MIEF2;VHL;ACVR1B;SOX5;DVL2;FGFR1;RAPGEF3;TLE6;CPEB3;BMP1;RPS6KA1;MST1;SHLD3;PHLDB1;HMCES;RTN4;FIS1;MAD2L2;MFF;CORO1B
gsea,regulation of innate immune response (GO:0045088),0.2912465384288082,0.9730801415392348,0.5,0.5210458055603445,1.0,9/16,54.34%,CASP8;NMI;PTPN1;APPL1;TIRAP;IFI35;POLR3C;TREM2;CDC37
gsea,regulation of telomere maintenance via telomerase (GO:0032210),-0.31621219855547683,-0.9711508548617991,0.4740740740740741,0.6514806677229318,1.0,17/17,87.95%,TNKS2;SMG5;HMBOX1;TNKS;STN1;SRC;MAP2K7;MAPK3;TERF1;MAPK1;PRKCQ;PNKP;ACD;TEN1;FBXO4;DCP2;CTNNB1
gsea,mRNA transport (GO:0051028),-0.30918332696878165,-0.9694786215621287,0.47609942638623326,0.6368363883520495,1.0,19/19,97.14%,SMG1;SMG5;POLDIP3;YTHDC1;TPR;ZC3H11A;FIP1L1;NUP50;SRSF5;WDR33;NXF2;AGFG1;SLU7;SRSF11;CDC40;CHTOP;U2AF1L4;THOC7;SEC13
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.30918332696878165,-0.9694786215621287,0.47609942638623326,0.6368363883520495,1.0,19/19,97.14%,SMG1;SMG5;POLDIP3;YTHDC1;TPR;ZC3H11A;FIP1L1;NUP50;SRSF5;WDR33;NXF2;AGFG1;SLU7;SRSF11;CDC40;CHTOP;U2AF1L4;THOC7;SEC13
gsea,cell-cell junction organization (GO:0045216),-0.27683561124420664,-0.9693161504973963,0.5486725663716814,0.6285627299145011,1.0,20/20,91.44%,TLN1;CDH11;PARD6B;TLN2;CDH24;OCLN;GJC1;TJP3;CXADR;ARVCF;TGFB1;FLCN;CDH15;LIMS2;NECTIN1;NECTIN3;ANG;LIMS1;PARD6A;CSK
gsea,cellular response to nutrient levels (GO:0031669),0.2995868419033819,0.9673788348039115,0.49619771863117873,0.5296395785126933,1.0,6/20,26.40%,MAP1LC3B;RRAGA;STK26;MAP1LC3A;KCNB1;RRAGC
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),0.3168806894417812,0.9594485213263706,0.5491329479768786,0.5415003988083981,1.0,7/18,26.61%,ADIPOR1;UCP2;HDAC3;GNAS;PRKAB1;PEMT;IGF1R
gsea,nervous system development (GO:0007399),0.22117181267324587,0.9519396203534547,0.5657418576598311,0.5528367488769063,1.0,47/100,56.80%,ITM2B;GSTP1;COX7B;NDUFV2;UNC119;ATXN10;EIF2B2;NDUFS2;TPP1;BTBD1;PTS;RAB29;LDB1;DPF2;ZC4H2;OBSL1;CDK5;NINJ2;MTF1;POU3F1;NHEJ1;CSPG5;TAGLN3;NBL1;PPT1;TMOD2;GJB1;GFRA1;ALDH5A1;SH3GL1;FZD9;DPF1;NRTN;WDPCP;SMO;APC2;RAPGEFL1;BTBD2;TGFB1;ZIC5;JAG1;TENM1;FAT4;SERPINI1;UNC119B;ERBB3;ACVR1B
gsea,regulation of cellular localization (GO:0060341),-0.2865094501621548,-0.9511873745256798,0.5283018867924528,0.6543843657205993,1.0,16/16,92.18%,KDM1A;STXBP2;DVL3;PARD6B;ADCY5;DVL1;UNC13D;LRP5;FER;STXBP4;NR1D1;BRSK2;PARD6G;GOSR1;PARD6A;REEP5
gsea,positive regulation of multicellular organismal process (GO:0051240),0.23197110369214616,0.9480290690445263,0.5514993481095176,0.5585722841244857,1.0,37/76,51.05%,PPIB;SDCBP;ADIPOR1;UCP2;EZH2;MAD2L2;CTNNB1;HDAC3;CD28;BAD;S100A13;RTN4;GNAS;IL15;PRKAB1;HMCES;SHLD3;MST1;PEMT;BMP1;IGF1R;FOXJ1;SNX4;BATF;SMAD2;LEF1;SNAI1;TLE6;LURAP1;SOX5;AVPR2;SMO;LRP1;IL18;FOXC1;TGFB1;TRIM16
gsea,negative regulation of defense response (GO:0031348),-0.2854876793526103,-0.9459280432942757,0.536723163841808,0.655667885141692,1.0,20/20,93.10%,ILRUN;RNF26;ITCH;TYRO3;GPS2;MUL1;PPARD;MAPKBP1;PCBP2;NR1D1;PRKCD;GBA;PPM1B;OTULIN;SHARPIN;FNDC4;LPCAT3;NMI;PTPN2;SIRT2
gsea,inorganic cation import across plasma membrane (GO:0098659),0.3201525216586214,0.9374315936451507,0.5387994143484627,0.5748666030238316,1.0,7/15,51.38%,ATP1B3;SLC24A1;ATP1B2;SLC39A8;ATP4A;KCNJ13;SLC5A2
gsea,regulation of cilium assembly (GO:1902017),-0.25910219898048975,-0.9363259738954431,0.5661914460285132,0.6655168841930806,1.0,26/26,92.37%,TBC1D2B;TBC1D22A;CYLD;TESK1;TBC1D9B;TBC1D24;MARK4;CDK10;LIMK2;TBC1D20;TBC1D2;TAPT1;CDKL5;TBC1D10C;TBC1D16;CROCC;RABEP2;ENTR1;TBC1D15;TBC1D17;TBC1D19;DYNC2LI1;TBC1D10A;ATG3;ATG5;IFT20
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.34886942906049623,0.9335954310441916,0.582089552238806,0.5803162527209986,1.0,8/18,56.08%,BECN1;HCST;IGF1R;UNC5B;FGFR1;IL18;TREM2;ERBB3
gsea,response to lipid (GO:0033993),-0.2318710924189142,-0.9235158137495065,0.5501519756838906,0.6812082675973291,1.0,37/37,95.90%,STAT3;IFNAR1;TAB2;FOXO1;STRN3;CD6;PTPN22;IRAK1;PPARD;GGT5;GGT7;FER;OVCA2;GGT1;SRR;OTUD5;TNFRSF11A;GPX3;ESR1;PELI1;RXRB;IL12A;TRIM16;TMEM161A;TGFB1;PAQR8;FOXP1;PALM3;NOS3;CITED1;TIRAP;ACER2;LY96;VPS4B;CTNNB1;HMGB2;LGALS9
gsea,regulation of neuron apoptotic process (GO:0043523),-0.2258846028460208,-0.922151769477985,0.6345177664974619,0.6752845937802392,1.0,31/31,87.95%,SOD1;TYRO3;CPEB4;EGLN2;POU4F1;BACE1;SIX1;SRPK2;FGF20;NSMF;CDK5R1;NTRK1;TFAP2A;MDK;AGAP2;CNTF;ERBB3;TREM2;MAG;CRLF1;FZD9;CITED1;NRBP2;PPT1;UNC5B;CDK5;KCNB1;WFS1;TRIM2;SNX6;CTNNB1
gsea,sterol metabolic process (GO:0016125),0.3222868604706443,0.9218980321775557,0.591869918699187,0.5987338191026609,1.0,6/16,46.69%,EBP;LIPA;INSIG2;SOAT2;GBA;PIP4P1
gsea,positive regulation of metabolic process (GO:0009893),0.303008140524194,0.9196122444756101,0.5742049469964664,0.6015898801963605,1.0,7/20,26.61%,ADIPOR1;UCP2;HDAC3;GNAS;PRKAB1;PEMT;IGF1R
gsea,negative regulation of cell motility (GO:2000146),0.271068829955669,0.9192296637985717,0.5536277602523659,0.6013974366617452,1.0,15/24,56.21%,THY1;WAS;STK26;SPINT2;TACSTD2;PTPRU;PIP5KL1;MAGI2;RNF41;EPHA1;FLCN;JAG1;RECK;ARPIN;ADARB1
gsea,regulation of neuron death (GO:1901214),0.28058162652092244,0.9174539351196933,0.5882352941176471,0.6035275315494435,1.0,11/22,48.59%,CHP1;ITGB2;SNCB;TRIM2;RAB29;NENF;CDK5;SARM1;CHMP4B;GBA;EGR1
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.30729916470091495,0.9172385683012858,0.5806451612903226,0.603085097593345,1.0,8/21,45.58%,LCK;IL15;ZAP70;PKDCC;IGF1R;FGFR1;FGFR3;EPHA1
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3040754458674497,-0.9163009349094863,0.563963963963964,0.6774506681168427,1.0,8/15,27.47%,EP300;CNOT6;CNOT6L;SOX4;CNOT3;CNOT4;CDKN1B;CRADD
gsea,DNA replication (GO:0006260),0.29227380309741446,0.9140338041412511,0.5918803418803419,0.60762131623268,1.0,7/16,44.02%,ORC4;POLD4;TREX1;NT5M;RMI1;POLB;PNKP
gsea,sensory perception of mechanical stimulus (GO:0050954),0.31241241884260507,0.9133584668380129,0.6046814044213265,0.6079590455453749,1.0,11/19,49.33%,NDUFB9;WDR1;EML2;OTOS;WFS1;TSPEAR;CACNA1D;LHFPL3;SPTBN4;MYH14;EYA1
gsea,epithelium development (GO:0060429),0.3118411408425486,0.9108570116565502,0.5813648293963255,0.6112229268165125,1.0,12/21,52.14%,CTSB;SLC9A3R1;TPP1;CASP6;FOXJ1;RIPK4;ACADVL;TAGLN;LOXL3;SMO;TGFB1;NDRG4
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.30056292873244617,-0.9085270608333342,0.5595238095238095,0.6832476527352572,1.0,16/16,96.15%,EP300;PKN1;KDM1A;KDM4C;RNF6;RNF14;TRIM68;ESR1;UBA5;GPAM;KCTD6;DDRGK1;CBFB;DNAAF4;UFM1;DDX5
gsea,regulation of TORC1 signaling (GO:1903432),0.29098267757513174,0.9034889271790377,0.5818540433925049,0.6224334387983679,1.0,6/16,48.02%,LAMTOR5;RRAGA;RRAGC;GPR137;PIP4P1;FLCN
gsea,negative regulation of response to external stimulus (GO:0032102),0.2500986633363492,0.902303602377539,0.5962264150943396,0.623463606970048,1.0,13/27,54.93%,SIRT2;CERS2;PTPN2;NMI;LPCAT3;RTN4RL1;FNDC4;SHARPIN;OTULIN;PPM1B;GBA;PRKCD;NR1D1
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.27996310784215045,-0.9005343193534098,0.5724137931034483,0.6896305461656231,1.0,19/19,87.13%,RNF31;IKBKB;TRAF6;TAB2;NFKBIL1;IRAK2;TICAM1;TBK1;NKIRAS1;RBCK1;AZI2;SHARPIN;UBA52;TRADD;LY96;FAIM;RELA;UBC;BCL10
gsea,transport across blood-brain barrier (GO:0150104),-0.2626921040180762,-0.8941828850759339,0.6130434782608696,0.6846284417019346,1.0,16/16,92.71%,SLC27A4;SLC28A2;SLC29A4;AGER;SLC24A3;SLC22A5;SLC1A1;SLC29A2;INSR;SLC4A3;SLC5A6;ABCC3;LRP1;SLC2A10;ATP1B2;SLC9A3R1
gsea,vascular transport (GO:0010232),-0.2626921040180762,-0.8941828850759339,0.6130434782608696,0.6846284417019346,1.0,16/16,92.71%,SLC27A4;SLC28A2;SLC29A4;AGER;SLC24A3;SLC22A5;SLC1A1;SLC29A2;INSR;SLC4A3;SLC5A6;ABCC3;LRP1;SLC2A10;ATP1B2;SLC9A3R1
gsea,chromatin remodeling (GO:0006338),-0.2453248929780826,-0.8911908615340715,0.5935613682092555,0.6819063722443608,1.0,26/26,93.68%,KDM6A;KDM5A;ZBTB7A;RSF1;MYSM1;KDM4C;SMARCD1;ACTR8;INO80B;EZH1;SATB1;ESR1;ACTR5;TOP1;MYB;MPND;HMGA2;PADI4;SMARCAD1;SMARCD2;GATAD1;SMARCD3;CHRAC1;SMARCE1;DR1;MBD2
gsea,ERBB signaling pathway (GO:0038127),-0.285043164050778,-0.8886910389952738,0.6095505617977528,0.6784692210964488,1.0,15/15,86.38%,IQGAP1;BRAF;NRG4;EGF;SRC;PTK2;ERBB3;CDC37;MAPK1;TGFB1;AAMP;PTPRR;NRG2;PTPN18;GRB2
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.26803737411537504,-0.887981471155177,0.62,0.6718934322977314,1.0,21/21,86.00%,EP300;CNOT6;FOXM1;CNOT6L;SOX4;CNOT3;CNOT4;ING4;CDKN1B;CRADD;KAT5;CASP2;RPL26;CNOT2;BATF;CNOT7;ACER2;CNOT11;TRIAP1;SP100;CNOT8
gsea,axon development (GO:0061564),0.28569397923508033,0.8860939688054894,0.6295264623955432,0.6488790398771164,1.0,10/23,46.24%,SVBP;RAB8A;RAB10;RTN4;RTN4RL1;CDK5;RAB3A;BRSK2;SPTBN4;MAP1B
gsea,peptidyl-tyrosine modification (GO:0018212),0.3147781303260497,0.8801581178722855,0.6466380543633763,0.6573528293131077,1.0,6/16,45.58%,LCK;ZAP70;PKDCC;FGFR1;FGFR3;EPHA1
gsea,sensory perception of sound (GO:0007605),0.29978644123650133,0.8773802494575933,0.6553459119496855,0.6609953744255143,1.0,11/20,49.33%,NDUFB9;WDR1;EML2;OTOS;WFS1;TSPEAR;CACNA1D;LHFPL3;SPTBN4;MYH14;EYA1
gsea,canonical Wnt signaling pathway (GO:0060070),0.264579873310376,0.8764722556682919,0.6182707993474714,0.6615089748592756,1.0,8/23,40.80%,PPP1CA;CTNNB1;NR4A2;TCF7;FRAT1;LEF1;FZD9;DVL2
gsea,ion transport (GO:0006811),0.2805810467582159,0.8681442526181838,0.6680613668061367,0.6739296601546414,1.0,10/25,59.66%,TSPO;SLC24A1;AQP11;SLC17A7;SLC26A6;MCOLN1;PANX1;SLC20A2;SLC9A6;SLC8B1
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.24819803029152465,-0.8592733909842436,0.6729411764705883,0.7126467832457578,1.0,19/19,96.05%,PTPRC;SEMA4D;DGKQ;CADM4;HGF;SRC;HCLS1;TNFRSF14;FYN;PRKCD;TREM2;TGFB1;IL11;PAK2;SAMSN1;CNOT7;IL15;ITGB2;PDCL3
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2508526658858065,0.8540652478160685,0.7064606741573034,0.6955585782806061,1.0,17/37,39.86%,FKBP1A;SDCBP;FAM89B;SNX6;UBC;LTBP4;CDKN1C;EMILIN1;DAND5;UBA52;SNW1;TGFBR3L;PPM1A;CITED1;WFIKKN1;SMAD2;SLC2A10
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.2455947259519685,0.8523606974641713,0.6832298136645962,0.6972176309826102,1.0,13/30,51.26%,CAPZB;RNH1;CTNNB1;SP100;PHLDB1;CDK5;PAK2;SARM1;HTATIP2;LFNG;BRSK2;TGFB1;FITM2
gsea,axonogenesis (GO:0007409),0.2300514630543679,0.8473832832259476,0.7130852340936374,0.704324172620026,1.0,29/56,55.56%,VASP;RAB8A;RAB10;NPTN;GRB2;EFNB1;CDK5;DOK1;UNC5B;EFNA4;SPTB;GFRA1;RAB3A;EFNA2;NRTN;NTN3;BRSK2;GAB2;SEMA6C;SPTBN4;EPHA1;MAP1B;PRKCQ;LYPLA2;MAPK1;SEMA3E;SPTBN2;FYN;KIF5A
gsea,potassium ion transport (GO:0006813),0.2620764926249893,0.8306000708070378,0.7149643705463183,0.7294667362982529,1.0,12/28,51.28%,ATP1B3;CHP1;KCNB1;SLC24A1;KCNA3;KCNK12;KCNG3;TMEM175;KCNIP2;KCNA7;KCNH1;KCNJ13
gsea,aminoglycan biosynthetic process (GO:0006023),-0.23254678876632204,-0.8093344194394623,0.7536656891495601,0.7847637819102753,1.0,18/18,78.82%,NDST1;B3GALT2;NDST2;EXT1;GPC2;B3GNT9;AGRN;HS3ST6;XYLT2;HS3ST3B1;B3GNT8;B3GNT4;B3GALT1;EXT2;B4GALT7;B3GNT2;B3GAT3;UGDH
gsea,B cell activation (GO:0042113),0.2768800530727211,0.8072651473835475,0.7322314049586777,0.7636188885041139,1.0,9/15,46.04%,PTPN2;CASP8;ZAP70;DNAJB9;TCF3;NHEJ1;CD22;FCRL1;IL11
gsea,lymphocyte differentiation (GO:0030098),0.24950722715261284,0.8057413497282934,0.7058823529411765,0.7648143340731615,1.0,8/18,34.32%,LCK;PTPN2;ZAP70;DNAJB9;TCF3;NHEJ1;LFNG;RHOH
gsea,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.25883997595179475,-0.7788374866445156,0.7680608365019012,0.8216128605298898,1.0,15/15,89.31%,ITCH;TRAF6;TAB2;CYLD;IRAK1;IRAK2;NOD1;AAMP;NOD2;UBE2V1;OTULIN;UBA52;RELA;UBC;CASP8
gsea,glycoprotein metabolic process (GO:0009100),-0.22981745666529665,-0.7668848140688649,0.7840909090909091,0.8294712434861596,1.0,18/18,93.39%,MAN2A2;MAN1A2;ENGASE;MANBA;GAL3ST4;NEU4;FBXO17;HIF1A;FBXO2;ST3GAL2;FBXO27;GOLPH3;B4GALT7;LARGE1;MAN2B1;NGLY1;FBXO6;ERP44
gsea,sodium ion transmembrane transport (GO:0035725),0.2619119007991104,0.7608941293801339,0.7972602739726027,0.8259675177077292,1.0,9/17,53.64%,ATP1B3;SLC24A1;ATP1B2;SCN3B;ATP4A;SLC6A8;SLC6A19;SLC5A2;ASIC1
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.25323788325041907,0.7581906417276145,0.8193103448275862,0.8284793138214847,1.0,8/20,46.24%,RAB8A;RAB10;TMEM106B;CDK5;RAB3A;BRSK2;SPTBN4;MAP1B
gsea,glycosaminoglycan metabolic process (GO:0030203),0.25086214496174414,0.7548200079081312,0.7790322580645161,0.8316182823058806,1.0,6/18,45.10%,GLB1;B3GAT2;UGDH;B3GAT3;B4GALT7;EXT2
gsea,glycosaminoglycan biosynthetic process (GO:0006024),0.2184896422664992,0.7325542242571983,0.8601997146932953,0.8573722933731581,1.0,15/28,55.39%,CHST12;B4GALT3;UGDH;B3GAT3;B3GNT2;CSPG5;HAS3;OMD;CHST14;B4GALT7;EXT2;OGN;B3GNT4;B4GALT2;B4GALT1
gsea,protein catabolic process (GO:0030163),0.21253571637113866,0.7107880817877462,0.8427350427350427,0.8803151356632155,1.0,12/22,57.34%,UBE2G1;TPP1;FBXO6;NGLY1;SIAH2;PPT1;CAPN3;UBE2G2;RNF41;NR1D1;LAMP2;FBXO27
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.22615481050960118,0.6871642424340629,0.9087759815242494,0.902714807376751,1.0,17/33,49.83%,GNAI2;GNAI3;GNAS;PSAP;P2RY12;GNA12;ADCY9;PTGER1;CACNA1D;GALR2;AVPR2;LGR4;GNAT2;LGR5;GNAZ;PTGER3;INSL3
gsea,potassium ion transmembrane transport (GO:0071805),0.20911725214011062,0.669961344840973,0.9137343927355278,0.9167055863702208,1.0,13/31,51.28%,ATP1B3;KCNB1;SLC24A1;ATP1B2;KCNA3;KCNK12;KCNG3;TMEM175;KCNIP2;KCNA7;KCNH1;ATP4A;KCNJ13
gsea,fatty acid metabolic process (GO:0006631),-0.17329561478238317,-0.6413902462772361,0.9427792915531336,0.9508820403347115,1.0,26/26,92.51%,SLC27A4;FAAH;ADIPOR2;ACBD5;ACOT11;PPARD;GGT5;GGT1;ACOT6;ACSBG1;AASDH;CPT1B;PER2;PLA2G15;CROT;ACSF3;GPAM;GPX4;CPT1C;PNPLA3;ACOT8;ACOT7;LPIN3;ACOT2;PON2;ADIPOR1
gsea,positive regulation of cell death (GO:0010942),-0.19595761241217216,-0.5910983664948121,0.9625,0.9707607409932034,1.0,15/15,85.75%,APC;GSK3B;MARK4;MAPT;CDKN1B;NTRK1;FYN;EGR1;LRP1;TRIM13;HTATIP2;SARM1;ACER2;PRODH;ITGB2
gsea,chemical homeostasis (GO:0048878),0.18712530789211484,0.5788322345355137,0.9655172413793104,0.9712554883605335,1.0,11/18,57.94%,PNPLA2;ABHD5;RBP1;AQP11;SLC4A11;PNPLA3;CEBPA;FITM2;SLC4A3;TREM2;NR1D2
gsea,phospholipid dephosphorylation (GO:0046839),-0.1730223613708932,-0.5637791454299542,0.9672131147540983,0.9720685726123887,1.0,17/17,86.21%,PTEN;MTMR11;OCRL;MTMR6;MTM1;INPP5K;MTMR10;MTMR2;PLPP6;PIP4P1;MTMR7;EPHX2;SGPP1;PLPPR3;PLPPR2;MTMR9;PIP4P2
